false
0001509957
0001509957
2023-10-27
2023-10-27
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): October 27, 2023
CAN
B CORP.
(Exact
name of registrant as specified in its charter)
Florida |
|
000-55753 |
|
20-3624118 |
(State
or other jurisdiction
of
incorporation) |
|
(Commission
File
Number) |
|
(IRS
Employer
Identification
No.) |
960
South Broadway, Suite 120 |
|
|
Hicksville,
NY 11801 |
|
11801 |
(Address
of principal executive offices) |
|
(Zip
Code) |
(516)
595-9544
Registrant’s
telephone number, including area code
Not
Applicable
Former
name or former address, if changed since last report
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
None
|
|
N/A |
|
N/A
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
ITEM
1.01. ENTRY INTO A DEFINITIVE MATERIAL AGREEMENT.
Issuance
of OID Note
On
October 27, 2023, Can B Corp., a Florida corporation (the “Company”), completed the sale of a promissory note (the “Initial
Note”) in the principal amount of $156,250 to Walleye Opportunities Fund, Ltd. (the “Investor”) pursuant to
a Securities Purchase Agreement between the Company and the Investor (the “Stock Purchase Agreement”). The purchase price
of the Note was $125,000, representing a 20% original issue discount. The Initial Note is non-interest bearing, except in the case of
the event of a default, in which case interest will accrue from the date of the default at a rate equal to the lower of 18% per annum
or the maximum rate permitted by law. The Initial Note becomes due on October 27, 2024.
The
Investor may elect to convert the principal amount of the Initial Note and default interest, if any, subject to adjustment at a price
equal to 90% of the lowest daily volume weighted average price of the common stock during the fifteen trading days preceding the conversion
date.
The
Investor and/or investors introduced by the Investor may purchase up to an additional $1,693,750 aggregate principal amount of notes
having terms substantially similar to the Initial Note (the “New Notes” and collectively with the Initial Note, the “Notes”).
In addition to the principal and interest payment obligations under the Notes, the Company has agreed to pay and/or cause its newly formed
70% owned subsidiary, Nascent Pharma, LLC (“Nascent”,) to pay the Investor fifteen percent (15%) of all amounts that would
otherwise be distributable to the Company by Nascent until the Investor receives distributions in the aggregate amount that equal the
sum of (a) 200% of the purchase price of notes previously issued by the Company to the Investor plus (b) 200% of the principal amount
of certain notes previously issued by the Company and acquired by the Investor from a third party plus (c) 100% of the purchase price
of Notes purchased pursuant to the Stock Purchase Agreement; provided, however, if the Investor and/or other investors purchase $1,875,000
aggregate principal amount of Notes pursuant to the Stock Purchase Agreement, the obligation to pay 100% of the purchase price of the
Notes shall be increased to 200% of the purchase price of such Notes. The amounts distributable by Nascent to the Company, if any, will
represent the proceeds of Nascent’s enforcement of certain patents it is seeking to acquire. Nascent has not yet acquired such
patents and no assurance can be given that it will be able to complete such acquisition. Under the terms of the Stock Purchase Agreement,
the purchase of New Notes by the Investor and/or investors introduced by the Investor is subject to, among other things, Nascent’s
acquisition of the patents. If Nascent does not complete the acquisition of the patents, the Company does not expect that any New Notes
will be purchased and the Company will have no obligation to pay additional consideration to the Investor.
In
the event of a default under a Note, the Company shall be required to pay the holder of the Note an amount equal to the amount determined
by multiplying the principal amount of the Note then outstanding plus default interest by 135%, plus costs of collection. The Investor
may elect to accept payment of any such amount in cash and/or shares of the Company’s common stock, valued for this purpose at
the lower of the conversion price then in effect or a 60% discount to the lowest volume weighted average price of the common stock during
the five trading days preceding the conversion date.
The
Investor has been granted a right of first refusal to participate in future financing transactions conducted by the Company.
The
Company has entered into a Registration Rights Agreement with the Investor pursuant to which the Company has agreed to file a registration
statement with the Securities and Exchange Commission by December 11, 2023 to register for public resale the shares of common stock issuable
upon the conversion of the Note and a consolidated note issued to the Investor in the principal amount of $1,354,210 (the “Consolidated
Note”) which combined certain notes held by the Investor into a single note. If the Company fails to file the registration
statement by December 11, 2023 or have the registration statement declared effective by the deadlines set forth in the Registration Rights
Agreement, the Company will be required to make a payment of 2% of the amount then owed under the Note and the Consolidated Note
for each 30 day period after the applicable deadline that the Company does not file the registration statement or the registration statement
is not declared effective. The Investor has also been granted piggyback registration rights with respect to the shares of common
stock issuable upon the conversion of the Notes it acquires and the Consolidated Note. Each of the Initial Note
and Consolidated Note grants full ratchet anti-dilution protection to the Investor in the event that the Company issues common
stock or rights to purchase common stock at a price less than the conversion or exercise price then in effect.
The
Initial Note contains and the New Notes will contain a provision which provides that the holder will not be converted if the conversion
would result in the holder becoming the beneficial owner of more than 9.99% of the Company’s outstanding common stock.
ITEM
2.03. CREATION OFA DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OFA REGISTRANT.
See
Item 1.01 regarding the Note issued to the Investor and the obligations of the Company relating thereto.
ITEM
3.02. UNREGISTERED SALES OF EQUITY SECURITIES.
See
Item 1.01 for discussion of the Note issued to the Investor. The foregoing securities were issued in reliance upon the exemption from
securities registration afforded by Section 4(a)(2) of the Securities Act of 1933 (the “Securities Act”), as amended, and
Regulation D as promulgated under the Securities Act.
ITEM
9.01. FINANCIAL STATEMENT AND EXHIBITS.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Date:
November 3, 2023
|
Can
B Corp. |
|
|
|
|
By: |
/s/
Marco Alfonsi |
|
Name: |
Marco
Alfonsi |
|
Title: |
CEO |
Exhibit
9.1
SECURITIES
PURCHASE AGREEMENT
This
SECURITIES PURCHASE AGREEMENT (as amended, amended and restated, supplemented or otherwise modified from time to time in accordance
with its terms, this “Agreement”), dated as of October 26, 2023, by and between CAN B̅ CORP., a Florida
corporation, with headquarters located at 960 South Broadway, Suite 120, Hicksville, NY 11801 (the “Company”), and
the buyer identified on the signature page hereto (the “Buyer”).
WHEREAS:
A.
The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded
by Section 4(a)(2) of the Securities Act of 1933, as amended (the “1933 Act”) and Rule 506(b) promulgated by the United
States Securities and Exchange Commission (the “SEC”) under the 1933 Act;
B.
The Buyer holds each of the following promissory notes of the Company: (i) that certain Promissory Note, dated August 30, 2022, in the
original principal amount of $385,000 (the “$385,000 Walleye Note”), (ii) that certain 20% Original Issue Discount
Promissory Note, dated May 16, 2023, in the original principal amount of $437,500 (the “$437,500 Walleye Note”), (iii)
that certain $100,000 Unsecured Promissory Note of the Borrower dated as of August 5, 2022, by and between the Company as borrower and
Emergent Health Corp., a Wyoming corporation (“Emergent”) as lender (the “$100,000 Walleye Note”),
which $100,000 Walleye Note was purchased by the Buyer from Emergent pursuant to that certain Note Purchase Agreement, dated August 3,
2023, by and between Emergent as seller and the Buyer as purchaser (the “Emergent NPA”), (iv) that certain $250,000
Unsecured Promissory Note of the Company, dated August 18, 2022, by and between the Company as borrower and Emergent as lender (the “$250,000
Walleye Note” and together with the $100,000 Walleye Note, collectively, the “Emergent Notes”), which $250,000
Walleye Note was purchased by the Buyer from Emergent pursuant to the Emergent NPA, and (v) that certain Promissory Note, dated February
27, 2023, in the original principal amount of $1,823,529 (the “February 2023 Walleye Secured Note”, together with
the $385,000 Walleye Note, the $437,500 Walleye Note, the $100,000 Walleye Note and the $250,000 Walleye Note, collectively, the “Existing
Notes”);
C.
The Company is currently in need of additional funds to help finance its operations;
D.
Subject to the terms and conditions set forth in this Agreement, the Buyer is willing to advance, or to cause to be advanced, up to $1,500,000
in additional funds, in one or more advances, to the Company, in exchange for (i) the issuance to the Buyer, of one or more 20% original
issue discount promissory notes of the Company in substantially the form attached as Exhibit A hereto, in the aggregate original
principal amount of up to $1,875,000 (reflecting 20% original issuance discount) (the “Maximum Offered Amount”), which
shall be convertible into shares of common stock, nil par value per share, of the Company (the “Common Stock”) upon
the terms and subject to the limitations and conditions set forth therein (such promissory notes substantially in the form of Exhibit
A hereto issued by the Company hereunder, collectively, the “Notes”, and each, individually, a “Note”),
and (ii) certain other consideration, including without limitation, the agreement of Nascent Pharma, LLC, a Nevada limited liability
company in which the Company holds a 67% equity interest (“Nascent”) to pay the Buyer a certain portion of the distributions
and proceeds that the Company would otherwise be entitled to receive from Nascent pursuant to the Nascent Operating Agreement and/or
the Proposed UCANN Distribution Agreement (as defined below), with the aggregate potential amount of such distributions and proceeds
to be paid by Nascent to the Buyer depending on, among other things, (1) the aggregate purchase price of the Existing Notes other than
the Emergent Notes, (2) the aggregate principal amount of the Emergent Notes, and (3) the aggregate purchase price of Notes purchased
by the Buyer hereunder, to be documented pursuant to a certain proposed Distribution and Assignment Agreement (as defined below) to be
entered by and among the Company, Nascent and the Buyer, as described in further detail below.
NOW
THEREFORE, in consideration of the foregoing and of the agreements and covenants herein contained, and for other good and valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, the Company and the Buyer hereby agree as follows:
1.
Definitions. As used in this Agreement, each of the following terms has the meaning given to such term in this Section 1
or in the sections and subsections of this Agreement referred to below.
“Additional
Consideration Amount” has the meaning set forth in Section 2(b).
“Business
Day” shall mean any day other than a Saturday, Sunday, or a day on which commercial banks in the city of New York, New York
are authorized or required by law or executive order to remain closed; provided, for the avoidance of doubt, that no such commercial
banks shall be considered to be authorized or required by law or executive order to remain closed as a result of “stay at home”,
“shelter-in-place”, “non-essential employee” or other similar orders or restrictions or the closure of any physical
branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire
transfers) of such commercial banks are generally open for sue by customers on such day.
“Conversion
Shares” means the shares of Common Stock issuable upon conversion of or otherwise pursuant to (i) any and all Notes issued
by the Company pursuant to this Agreement and (ii) the Consolidated Amended and Restated Walleye Note.
“Consolidated
Amended and Restated Walleye Note” has the meaning set forth in Section 8.
“Distribution
and Assignment Agreement” has the meaning set forth in Section 2(b).
“Patent”
means, (i) United States Patent No. US 9,730,911 B2 (Cannabis Extracts and Methods of Preparing and Using Same) and (ii) United States
Patent No. US 10,555,928 B2 (Cannabis Extracts and Methods and Preparing and Using Same), or any of them (collectively, the “Patents”).
“Proposed
UCANN Distribution Agreement” means a proposed Agreement for Distribution of Cash Distributions contemplated to be entered
into between and among Earnest Blackmon, an individual, John Walsh, an individual, United Cannabis Corporation, a Colorado Corporation,
UC Colorado Corporation, a Colorado corporation, DCS Enterprises of Green Bay, Inc., a Wisconsin corporation (“DCS”),
the Company, Nascent and The Receivers, Inc., a Colorado Corporation, in its capacity as the court-appointed receiver in Case No. 2020CV30483,
in Jefferson County District Court, State of Colorado pursuant to which, (1) the Company would among other things, cause Nascent to make
distributions to the “Creditors” (as to be defined in the Proposed UCANN Distribution Agreement) on the “Creditor List”
(as to be defined in the Proposed UCANN Distribution Agreement), of 5% of the Company’s share of the “Cash Available for
Distribution” (as to be defined in the Proposed UCANN Distribution Agreement) until such Creditors have been paid an aggregate
of $10,000,000.00 for their claims as set forth on the Creditor List (such distributions, “Proposed UCANN Pool Distributions”),
and (2) Nascent would agree, among other things, to make such Proposed UCANN Pool Distributions simultaneously with distributions of
“Cash Available for Distributions” (as to be defined in the Proposed UCANN Distribution Agreement) to DCS and the Company.
“Senior
Distribution and Contingent Payment Agreements” has the meaning set forth in Section 8.
“Securities”
means the Conversion Shares, the Notes issued by the Company pursuant to this Agreement, and the Consolidated Amended and Restated Walleye
Note.
“Transaction
Documents” means, collectively, this Agreement, the Notes, the Consolidated Amended and Restated Walleye Note, the Distribution
and Assignment Agreement, the RRAs, all exhibits and schedules hereto and thereto, and any other documents or agreements executed in
connection with the transactions contemplated hereunder (each, individually, a “Transaction Document”).
“Uplist
Offering” means an offering of Common Stock (or units consisting of Common Stock and warrants to purchase Common Stock) that
will result in the immediate listing for trading of the Common Stock on the NYSE American, the Nasdaq Capital Market, the Nasdaq Global
Market, the Nasdaq Global Select Market, the New York Stock Exchange, or any other national securities exchange (or any successors to
any of the foregoing).
2.
Purchase and Sale of Notes; Additional Consideration Amount.
(a)
Purchase of Notes. Upon the terms and subject to the conditions set forth herein, (i) on the initial Closing Date (as defined
below), the Company agrees to sell to the Buyer, and the Buyer agrees to purchase from the Company, a Note in the original principal
amount of $156,250 (the “Initial Note”), and (ii) one or more subsequent Closing Dates, the Company agrees to sell
to the Buyer, and the Buyer agrees to purchase from the Company, one or more additional Notes in the aggregate original principal amount
of $1,718,750; provided, notwithstanding anything to the contrary set forth herein, (1) there shall be no additional Closings
under this Agreement after February 15, 2024 (the “New Money Multiple Deadline”), and (2) at any time on or prior
to the New Money Multiple Deadline, the Buyer may elect to introduce an additional party to act as the replacement for the Buyer in the
purchase of such additional Notes other than the Initial Note (any such party, a “New Buyer”), in which case this
Agreement shall be amended or amended and restated as needed and for the sole purpose of appropriately accounting for such New Buyer.
(b)
Additional Consideration Amount; Distribution and Assignment Agreement. As additional consideration for the Buyer’s purchase
of the Initial Note, simultaneously with the issuance of the Initial Note to the Buyer at the initial Closing, the Company and Nascent
shall enter into a Distribution and Assignment Agreement with the Buyer substantially in the form attached as Exhibit B hereto
(the “Distribution and Assignment Agreement”), which Distribution and Assignment Agreement shall provide, among other
things, that Nascent shall pay the Buyer fifteen percent (15%) of the distributions and proceeds that the Company would otherwise be
entitled to receive pursuant to the Nascent Operating Agreement and/or the Proposed UCANN Distribution Agreement until the Buyer receives
an amount of such distributions and proceeds (the “Additional Consideration Amount”) equal to the sum of (A) two hundred
percent (200%) of the aggregate purchase price of the Existing Notes other than the Emergent Notes (i.e., $4,500,000), plus (B)
two hundred percent (200%) of the aggregate original principal amount of the Emergent Notes (i.e., $700,000), plus (C) one hundred
percent (100%) of the purchase price of the Initial Note (i.e. $125,000) (the “Initial New Money Distribution Amount”),
plus (D) one hundred percent (100%) of the aggregate purchase price of any subsequent Notes purchased by the Buyer from the Company
pursuant this Agreement (the “Subsequent New Money Distribution Amount”), such that in the event the only Note purchased
by the Buyer is the Initial Note, the Additional Consideration Amount would be $5,325,000; provided, that if the Buyer and/or
one or more New Buyers purchase Notes in the aggregate principal amount of the Maximum Offered Amount pursuant to this Agreement on or
prior to the New Money Multiple Deadline, then (1) the Initial New Money Distribution Amount shall be increased to two hundred percent
(200%) of the purchase price of the Initial Note (i.e. $250,000), and (2) the Subsequent New Money Distribution Amount shall be increased
to two hundred percent (200%) of the aggregate purchase price of the subsequent Notes purchased pursuant to this Agreement (i.e. $2,750,000),
such that the Additional Consideration Amount (if the Maximum Offered Amount of Notes is purchased on or prior to the New Money Multiple
Deadline) would be $8,200,000. In the event any New Buyer purchases any Notes hereunder on or prior to the New Money Multiple Deadline,
the Distribution and Assignment Agreement shall be amended or amended and restated as needed and for the sole purpose of appropriately
accounting for such New Buyer.
(c)
Form of Payment. On each Closing Date: (i) the Buyer shall pay the amount identified as the actual amount of the purchase price
of each Note to be issued and sold to the Buyer as of such Closing (the “Purchase Price” with respect to each Note)
minus the amount of any legal fee reimbursement amount applicable to such Closing withheld from such Purchase Price pursuant to this
Section 2(c) by wire transfer of immediately available funds to the Company, in accordance with the Company’s written wiring
instructions, and (ii) the Company shall deliver such duly executed Note, together with the duly executed Distribution and Assignment
Agreement and any other applicable deliverables provided for herein, to the Buyer. At the initial Closing for the purchase of the Initial
Note, the Company shall reimburse the Buyer for a portion of its legal fees in connection with the transactions contemplated by this
Agreement in the amount of $33,333, which amount may be withheld from the Purchase Price for the Initial Note at the Buyer’s discretion.
At each subsequent Closing, the Company shall reimburse the Buyer for a prorated portion of $66,667 of Buyer’s legal fees in connection
with the transactions contemplated by this Agreement, which amount may be withheld from the Purchase Price for the applicable Note at
the Buyer’s discretion. By way of example, if a subsequent Closing occurs with respect to Notes having an aggregate Purchase Price
of $500,000, $24,243 of Buyer’s legal fees will be reimbursed to the Buyer at such subsequent Closing. It is hereby acknowledged
and agreed that (i) the Initial Note to be purchased by the Buyer at the initial Closing shall be in the original principal amount of
$156,250, and the Purchase Price for such Initial Note shall be $125,000 (reflecting an original issuance discount of 20% on such Initial
Note), and (ii) the aggregate original principal amount of all Notes being offered pursuant to this Agreement (including without limitation
the Initial Note and any additional Notes purchased at any subsequent Closing) will be no more than $1,875,000, and the aggregate Purchase
Price for all Notes being offered pursuant to this Agreement (including without limitation the Initial Note and any additional Notes
purchased at any subsequent Closing) will be no more than $1,500,000 (reflecting an original issuance discount of 20% on all such Notes).
(d)
Closing Date. Subject to the satisfaction (or written waiver) of the conditions thereto set forth in Section 7, Section
8, Section 9 and/or Section 10 below, as applicable, the date and time of the issuance and sale of each Note pursuant
to this Agreement (each, a “Closing Date”) shall be on the date that the applicable Purchase Price for such Note is
paid by Buyer and/or any other New Buyer purchasing such Note, as applicable, to the Company pursuant to terms of this Agreement.
(e)
Closing. Each closing of the transactions contemplated by this Agreement (each, a “Closing”) shall occur on
the applicable Closing Date at such location as may be agreed to by the parties (including via exchange of electronic signatures).
3.
Buyer’s Representations and Warranties. The Buyer represents and warrants to the Company as of the initial Closing Date
that:
(a)
Investment Purpose. Buyer is acquiring the Securities for its own account and not with a present view towards the public sale
or distribution thereof, except pursuant to sales registered or exempted from registration under the 1933 Act; provided, however,
that by making the representations herein, the Buyer does not agree to hold any of the Securities for any minimum or other specific term
and reserves the right to dispose of the Securities at any time in accordance with or pursuant to a registration statement or an exemption
under the 1933 Act.
(b)
Accredited Investor Status. The Buyer is an “accredited investor” as that term is defined in Rule 501(a) of Regulation
D (an “Accredited Investor”).
(c)
Reliance on Exemptions. The Buyer understands that the Securities are being offered and sold to it in reliance upon specific exemptions
from the registration requirements of United States federal and state securities laws and that the Company is relying upon the truth
and accuracy of, and the Buyer’s compliance with, the representations, warranties, agreements, acknowledgments and understandings
of the Buyer set forth herein in order to determine the availability of such exemptions and the eligibility of the Buyer to acquire the
Securities.
(d)
Information. The Buyer and its advisors, if any, have been, and for so long as any Note or the Consolidated Amended and Restated
Walleye Note remains outstanding, will continue to be, furnished with all materials relating to the business, finances and operations
of the Company and materials relating to the offer and sale of the Securities which have been requested by the Buyer or its advisors.
The Buyer and its advisors, if any, have been, and for so long as any Note or the Consolidated Amended and Restated Walleye Note remains
outstanding, will continue to be, afforded the opportunity to ask questions of the Company regarding its business and affairs. Notwithstanding
the foregoing, the Company has not disclosed to the Buyer any material nonpublic information regarding the Company or otherwise and will
not disclose such information unless such information is disclosed to the public prior to or promptly following such disclosure to the
Buyer. Neither such inquiries nor any other due diligence investigation conducted by Buyer or any of its advisors or representatives
shall modify, amend or affect Buyer’s right to rely on the Company’s representations and warranties contained in Section
4 below.
(e)
Governmental Review. The Buyer understands that no United States federal or state agency or any other government or governmental
agency has passed upon or made any recommendation or endorsement of the Securities.
(f)
Transfer or Re-sale. The Buyer understands that (i) the sale or resale of the Securities has not been and is not being registered
under the 1933 Act or any applicable state securities laws, and the Securities may not be transferred unless (1) the Securities are sold
pursuant to an effective registration statement under the 1933 Act, (2) the Buyer shall have delivered to the Company, at the cost of
the Company, an opinion of counsel (which may be the Legal Counsel Opinion (as defined below)) that shall be in form, substance and scope
customary for opinions of counsel in comparable transactions to the effect that the Securities to be sold or transferred may be sold
or transferred pursuant to an exemption from such registration, which opinion shall be accepted by the Company, (3) the Securities are
sold or transferred to an “affiliate” (as defined in Rule 144 promulgated under the 1933 Act (or a successor rule) (“Rule
144”)) of the Buyer who agrees to sell or otherwise transfer the Securities only in accordance with this Section 3(f)
and who is an Accredited Investor, (4) the Securities are sold pursuant to Rule 144 or other applicable exemption, or (5) the Securities
are sold pursuant to Regulation S under the 1933 Act (or a successor rule) (“Regulation S”), and the Buyer shall have
delivered to the Company, at the cost of the Company, an opinion of counsel that shall be in form, substance and scope customary for
opinions of counsel in corporate transactions, which opinion shall be accepted by the Company; (ii) any sale of such Securities made
in reliance on Rule 144 may be made only in accordance with the terms of said Rule and further, if said Rule is not applicable, any re-sale
of such Securities under circumstances in which the seller (or the person through whom the sale is made) may be deemed to be an underwriter
(as that term is defined in the 1933 Act) may require compliance with some other exemption under the 1933 Act or the rules and regulations
of the SEC thereunder; and (iii) neither the Company nor any other person is under any obligation to register such Securities under the
1933 Act or any state securities laws or to comply with the terms and conditions of any exemption thereunder (in each case). Notwithstanding
the foregoing or anything else contained herein to the contrary, the Securities may be pledged in connection with a bona fide
margin account or other lending arrangement secured by the Securities, and such pledge of Securities shall not be deemed to be a transfer,
sale or assignment of the Securities hereunder, and the Buyer in effecting such pledge of Securities shall be not required to provide
the Company with any notice thereof or otherwise make any delivery to the Company pursuant to this Agreement or otherwise.
(g)
Legends. The Buyer understands that until such time as the Securities have been registered under the 1933 Act or may be sold pursuant
to Rule 144, Rule 144A under the 1933 Act, Regulation S, or other applicable exemption without any restriction as to the number of securities
as of a particular date that can then be immediately sold, the Securities may bear a restrictive legend in substantially the following
form (and a stop-transfer order may be placed against transfer of such Securities):
“NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED
FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM,
THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144, RULE 144A, REGULATION S, OR OTHER APPLICABLE
EXEMPTION UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT
OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.”
The
legend set forth above shall be removed and the Company shall issue a certificate or book entry statement for the applicable shares of
Common Stock without such legend to the holder of any Security upon which it is stamped or (as requested by such holder) issue the applicable
shares of Common Stock to such holder by electronic delivery by crediting the account of such holder’s broker with The Depository
Trust Company (“DTC”), if, unless otherwise required by applicable state securities laws, (i) such Security is registered
for sale under an effective registration statement filed under the 1933 Act or otherwise may be sold pursuant to Rule 144, Rule 144A,
Regulation S, or other applicable exemption without any restriction as to the number of securities as of a particular date that can then
be immediately sold, or (ii) the Company or the Buyer provides the Legal Counsel Opinion (as contemplated by and in accordance with Section
5(n) hereof) to the effect that a public sale or transfer of such Security may be made without registration under the 1933 Act, which
opinion shall be accepted by the Company so that the sale or transfer is effected. The Company shall be responsible for the fees of its
transfer agent and all DTC fees associated with any such issuance. The Buyer agrees to sell all Securities, including those represented
by a certificate(s) from which the legend has been removed, in compliance with applicable prospectus delivery requirements, if any. In
the event that the Company does not accept the opinion of counsel provided by the Buyer with respect to the transfer of Securities pursuant
to an exemption from registration, such as Rule 144, Rule 144A, Regulation S, or other applicable exemption at the Deadline (as defined
in the Note), it will be considered an Event of Default (as defined in the Note).
(h)
Authorization; Enforcement. This Agreement has been duly and validly authorized by the Buyer and has been duly executed and delivered
on behalf of the Buyer, and this Agreement constitutes a valid and binding agreement of the Buyer enforceable in accordance with its
terms, except as enforcement may be limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting creditors’
rights generally and except as may be limited by the exercise of judicial discretion in applying principles of equity.
4.
Representations and Warranties of the Company. The Company represents and warrants to the Buyer:
(a)
Organization and Qualification. The Company and each of its Subsidiaries (as defined below), if any, is a corporation duly organized,
validly existing and in good standing under the laws of the jurisdiction in which it is incorporated, with full power and authority (corporate
and other) to own, lease, use and operate its properties and to carry on its business as and where now owned, leased, used, operated
and conducted. The Company and each of its Subsidiaries is duly qualified as a foreign corporation to do business and is in good standing
in every jurisdiction in which its ownership or use of property or the nature of the business conducted by it makes such qualification
necessary except where the failure to be so qualified or in good standing would not have a Material Adverse Effect. The Company owns,
directly or indirectly, all of the capital stock or other equity interests of each Subsidiary, if any, free and clear of any liens, and
all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid. Neither the Company
nor any of its Subsidiaries are in violation nor default of any of the provisions of its respective certificate or articles of incorporation,
bylaws or other organizational or charter documents. As used in this Agreement, the term “Material Adverse Effect”
means any material adverse effect on the business, operations, assets, financial condition or prospects of the Company or its Subsidiaries,
if any, taken as a whole, or on the transactions contemplated hereby or by the agreements or instruments to be entered into in connection
herewith. As used in this Agreement, the term “Subsidiary” means any corporation, limited liability company or other
organization, whether incorporated or unincorporated, in which the Company owns, directly or indirectly, any equity or other ownership
interest.
(b)
Authorization; Enforcement. (i) The Company has all requisite corporate power and authority to enter into and perform this Agreement,
the Note, and to consummate the transactions contemplated hereby and thereby and to issue the Securities, in accordance with the terms
hereof and thereof, (ii) the execution and delivery of this Agreement, the Note and the Conversion Shares by the Company and the consummation
by it of the transactions contemplated hereby and thereby (including without limitation, the issuance of the Note, as well as the issuance
and reservation for issuance of the Conversion Shares issuable upon conversion of the Note) have been duly authorized by the Company’s
Board of Directors and no further consent or authorization of the Company, its Board of Directors, its shareholders, or its debt holders
is required, (iii) the Transaction Documents have been duly executed and delivered by the Company by its authorized representative, and
such authorized representative is the true and official representative with authority to sign such Transaction Documents and bind the
Company accordingly, and (iv) this Agreement constitutes, and upon execution and delivery by the Company of the Transaction Documents,
each of such instruments will constitute, a legal, valid and binding obligation of the Company, enforceable against the Company in accordance
with their terms.
(c)
Capitalization; Governing Documents. As of October 26, 2023, the authorized capital stock of the Company consisted of: 1,500,000,000
authorized shares of Common Stock, of which 26,156,663 shares were issued and outstanding, and 5,000,000 authorized shares of preferred
stock, of which 15 shares of Series A Preferred Stock, and 4,000 shares of Series D Preferred Stock were issued and outstanding. All
of such outstanding shares of capital stock of the Company and the Conversion Shares are, or upon issuance will be, duly authorized,
validly issued, fully paid and non-assessable. No shares of capital stock of the Company are subject to preemptive rights or any other
similar rights of the shareholders of the Company or any liens or encumbrances imposed through the actions or failure to act of the Company.
As of the effective date of this Agreement, other than as disclosed on Schedule 4(c), (i) there are no outstanding options, warrants,
scrip, rights to subscribe for, puts, calls, rights of first refusal, agreements, understandings, claims or other commitments or rights
of any character whatsoever relating to, or securities or rights convertible into or exchangeable for any shares of capital stock of
the Company or any of its Subsidiaries, or arrangements by which the Company or any of its Subsidiaries is or may become bound to issue
additional shares of capital stock of the Company or any of its Subsidiaries, (ii) there are no agreements or arrangements under which
the Company or any of its Subsidiaries is obligated to register the sale of any of its or their securities under the 1933 Act and (iii)
there are no anti-dilution or price adjustment provisions contained in any security issued by the Company (or in any agreement providing
rights to security holders) that will be triggered by the issuance of any of the Securities. The Company has furnished to the Buyer true
and correct copies of the Company’s Certificate of Incorporation as in effect on the date hereof (“Certificate of Incorporation”),
the Company’s By-laws, as in effect on the date hereof (the “By-laws”), and the terms of all securities convertible
into or exercisable for Common Stock and the material rights of the holders thereof in respect thereto.
(d)
Issuance of Conversion Shares. The Conversion Shares are duly authorized and reserved for issuance and, upon conversion of the
Note in accordance with its terms, will be validly issued, fully paid and non-assessable, and free from all taxes, liens, claims and
encumbrances with respect to the issue thereof and shall not be subject to preemptive rights or other similar rights of shareholders
of the Company and will not impose personal liability upon the holder thereof.
(e)
Acknowledgment of Dilution. The Company understands and acknowledges the potentially dilutive effect of the Conversion Shares
to the Common Stock upon the conversion of the Note. The Company further acknowledges that its obligation to issue, upon conversion of
the Note and the Conversion Shares, are absolute and unconditional regardless of the dilutive effect that such issuance may have on the
ownership interests of other shareholders of the Company.
(f)
No Conflicts. The execution, delivery and performance of the Transaction Documents by the Company and the consummation by the
Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance and reservation for issuance
of the Conversion Shares) will not (i) conflict with or result in a violation of any provision of the Certificate of Incorporation or
By-laws, (ii) violate or conflict with, or result in a breach of any provision of, or constitute a default (or an event which with notice
or lapse of time or both could become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation
of, any agreement, note, evidence of indebtedness, indenture, patent, patent license or instrument to which the Company or any of its
Subsidiaries is a party, (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state
securities laws and regulations and regulations of any self-regulatory organizations to which the Company or its securities is subject)
applicable to the Company or any of its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries is bound
or affected (except for such conflicts, defaults, terminations, amendments, accelerations, cancellations and violations as would not,
individually or in the aggregate, have a Material Adverse Effect), or (iv) except as disclosed on Schedule 4(c)(iii) trigger any
anti-dilution and/or ratchet provision contained in any other contract in which the Company is a party thereto or any security issued
by the Company. Neither the Company nor any of its Subsidiaries is in violation of its Certificate of Incorporation, By-laws or other
organizational documents and neither the Company nor any of its Subsidiaries is in default (and no event has occurred which with notice
or lapse of time or both could put the Company or any of its Subsidiaries in default) under, and neither the Company nor any of its Subsidiaries
has taken any action or failed to take any action that would give to others any rights of termination, amendment, acceleration or cancellation
of, any agreement, indenture or instrument to which the Company or any of its Subsidiaries is a party or by which any property or assets
of the Company or any of its Subsidiaries is bound or affected, except for possible defaults as would not, individually or in the aggregate,
have a Material Adverse Effect. The businesses of the Company and its Subsidiaries, if any, are not being conducted, and shall not be
conducted so long as the Buyer owns any of the Securities, in violation of any law, ordinance or regulation of any governmental entity.
Except as specifically contemplated by this Agreement and as required under the 1933 Act and any applicable state securities laws, the
Company is not required to obtain any consent, authorization or order of, or make any filing or registration with, any court, governmental
agency, regulatory agency, self-regulatory organization or stock market or any third party in order for it to execute, deliver or perform
any of its obligations under the Transaction Documents in accordance with the terms hereof or thereof or to issue and sell the Note in
accordance with the terms hereof and, upon conversion of the Note and/or issue the Conversion Shares as applicable. All consents, authorizations,
orders, filings and registrations which the Company is required to obtain pursuant to the preceding sentence have been obtained or effected
on or prior to the date hereof. The Company is not in violation of the listing requirements of the Principal Market (as defined herein)
and does not reasonably anticipate that the Common Stock will be delisted by the Principal Market in the foreseeable future. The Company
and its Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing. The “Principal
Market” shall mean the principal securities exchange or trading market where such Common Stock is listed or traded, including
but not limited to any tier of the OTC Markets, any tier of the NASDAQ Stock Market (including NASDAQ Capital Market), or the NYSE American,
or any successor to such markets.
(g)
SEC Documents; Financial Statements. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by it with the SEC pursuant to the reporting requirements of the Securities Exchange Act of 1934, as amended (the “1934
Act”) (all of the foregoing filed prior to the date hereof and all exhibits included therein and financial statements and schedules
thereto and documents (other than exhibits to such documents) incorporated by reference therein, being hereinafter referred to herein
as the “SEC Documents”). As of their respective dates, the SEC Documents complied in all material respects with the
requirements of the 1934 Act and the rules and regulations of the SEC promulgated thereunder applicable to the SEC Documents, and none
of the SEC Documents, at the time they were filed with the SEC, contained any untrue statement of a material fact or omitted to state
a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under
which they were made, not misleading. None of the statements made in any such SEC Documents is, or has been, required to be amended or
updated under applicable law (except for such statements as have been amended or updated in subsequent filings prior the date hereof).
As of their respective dates, the financial statements of the Company included in the SEC Documents complied as to form in all material
respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto. Such financial
statements have been prepared in accordance with United States generally accepted accounting principles, consistently applied, during
the periods involved and fairly present in all material respects the consolidated financial position of the Company and its consolidated
Subsidiaries as of the dates thereof and the consolidated results of their operations and cash flows for the periods then ended (subject,
in the case of unaudited statements, to normal year-end audit adjustments). Except as set forth in the financial statements of the Company
included in the SEC Documents, the Company has no liabilities, contingent or otherwise, other than (i) liabilities incurred in the ordinary
course of business subsequent to December 31, 2022, and (ii) obligations under contracts and commitments incurred in the ordinary course
of business and not required under generally accepted accounting principles to be reflected in such financial statements, which, individually
or in the aggregate, are not material to the financial condition or operating results of the Company. The Company is subject to the reporting
requirements of the 1934 Act. The Company has never been a “shell company” as described in Rule 144(i)(1)(i).
(h)
Absence of Certain Changes. Except as set forth on Schedule 4(h), since December 31, 2022, there has been no material adverse
change and no material adverse development in the assets, liabilities, business, properties, operations, financial condition, results
of operations, prospects or 1934 Act reporting status of the Company or any of its Subsidiaries.
(i)
Absence of Litigation. Except as disclosed in the SEC Documents, there is no action, suit, claim, proceeding, inquiry or investigation
before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company
or any of its Subsidiaries, threatened against or affecting the Company or any of its Subsidiaries, or their officers or directors in
their capacity as such, that could have a Material Adverse Effect. The SEC Documents contain a complete list and summary description
of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its Subsidiaries,
without regard to whether it would have a Material Adverse Effect. The Company and its Subsidiaries are unaware of any facts or circumstances
which might give rise to any of the foregoing.
(j)
Intellectual Property. The Company and each of its Subsidiaries owns or possesses the requisite licenses or rights to use all
patents, patent applications, patent rights, inventions, know-how, trade secrets, trademarks, trademark applications, service marks,
service names, trade names and copyrights (“Intellectual Property”) necessary to enable it to conduct its business
as now operated (and, as presently contemplated to be operated in the future) except that as of October 26, 2023, neither the Company
nor Nascent has yet acquired title to the Patents; there is no claim or action by any person pertaining to, or proceeding pending, or
to the Company’s knowledge threatened, which challenges the right of the Company or of a Subsidiary with respect to any Intellectual
Property necessary to enable it to conduct its business as now operated (and, as presently contemplated to be operated in the future);
to the best of the Company’s knowledge, the Company’s or its Subsidiaries’ current and intended products, services
and processes do not infringe on any Intellectual Property or other rights held by any person; and the Company is unaware of any facts
or circumstances which might give rise to any of the foregoing. The Company and each of its Subsidiaries have taken reasonable security
measures to protect the secrecy, confidentiality and value of their Intellectual Property.
(k)
No Materially Adverse Contracts, Etc. Neither the Company nor any of its Subsidiaries is subject to any charter, corporate or
other legal restriction, or any judgment, decree, order, rule or regulation which in the judgment of the Company’s officers has
or is expected in the future to have a Material Adverse Effect. Neither the Company nor any of its Subsidiaries is a party to any contract
or agreement which in the judgment of the Company’s officers has or is expected to have a Material Adverse Effect.
(l)
Tax Status. The Company and each of its Subsidiaries has made or filed all federal, state and foreign income and all other tax
returns, reports and declarations required by any jurisdiction to which it is subject (unless and only to the extent that the Company
and each of its Subsidiaries has set aside on its books provisions reasonably adequate for the payment of all unpaid and unreported taxes)
and has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such
returns, reports and declarations, except those being contested in good faith and has set aside on its books provisions reasonably adequate
for the payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no
unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company know
of no basis for any such claim. The Company has not executed a waiver with respect to the statute of limitations relating to the assessment
or collection of any foreign, federal, state or local tax. None of the Company’s tax returns is presently being audited by any
taxing authority.
(m)
Transactions with Affiliates. Except for arm’s length transactions pursuant to which the Company or any of its Subsidiaries
makes payments in the ordinary course of business upon terms no less favorable than the Company or any of its Subsidiaries could obtain
from third parties and other than the grant of stock options described in the SEC Documents, none of the officers, directors, or employees
of the Company is presently a party to any transaction with the Company or any of its Subsidiaries (other than for services as employees,
officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing
for rental of real or personal property to or from, or otherwise requiring payments to or from any officer, director or such employee
or, to the knowledge of the Company, any corporation, partnership, trust or other entity in which any officer, director, or any such
employee has a substantial interest or is an officer, director, trustee or partner.
(n)
Disclosure. All information relating to or concerning the Company or any of its Subsidiaries set forth in this Agreement and provided
to the Buyer pursuant to Section 3(d) hereof and otherwise in connection with the transactions contemplated hereby is true and
correct in all material respects and the Company has not omitted to state any material fact necessary in order to make the statements
made herein or therein, in light of the circumstances under which they were made, not misleading. No event or circumstance has occurred
or exists with respect to the Company or any of its Subsidiaries or its or their business, properties, prospects, operations or financial
conditions, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has
not been so publicly announced or disclosed (assuming for this purpose that the Company’s reports filed under the 1934 Act are
being incorporated into an effective registration statement filed by the Company under the 1933 Act).
(o)
Acknowledgment Regarding Buyer’s Purchase of Securities. The Company acknowledges and agrees that the Buyer is acting solely
in the capacity of arm’s length purchaser with respect to this Agreement and the transactions contemplated hereby. The Company
further acknowledges that the Buyer is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with
respect to this Agreement and the transactions contemplated hereby and any statement made by the Buyer or any of its respective representatives
or agents in connection with this Agreement and the transactions contemplated hereby is not advice or a recommendation and is merely
incidental to the Buyer’s purchase of the Securities. The Company further represents to the Buyer that the Company’s decision
to enter into this Agreement has been based solely on the independent evaluation of the Company and its representatives.
(p)
No Integrated Offering. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf, has directly
or indirectly made any offers or sales in any security or solicited any offers to buy any security under circumstances that would require
registration under the 1933 Act of the issuance of the Securities to the Buyer. The issuance of the Securities to the Buyer will not
be integrated with any other issuance of the Company’s securities (past, current or future) for purposes of any shareholder approval
provisions applicable to the Company or its securities.
(q)
No Brokers; No Solicitation. Other than as set forth on Schedule 4(q), the Company has taken no action which would give
rise to any claim by any person for brokerage commissions, transaction fees or similar payments relating to this Agreement, or the transactions
contemplated hereby. The Company acknowledges and agrees that neither the Buyer nor its employee(s), member(s), beneficial owner(s),
or partner(s) solicited the Company to enter into this Agreement and consummate the transactions described in this Agreement.
(r)
Permits; Compliance. The Company and each of its Subsidiaries is in possession of all franchises, grants, authorizations, licenses,
permits, easements, variances, exemptions, consents, certificates, approvals and orders necessary to own, lease and operate its properties
and to carry on its business as it is now being conducted (collectively, the “Company Permits”), and there is no action
pending or, to the knowledge of the Company, threatened regarding suspension or cancellation of any of the Company Permits. Neither the
Company nor any of its Subsidiaries is in conflict with, or in default or violation of, any of the Company Permits, except for any such
conflicts, defaults or violations which, individually or in the aggregate, would not reasonably be expected to have a Material Adverse
Effect. Since December 31, 2022, neither the Company nor any of its Subsidiaries has received any notification with respect to possible
conflicts, defaults or violations of applicable laws, except for notices relating to possible conflicts, defaults or violations, which
conflicts, defaults or violations would not have a Material Adverse Effect.
(s)
Environmental Matters.
(i)
There are, to the Company’s knowledge, with respect to the Company or any of its Subsidiaries or any predecessor of the Company,
no past or present violations of Environmental Laws (as defined below), releases of any material into the environment, actions, activities,
circumstances, conditions, events, incidents, or contractual obligations which may give rise to any common law environmental liability
or any liability under any Environmental Laws, and neither the Company nor any of its Subsidiaries has received any notice with respect
to any of the foregoing, nor is any action pending or, to the Company’s knowledge, threatened in connection with any of the foregoing.
The term “Environmental Laws” means all federal, state, local or foreign laws relating to pollution or protection
of human health or the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface
strata), including, without limitation, laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants
contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment,
or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous
Materials, as well as all authorizations, codes, decrees, demands or demand letters, injunctions, judgments, licenses, notices or notice
letters, orders, permits, plans or regulations issued, entered, promulgated or approved thereunder.
(ii)
Other than those that are or were stored, used or disposed of in compliance with applicable law, no Hazardous Materials are contained
on or about any real property currently owned, leased or used by the Company or any of its Subsidiaries, and no Hazardous Materials were
released on or about any real property previously owned, leased or used by the Company or any of its Subsidiaries during the period the
property was owned, leased or used by the Company or any of its Subsidiaries, except in the normal course of the Company’s or any
of its Subsidiaries’ business.
(iii)
There are no underground storage tanks on or under any real property owned, leased or used by the Company or any of its Subsidiaries
that are not in compliance with applicable law.
(t)
Title to Property; Liens. The Company and its Subsidiaries have good and marketable title in fee simple to all real property and
good and marketable title to all personal property owned by them which is material to the business of the Company and its Subsidiaries,
in each case free and clear of all liens, encumbrances and defects except such as are described in Schedule 4(t), if attached
hereto, or such as would not have a Material Adverse Effect. Any real property and facilities held under lease by the Company and its
Subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as would not have a Material Adverse
Effect.
(u)
Insurance. The Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility against such
losses and risks and in such amounts as management of the Company reasonably believes to be prudent and customary in the businesses in
which the Company and its Subsidiaries are engaged. Neither the Company nor any such Subsidiary has any reason to believe that it will
not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers
as may be necessary to continue its business at a cost that would not have a Material Adverse Effect. Upon written request the Company
will provide to the Buyer true and correct copies of all policies relating to directors’ and officers’ liability coverage,
errors and omissions coverage, and commercial general liability coverage.
(v)
Labor Relations. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company or any Subsidiary, which could reasonably be expected to result in a Material Adverse Effect. None of the Company’s
or its Subsidiaries’ employees is a member of a union that relates to such employee’s relationship with the Company or such
Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and
its Subsidiaries believe that their relationships with their employees are good. To the knowledge of the Company, no executive officer
of the Company or any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality,
disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant
in favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries
to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal,
state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and
wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to
have a Material Adverse Effect.
(w)
Internal Accounting Controls. The Company and its Subsidiaries are in compliance with any and all applicable requirements of the
Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by
the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company and each of its Subsidiaries
maintain a system of internal accounting controls sufficient, in the judgment of the Company’s board of directors, to provide reasonable
assurance that (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions
are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles and
to maintain asset accountability, (iii) access to assets is permitted only in accordance with management’s general or specific
authorization and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate
action is taken with respect to any differences. The Company’s certifying officers have evaluated the effectiveness of the disclosure
controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report
under the 1934 Act (such date, the “Evaluation Date”). The Company presented in its most recently filed periodic report
under the 1934 Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based
on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial
reporting (as such term is defined in the 1934 Act) that have materially affected, or is reasonably likely to materially affect, the
internal control over financial reporting of the Company and its Subsidiaries.
(x)
Foreign Corrupt Practices. Neither the Company, nor any of its Subsidiaries, nor any director, officer, agent, employee or other
person acting on behalf of the Company or any Subsidiary has, in the course of his actions for, or on behalf of, the Company, used any
corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses relating to political activity; made any
direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds; violated or is in
violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended, or made any bribe, rebate, payoff, influence
payment, kickback or other unlawful payment to any foreign or domestic government official or employee.
(y)
Solvency; Indebtedness. The Company (after giving effect to the transactions contemplated by this Agreement) is solvent (i.e.,
its assets have a fair market value in excess of the amount required to pay its probable liabilities on its existing debts as they become
absolute and matured) and currently the Company has no information that would lead it to reasonably conclude that the Company would not,
after giving effect to the transaction contemplated by this Agreement, have the ability to, nor does it intend to take any action that
would impair its ability to, pay its debts from time to time incurred in connection therewith as such debts mature. The Company’s
financial statements for its most recent fiscal year end and interim financial statements have been prepared assuming the Company will
continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of
business. Schedule 4(y) sets forth as of the date hereof all outstanding secured and unsecured Indebtedness of the Company or
any Subsidiary, or for which the Company or any Subsidiary has commitments, and except as set forth in Schedule 4(y) none of the
Company or its Subsidiaries are in default of any such Indebtedness. For the purposes of this Agreement, “Indebtedness”
means (x) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the
ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others,
whether or not the same are or should be reflected in the Company’s consolidated balance sheet (or the notes thereto), except guaranties
by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (z)
the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance with GAAP.
(z)
No Investment Company. The Company is not, and upon the issuance and sale of the Securities as contemplated by this Agreement
will not be an “investment company” required to be registered under the Investment Company Act of 1940 (an “Investment
Company”). The Company is not controlled by an Investment Company.
(aa)
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its
Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act
filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
(bb)
No Disqualification Events. None of the Company, any of its predecessors, any affiliated issuer, any director, executive officer,
other officer of the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company’s outstanding
voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the 1933
Act) connected with the Company in any capacity at the time of sale (each, an “Issuer Covered Person”) is subject
to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii) under the 1933 Act (a “Disqualification
Event”), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care
to determine whether any Issuer Covered Person is subject to a Disqualification Event.
(cc)
Manipulation of Price. The Company has not, and to its knowledge no one acting on its behalf has: (i) taken, directly or indirectly,
any action designed to cause or to result, or that could reasonably be expected to cause or result, in the stabilization or manipulation
of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased,
or paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any person any compensation
for soliciting another to purchase any other securities of the Company.
(dd)
Bank Holding Company Act. Neither the Company nor any of its Subsidiaries is subject to the Bank Holding Company Act of 1956,
as amended (the “BHCA”) and to regulation by the Board of Governors of the Federal Reserve System (the “Federal
Reserve”). Neither the Company nor any of its Subsidiaries or affiliates owns or controls, directly or indirectly, five percent
(5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of
a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries
or affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and
to regulation by the Federal Reserve.
(ee)
Illegal or Unauthorized Payments; Political Contributions. Neither the Company nor any of its Subsidiaries nor, to the Company’s
knowledge, any of the officers, directors, employees, agents or other representatives of the Company or any of its Subsidiaries or any
other business entity or enterprise with which the Company or any Subsidiary is or has been affiliated or associated, has, directly or
indirectly, made or authorized any payment, contribution or gift of money, property, or services, whether or not in contravention of
applicable law, (i) as a kickback or bribe to any person or (ii) to any political organization, or the holder of or any aspirant to any
elective or appointive public office except for personal political contributions not involving the direct or indirect use of funds of
the Company or any of its Subsidiaries.
(ff)
Breach of Representations and Warranties by the Company. The Company agrees that if the Company breaches any of the representations
or warranties set forth in this Section 4 and in addition to any other remedies available to the Buyer pursuant to this Agreement,
it will be considered an Event of Default under Section 3.1(d) of the Notes and the Consolidated Amended and Restated Walleye Note.
5.
Additional Covenants, Agreements and Acknowledgments.
(a)
Form D; Blue Sky Laws. The Company agrees to file a Form D with respect to the Securities if required under Regulation D and to
provide a copy thereof to the Buyer promptly after such filing. The Company shall, on or before the Closing Date, take such action as
the Company shall reasonably determine is necessary to qualify the Securities for sale to the Buyer at the applicable closing pursuant
to this Agreement under applicable securities or “blue sky” laws of the states of the United States (or to obtain an exemption
from such qualification), and shall provide evidence of any such action so taken to the Buyer on or prior to the Closing Date.
(b)
Use of Proceeds. The Company shall use the proceeds advanced to the Company from the Buyer and any New Buyer pursuant to this
Agreement for business development and the repayment of existing indebtedness as agreed upon between the Company and the Buyer, and not
for (i) the repayment of any indebtedness owed to officers, directors or employees of the Company or their affiliates, (ii) any loan
to or investment in any other corporation, partnership, enterprise or other person other than Nascent, (iii) any loan, credit, or advance
to any officers, directors, employees, or affiliates of the Company, or (iv) in violation or contravention of any applicable law, rule
or regulation.
(c)
Intentionally Omitted.
(d)
Most Favored Nations. Buyer, whether or not participating in a particular Subsequent Placement, shall have the right, exercisable
at any time prior to the expiration of the Offer Period for such Subsequent Placement, to accept the securities and terms of such Subsequent
Placement in lieu of the Securities and the terms of this Agreement (“MFN Right”). If the Company receives such notice
from Buyer of the exercise of its MFN Right as of the expiration of the Offer Period for such Subsequent Placement, then: (i) effective
upon the closing of such Subsequent Placement, the terms of the securities (and, if and to the extent relevant, the underlying securities)
then held by Buyer and this Agreement (collectively, “Present Terms”) shall automatically be amended by (x) substituting
the form, mix and terms of such securities (and, if and to the extent relevant, the underlying securities) with those of the securities
from the Subsequent Placement and (y) incorporating by reference, mutatis mutandis, the terms of the Subsequent Placement in lieu of
the Present Terms; and (ii) thereafter, upon the reasonable request of the Company or Buyer, the parties shall reasonably cooperate with
each other in order to further or better evidence or effect such substitution(s) and amendment(s), and to otherwise carry out the intent
and purposes of this Section, including the physical exchange of securities.
(e)
Usury. To the extent it may lawfully do so, the Company hereby agrees not to insist upon or plead or in any manner whatsoever
claim, and will resist any and all efforts to be compelled to take the benefit or advantage of, usury laws wherever enacted, now or at
any time hereafter in force, in connection with any action or proceeding that may be brought by the Buyer in order to enforce any right
or remedy under this Agreement, the Note and any document, agreement or instrument contemplated thereby. Notwithstanding any provision
to the contrary contained in this Agreement, the Note and any document, agreement or instrument contemplated thereby, it is expressly
agreed and provided that the total liability of the Company under this Agreement, the Note or any document, agreement or instrument contemplated
thereby for payments which under applicable law are in the nature of interest shall not exceed the maximum lawful rate authorized under
applicable law (the “Maximum Rate”), and, without limiting the foregoing, in no event shall any rate of interest or
default interest, or both of them, when aggregated with any other sums which under applicable law in the nature of interest that the
Company may be obligated to pay under this Agreement, the Note and any document, agreement or instrument contemplated thereby exceed
such Maximum Rate. It is agreed that if the maximum contract rate of interest allowed by law applicable to this Agreement, the Note and
any document, agreement or instrument contemplated thereby is increased or decreased by statute or any official governmental action subsequent
to the date hereof, the new maximum contract rate of interest allowed by law will be the Maximum Rate applicable to this Agreement, the
Note and any document, agreement or instrument contemplated thereby from the effective date thereof forward, unless such application
is precluded by applicable law. If under any circumstances whatsoever, interest in excess of the Maximum Rate is paid by the Company
to the Buyer with respect to indebtedness evidenced by this Agreement, the Note and any document, agreement or instrument contemplated
thereby, such excess shall be applied by the Buyer to the unpaid principal balance of any such indebtedness or be refunded to the Company,
the manner of handling such excess to be at the Buyer’s election.
(f)
Restriction on Activities. Commencing as of the date first above written, and until the earlier of payment of the Note in full
or full conversion of the Note, the Company shall not, directly or indirectly, without the Buyer’s prior written consent, which
consent shall not be unreasonably withheld: (i) change the nature of its business; or (ii) sell, divest, acquire, change the structure
of any material assets other than in the ordinary course of business; provided, however, that nothing contained herein shall prohibit
the Company, through Nascent, from enforcing the Patents.
(g)
Listing. The Company will, so long as the Buyer owns any of the Securities, maintain the listing and trading of its Common Stock
on the Principal Market or any equivalent replacement exchange or electronic quotation system (including but not limited to the Pink
Sheets electronic quotation system) and will comply in all respects with the Company’s reporting, filing and other obligations
under the bylaws or rules of the Financial Industry Regulatory Authority (“FINRA”) and such exchanges, as applicable.
The Company shall promptly provide to the Buyer copies of any notices it receives from the Principal Market and any other exchanges or
electronic quotation systems on which the Common Stock is then traded regarding the continued eligibility of the Common Stock for listing
on such exchanges and quotation systems.
(h)
Corporate Existence. The Company will, so long as the Buyer beneficially owns any of the Securities, maintain its corporate existence
and shall not sell all or substantially all of the Company’s assets, except in the event of a merger or consolidation or sale of
all or substantially all of the Company’s assets, where the surviving or successor entity in such transaction (i) assumes the Company’s
obligations hereunder and under the agreements and instruments entered into in connection herewith and (ii) is a publicly traded corporation
whose Common Stock is listed for trading or quotation on the Principal Market, any tier of the NASDAQ Stock Market, the New York Stock
Exchange or the NYSE MKT.
(i)
No Integration. The Company shall not make any offers or sales of any security (other than the Securities) under circumstances
that would require registration of the Securities being offered or sold hereunder under the 1933 Act or cause the offering of the Securities
to be integrated with any other offering of securities by the Company for the purpose of any stockholder approval provision applicable
to the Company or its securities.
(j)
Breach of Covenants. The Company acknowledges and agrees that if the Company breaches any of the covenants set forth in this Section
5, in addition to any other remedies available to the Buyer pursuant to this Agreement, it will be considered an Event of Default
under Section 3.1(c) of the Notes and the Consolidated Amended and Restated Walleye Note.
(k)
Compliance with 1934 Act; Public Information Failures. For so long as the Buyer beneficially owns any Note, the Consolidated Amended
and Restated Walleye Note or any Conversion Shares, the Company shall comply with the reporting requirements of the 1934 Act; and the
Company shall continue to be subject to the reporting requirements of the 1934 Act. During the period that the Buyer beneficially owns
any Note and/or the Consolidated Amended and Restated Walleye Note, if the Company shall (i) fail for any reason to satisfy the requirements
of Rule 144(c)(1), including, without limitation, the failure to satisfy the current public information requirements under Rule 144(c)
or (ii) if the Company has ever been an issuer described in Rule 144(i)(1)(i) or becomes such an issuer in the future, and the Company
shall fail to satisfy any condition set forth in Rule 144(i)(2) (each, a “Public Information Failure”) then, as partial
relief for the damages to the Buyer by reason of any such delay in or reduction of its ability to sell the Securities (which remedy shall
not be exclusive of any other remedies available pursuant to this Agreement, the Note, or at law or in equity), the Company shall pay
to the Buyer an amount in cash equal to three percent (3%) of the Purchase Price on each of the day of a Public Information Failure and
on every thirtieth day (pro rated for periods totaling less than thirty days) thereafter until the date such Public Information Failure
is cured. The payments to which a holder shall be entitled pursuant to this Section 5(k) are referred to herein as “Public
Information Failure Payments.” Public Information Failure Payments shall be paid on the earlier of (x) the last day of the
calendar month during which such Public Information Failure Payments are incurred and (y) the third Business Day after the event or failure
giving rise to the Public Information Failure Payments is cured. In the event the Company fails to make Public Information Failure Payments
in a timely manner, such Public Information Failure Payments shall bear interest at the rate of 5% per month (prorated for partial months)
until paid in full.
(l)
Acknowledgement Regarding Buyer’s Trading Activity. Until all of the Notes purchased by the Buyer and the Consolidated Amended
and Restated Walleye Note is fully repaid or fully converted, the Buyer shall not effect any “short sale” (as such term is
defined in Rule 200 of Regulation SHO of the 1934 Act) of the Common Stock which establishes a net short position with respect to the
Common Stock.
(m)
Disclosure of Transactions and Other Material Information. By 9:00 a.m., New York time, following the date this Agreement has
been fully executed, the Company shall file a Current Report on Form 8-K (if required) describing the terms of the transactions contemplated
by this Agreement in the form required by the 1934 Act and attaching this Agreement, the form of Note and the form of Consolidated Amended
and Restated Walleye Note (the “8-K Filing”). From and after the filing of the 8-K Filing with the SEC, the Buyer
shall not be in possession of any material, nonpublic information received from the Company, any of its Subsidiaries or any of their
respective officers, directors, employees or agents that is not disclosed in the 8-K Filing. In addition, effective upon the filing of
the 8-K Filing, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether
written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, affiliates, employees or
agents, on the one hand, and the Buyer or any of its affiliates, on the other hand, shall terminate.
(n)
Legal Counsel Opinions. Upon the request of the Buyer from to time to time, the Company shall be responsible (at its cost) for
promptly supplying to the Company’s transfer agent and the Buyer a customary legal opinion letter of its counsel (the “Legal
Counsel Opinion”) to the effect that the resale of the Conversion Shares by the Buyer or its affiliates, successors and assigns
is exempt from the registration requirements of the 1933 Act pursuant to Rule 144 (provided the holding period requirements of Rule 144
are satisfied and provided the Conversion Shares are not then registered under the 1933 Act for resale pursuant to an effective registration
statement) or other applicable exemption (provided the requirements of such other applicable exemption are satisfied). In addition, the
Buyer may (at the Company’s cost) at any time secure its own legal counsel to issue the Legal Counsel Opinion, and the Company
will instruct its transfer agent to accept such opinion. The Company hereby agrees that it may never take the position that it is a “shell
company” in connection with its obligations under this Agreement or otherwise.
(o)
Piggyback Registration Rights. The Company hereby grants to the Buyer the piggy-back registration rights set forth on Exhibit
C hereto, which piggy-back registration rights shall be in addition to and not in substitution for the registration rights set forth
in each RRA (as defined in Section 8 below) delivered pursuant to this Agreement.
(p)
Intentionally Omitted.
(q)
Subsequent Variable Rate Transactions. From the date hereof until such time as the Note is fully converted or fully repaid, the
Company shall be prohibited from effecting or entering into an agreement involving a Variable Rate Transaction. “Variable Rate
Transaction” means a transaction in which the Company (i) issues or sells any debt or equity securities that are convertible
into, exchangeable or exercisable for, or include the right to receive, additional shares of Common Stock either (A) at a conversion
price, exercise price or exchange rate or other price that is based upon, and/or varies with, the trading prices of or quotations for
the shares of Common Stock at any time after the initial issuance of such debt or equity securities or (B) with a conversion, exercise
or exchange price that is subject to being reset at some future date after the initial issuance of such debt or equity security or upon
the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for the
Common Stock or (ii) enters into any agreement, including, but not limited to, an equity line of credit, whereby the Company may issue
securities at a future determined price. The Buyer shall be entitled to obtain injunctive relief against the Company to preclude any
such issuance, which remedy shall be in addition to any right to collect damages.
(r)
Intentionally Omitted.
(s)
Non-Public Information. The Company covenants and agrees that neither it, nor any other person acting on its behalf will provide
the Buyer or its agents or counsel with any information that constitutes, or the Company reasonably believes constitutes, material non-public
information, unless prior thereto the Buyer shall have consented to the receipt of such information and agreed with the Company to keep
such information confidential. The Company understands and confirms that the Buyer shall be relying on the foregoing covenant in effecting
transactions in securities of the Company. To the extent that the Company delivers any material, non-public information to the Buyer
without such Buyer’s consent, the Company hereby covenants and agrees that such Buyer shall not have any duty of confidentiality
to the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees or affiliates, not to trade
on the basis of, such material, non- public information, provided that the Buyer shall remain subject to applicable law. To the extent
that any notice provided, information provided, or any other communications made by the Company, to the Buyer, constitutes or contains
material non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice or other
material information with the SEC pursuant to a Current Report on Form 8-K. In addition to any other remedies provided by this Agreement
or the related transaction documents, if the Company provides any material non-public information to the Buyer without their prior written
consent, and it fails to immediately (no later than that Business Day) file a Form 8-K disclosing this material non-public information,
it shall pay the Buyer as partial liquidated damages and not as a penalty a sum equal to $3,000 per day beginning with the day the information
is disclosed to the Buyer and ending and including the day the Form 8-K disclosing this information is filed.
6.
Transfer Agent Instructions. The Company shall issue irrevocable instructions to the Company’s transfer agent to issue certificates
and/or issue shares electronically at the Buyer’s option, registered in the name of the Buyer or its nominee, upon conversion of
the Notes, the Consolidated Amended and Restated Walleye Note and the issuance of the Conversion Shares issuable under the Notes and
the Consolidated Amended and Restated Walleye Note, in such amounts as specified from time to time by the Buyer to the Company in accordance
with the terms thereof (the “Irrevocable Transfer Agent Instructions”). In the event that the Company proposes to
replace its transfer agent, the Company shall provide, prior to the effective date of such replacement, a fully executed Irrevocable
Transfer Agent Instructions in a form as initially delivered pursuant to this Agreement (including but not limited to the provision in
each of the Notes and the Consolidated Amended and Restated Walleye Note to irrevocably reserve shares of Common Stock in the Reserved
Amount (as defined in each Note and in the Consolidated Amended and Restated Walleye Note)) signed by the successor transfer agent to
the Company and the Company. Prior to registration of the Conversion Shares under the 1933 Act or the date on which the Conversion Shares
may be sold pursuant to Rule 144, Rule 144A, Regulation S, or other applicable exemption without any restriction as to the number of
Securities as of a particular date that can then be immediately sold, all such certificates or book entry shares shall bear the restrictive
legend specified in Section 3(g) of this Agreement. The Company warrants that: (i) no instruction other than the Irrevocable Transfer
Agent Instructions referred to in this Section 6 will be given by the Company to its transfer agent and that the Securities shall
otherwise be freely transferable on the books and records of the Company as and to the extent provided in this Agreement and the Note;
(ii) it will not direct its transfer agent not to transfer or delay, impair, and/or hinder its transfer agent in transferring (or issuing)
(electronically or in certificated form) any certificate for Securities to be issued to the Buyer upon conversion of or otherwise pursuant
to the Note as and when required by the Note and this Agreement; (iii) it will not fail to remove (or directs its transfer agent not
to remove or impairs, delays, and/or hinders its transfer agent from removing) any restrictive legend (or to withdraw any stop transfer
instructions in respect thereof) on any certificate for any Securities issued to the Buyer upon conversion of or otherwise pursuant to
the Note as and when required by the Note or this Agreement and (iv) it will provide any required corporate resolutions and issuance
approvals to its transfer agent within 6 hours of each conversion of the Note. Nothing in this Section shall affect in any way the Buyer’s
obligations and agreement set forth in Section 3(g) hereof to comply with all applicable prospectus delivery requirements, if
any, upon re-sale of the Securities. If the Buyer provides the Company, at the cost of the Company, with (i) an opinion of counsel in
form, substance and scope customary for opinions in comparable transactions, to the effect that a public sale or transfer of such Securities
may be made without registration under the 1933 Act and such sale or transfer is effected or (ii) the Buyer provides reasonable assurances
that the Securities can be sold pursuant to 144, Rule 144A, Regulation S, or other applicable exemption, the Company shall permit the
transfer, and, in the case of the Securities, promptly instruct its transfer agent to issue one or more certificates, free from restrictive
legend, in such name and in such denominations as specified by the Buyer. The Company acknowledges that a breach by it of its obligations
hereunder will cause irreparable harm to the Buyer, by vitiating the intent and purpose of the transactions contemplated hereby. Accordingly,
the Company acknowledges that the remedy at law for a breach of its obligations under this Section 5 may be inadequate and agrees,
in the event of a breach or threatened breach by the Company of the provisions of this Section, that the Buyer shall be entitled, in
addition to all other available remedies, to an injunction restraining any breach and requiring immediate transfer, without the necessity
of showing economic loss and without any bond or other security being required.
7.
Conditions to the Company’s Obligation to Sell the Initial Note. The obligation of the Company hereunder to issue and sell
the Initial Note to the Buyer at the initial Closing is subject to the satisfaction, at or before the initial Closing Date, of each of
the following conditions set forth in this Section 7, provided that these conditions are for the Company’s sole benefit
and may be waived by the Company at any time in its sole discretion:
(a)
The Buyer shall have executed this Agreement and delivered the same to the Company.
(b)
The Buyer shall have delivered the Purchase Price for the Initial Note, net of any applicable withheld legal fee reimbursement amount,
in accordance with Section 2(c) above.
(c)
The Buyer shall have delivered to the Company a counterpart of the Distribution and Assignment Agreement, duly executed by the Buyer.
(d)
The Buyer shall have delivered to the Company a counterpart of the RRA referred to in Section 8(i) below.
(e)
The representations and warranties of the Buyer in this Agreement shall be true and correct in all material respects as of the date when
made and as of the Closing Date, as though made at that time (except for representations and warranties that speak as of a specific date),
and the Buyer shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required
by this Agreement to be performed, satisfied or complied with by the Buyer at or prior to the Closing Date.
(f)
No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority
over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this Agreement.
8.
Conditions to the Buyer’s Obligation to Purchase the Initial Note. The obligation of the Buyer hereunder to purchase the
Initial Note at the initial Closing is subject to the satisfaction, at or before the initial Closing Date, of each of the following conditions
set forth in this Section 8, provided that these conditions are for the Buyer’s sole benefit and may be waived by the Buyer
at any time in its sole discretion:
(a)
The Company shall have executed this Agreement and delivered the same to the Buyer.
(b)
The Company shall have delivered to the Buyer the duly executed Initial Note in such denominations as the Buyer shall request and in
accordance with Section 2(c) above.
(c)
The Company shall have delivered to the Buyer that certain Consolidated Amended and Restated Promissory Note in the original principal
amount of $1,354,210, substantially in the form attached hereto as Exhibit E (the “Consolidated Amended and Restated
Walleye Note”), duly executed by the Company, which Consolidated Amended and Restated Walleye Note consolidates, amends and
restates (i) the $385,000 Walleye Note, (ii) the $437,500 Walleye Note, (iii) the $100,000 Walleye Note and (iv) the $250,000 Walleye
Note, subject to the terms and conditions set forth therein.
(d)
The Company shall have delivered to the Buyer the Distribution and Assignment Agreement, duly executed by the Company and Nascent.
(e)
Intentionally Omitted.
(f)
The Company shall have delivered to the Buyer a true and complete copy of the limited liability company operating agreement of Nascent,
together with all amendments thereto, as in effect on the Closing Date (the “Nascent Operating Agreement”), which
Nascent Operating Agreement shall be to the satisfaction of the Buyer in its sole and absolute discretion.
(g)
The Company shall have delivered to the Buyer true and complete copies of any and all agreements, instruments or other documents, together
with any and all amendments thereto, entered into by the Company, any Affiliate of the Company, Nascent and/or any Affiliate of Nascent,
in each case as in effect as of the initial Closing Date, pursuant to which (i) the Company, Nascent or any Affiliate of the Company
or of Nascent has any obligations or commitments to pay or distribute any “Cash Available for Distribution” (as such term
is defined in the Nascent Operating Agreement) that the Company would otherwise be entitled to receive pursuant to the Nascent Operating
Agreement, to any Person other than the Company, (ii) materially affecting the amount of “Cash Available for Distribution”
that would be available for distribution to members of Nascent (including the Company), in the event Nascent, the Company or any Affiliate
of the Company or Nascent is successful in prosecuting any claim, litigation, or other proceeding brought by or on behalf of Nascent,
the Company or any Affiliate of the Company in order to enforce any alleged breach or infringement of the rights of the Company, Nascent
or any Affiliate of the Company or Nascent with respect to any of the Patents, including without limitation (any such claim, litigation,
or other proceeding, whether successful or not, a “Patent Claim”), or (iii) providing for the payment of any fees,
distributions or other consideration to any third party Person (other than Nascent or the members of Nascent) contingent or payable upon
or in connection with a successful prosecution of one or more Patent Claims (any and all of such agreements, instruments, and other documents
executed by the Company, any Affiliate of the Company, Nascent and/or any Affiliate of Nascent as in effect as of any date, “Senior
Distribution and Contingent Payment Agreements”), including without limitation, (1) the Proposed UCANN Distribution Agreement
(provided the same has been executed on or prior to the initial Closing Date), (2) any and all agreements by and among any of the Company
and/or Nascent, and Earnest Blackmon and/or one or more Affiliates of Earnest Blackmon, (3) any and all agreements, instruments or other
documents providing for the payment of any fees to any third party for the provision of legal and/or other services to the Company, Nascent
and/or any Affiliate of the Company or Nascent contingent or payable upon or in connection a successful prosecution of any Patent Claim,
and (4) any and all agreements, promissory notes and other loan, investment and/or financing documents entered into by and among the
Company, Nascent, and/or any Affiliate of the Company with one or more third party lenders or other financial institutions providing
for the advance of funds to or on behalf of the Company, Nascent and/or any Affiliate of the Company or Nascent to be used in connection
with the prosecution of any Patent Claim, all of which Senior Distribution and Contingent Payment Agreements shall be to the satisfaction
of the Buyer in its sole and absolute discretion.
(h)
The Company shall have delivered to the Buyer duly executed consents and waivers from the holders of those certain outstanding promissory
notes of the Company set forth on Schedule 8(h) with respect to the transactions contemplated herein, each in form and substance
satisfactory to the Buyer (the “Consents”).
(i)
The Company shall have delivered to the Buyer a duly executed Registration Rights Agreement in the form attached as Exhibit D
hereto (any such Registration Rights Agreement delivered by the Company to Buyer at the initial Closing and/or at any subsequent Closing
pursuant to this Agreement, an “RRA”) covering the Conversion Shares issuable under the Initial Note purchased by
the Buyer on the initial Closing Date and the Conversion Shares issuable under the Consolidated Amended and Restated Walleye Note.
(j)
The Irrevocable Transfer Agent Instructions with respect to the initial Note, the Consolidated Amended and Restated Walleye Note and
the Conversion Shares issuable thereunder, in form and substance satisfactory to the Buyer, shall have been delivered to and acknowledged
in writing by the Company’s Transfer Agent.
(k)
The representations and warranties of the Company in this Agreement shall be true and correct in all material respects as of the date
when made and as of the Closing Date, as though made at such time (except for representations and warranties that speak as of a specific
date) and the Company shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions
required by this Agreement to be performed, satisfied or complied with by the Company at or prior to the Closing Date.
(l)
No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority
over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this Agreement.
(m)
No event shall have occurred which could reasonably be expected to have a Material Adverse Effect on the Company including but not limited
to a change in the 1934 Act reporting status of the Company or the failure of the Company to be timely in its 1934 Act reporting obligations.
(n)
Trading in the Common Stock on the Principal Market shall not have been suspended by the SEC, FINRA or the Principal Market.
(o)
The Company shall have delivered to the Buyer (i) a certificate of an officer of the Company and of Nascent evidencing the formation
and good standing of the Company and of Nascent in such entity’s jurisdiction of formation issued by the Secretary of State (or
comparable office) of such jurisdiction, as of a recent date prior to the Closing Date and (ii) resolutions adopted by the Company’s
Board of Directors and the applicable governing body of Nascent by written consent duly authorizing this Agreement and all other documents,
instruments and transactions contemplated hereby, in form and substance satisfactory to the Buyer.
(p)
The Company shall have delivered to the Buyer a certificate of an officer of the Company, dated as of the Closing Date, certifying as
to the fulfillment of the conditions set forth in subparagraphs (a) through (n) of this Section.
(q)
From the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the SEC or the Principal Market
and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been suspended
or limited, or minimum prices shall not have been established on securities whose trades are reported by such service, nor shall a banking
moratorium have been declared either by the United States or New York State authorities nor shall there have occurred any material outbreak
or escalation of hostilities or other national or international calamity of such magnitude in its effect on, or any material adverse
change in, any financial market which, in each case, in the reasonable judgment of Buyer, makes it impracticable or inadvisable to purchase
the Securities at the Closing.
(r)
The Company shall have delivered any and all other documents and information that may be requested by the Buyer in connection with the
transactions contemplated herein.
9.
Conditions to the Company’s Obligation to Sell Subsequent Notes. The obligation of the Company hereunder to issue and sell
additional Notes to the Buyer following the initial Closing is subject to the satisfaction, at or before such subsequent Closing Date,
of each of the following conditions set forth in this Section 9, provided that all such conditions are for the Company’s
sole benefit and may be waived by the Company at any time in its sole discretion:
(a)
The Buyer shall have delivered the applicable Purchase Price for the subsequent Note to be purchased on such subsequent Closing Date
in accordance with Section 2(c) above.
(b)
The Buyer shall have delivered to the Company a counterpart of the additional RRA covering the Conversion Shares issuable under such
subsequent Note, duly executed by the Buyer.
(c)
The representations and warranties of the Buyer in this Agreement shall be true and correct in all material respects as of the date when
made and as of the Closing Date, as though made at that time (except for representations and warranties that speak as of a specific date),
and the Buyer shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required
by this Agreement to be performed, satisfied or complied with by the Buyer at or prior to the Closing Date.
(d)
No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority
over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this Agreement.
10.
Conditions to the Buyer’s Obligation to Purchase Subsequent Notes. The obligation of the Buyer hereunder to purchase any
additional Note following the initial Closing is subject to the satisfaction, at or before the subsequent Closing Date with respect to
such additional Note, of each of the following conditions set forth in this Section 10, provided that all such conditions are
for the Buyer’s sole benefit and may be waived by the Buyer at any time in its sole discretion, provided further that this Agreement
will be amended as needed if the Buyer elects to cause another person to provide for the Additional Funds:
(a)
The Company shall have delivered to the Buyer the duly executed subsequent Note to be purchased on such subsequent Closing Date in such
denominations as the Buyer shall request and in accordance with Section 2(c) above.
(b)
The Company shall have delivered to the Buyer an additional RRA covering the Conversion Shares issuable under the applicable subsequent
Note, duly executed by the Company.
(c)
The Irrevocable Transfer Agent Instructions with respect to the applicable subsequent Note and the Conversion Shares issuable thereunder,
in form and substance satisfactory to the Buyer, shall have been delivered to and acknowledged in writing by the Company’s Transfer
Agent.
(d)
The Company shall have delivered evidence satisfactory to the Buyer that Nascent is the sole owner of the Patents, free and clear of
all liens, encumbrances, security interests, and rights of others.
(e)
All Senior Distribution and Contingent Payment Agreements contemplated to be entered into by the Company, Nascent, or any Affiliate of
the Company or Nascent shall have been executed and delivered to the Buyer, including without limitation, (1) the Proposed UCANN Distribution
Agreement, (2) any and all agreements contemplated to be entered into by and among any of the Company and/or Nascent, and Earnest Blackmon
and/or one or more Affiliates of Earnest Blackmon, (3) any and all agreements, instruments or other documents providing for the payment
of any fees to any third party for the provision of legal and/or other services to the Company, Nascent and/or any Affiliate of the Company
or Nascent contingent or payable upon or in connection a successful prosecution of any Patent Claim contemplated to be entered into by
any of the Company, and/or Nascent or any Affiliate of the Company and/or Nascent, and (4) any and all agreements, promissory notes and
other loan, investment and/or financing documents contemplated to be entered into by and among the Company, Nascent, and/or any Affiliate
of the Company with one or more third party lenders or other financial institutions providing for the advance of funds to or on behalf
of the Company, Nascent and/or any Affiliate of the Company or Nascent to be used in connection with the prosecution of any Patent Claim,
and all of such executed Senior Distribution and Contingent Payment Agreements shall be to the satisfaction of the Buyer in its sole
and absolute discretion.
(f)
The Company shall have delivered to the Buyer the duly executed Consents.
(g)
Neither the Company nor Nascent shall have breached or otherwise defaulted on any of its obligations under any Transaction Document executed
and/or delivered prior to such subsequent Closing Date.
(h)
The representations and warranties of the Company in this Agreement and in any other Transaction Document delivered prior to the applicable
subsequent Closing Date shall be true and correct in all material respects as of the date when made and as of applicable subsequent Closing
Date, as though made at such time (except for representations and warranties that speak as of a specific date) and the Company shall
have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required by this Agreement
and any other Transaction Document delivered prior to the applicable Subsequent Closing Date to be performed, satisfied or complied with
by the Company at or prior to the applicable subsequent Closing Date.
(i)
No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority
over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this Agreement.
(j)
No event shall have occurred which could reasonably be expected to have a Material Adverse Effect on the Company including but not limited
to a change in the 1934 Act reporting status of the Company or the failure of the Company to be timely in its 1934 Act reporting obligations.
(k)
Trading in the Common Stock on the Principal Market shall not have been suspended by the SEC, FINRA or the Principal Market.
(l)
The Company shall have delivered to the Buyer a certificate of an officer of the Company, dated as of the applicable subsequent Closing
Date, certifying as to the fulfillment of the conditions set forth in subparagraphs (a) through (h) of this Section.
(m)
From the date hereof to the applicable subsequent Closing Date, trading in the Common Stock shall not have been suspended by the SEC
or the Principal Market and, at any time prior to the applicable subsequent Closing Date, trading in securities generally as reported
by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades
are reported by such service, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such
magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of
Buyer, makes it impracticable or inadvisable to purchase the Securities at the applicable subsequent Closing.
(n)
The Company shall have delivered any and all other documents and information that may be requested by the Buyer in connection with the
transactions contemplated herein on or prior to the applicable subsequent Closing Date.
11.
Governing Law; Miscellaneous.
(a)
Governing Law; Venue. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware without
regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated
by this Agreement, the Note, or any other agreement, certificate, instrument or document contemplated hereby shall be brought only in
the Court of Chancery of the State of Delaware or, to the extent such court does not have subject matter jurisdiction, the United States
District Court for the District of Delaware or, to the extent that neither of the foregoing courts has jurisdiction, the Superior Court
of the State of Delaware. The parties to this Agreement hereby irrevocably waive any objection to jurisdiction and venue of any action
instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens.
EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE
HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTIONS CONTEMPLATED HEREBY. The prevailing party shall
be entitled to recover from the other party its reasonable attorney’s fees and costs. Each party hereby irrevocably waives personal
service of process and consents to process being served in any suit, action or proceeding in connection with this Agreement, the Note,
or any other agreement, certificate, instrument or document contemplated hereby or thereby by mailing a copy thereof via registered or
certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained
herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.
(b)
Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of
which shall constitute one and the same agreement and shall become effective when counterparts have been signed by each party and delivered
to the other party. A facsimile or .pdf signature shall be considered due execution and shall be binding upon the signatory thereto with
the same force and effect as if the signature were an original, not a facsimile or .pdf signature. Delivery of a counterpart signature
hereto by facsimile or email/.pdf transmission shall be deemed validly delivery thereof.
(c)
Construction; Headings. This Agreement shall be deemed to be jointly drafted by the Company and the Buyer and shall not be construed
against any person as the drafter hereof. The headings of this Agreement are for convenience of reference only and shall not form part
of, or affect the interpretation of, this Agreement.
(d)
Severability. In the event that any provision of the Transaction Documents is invalid or unenforceable under any applicable statute
or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified
to conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect
the validity or enforceability of any other provision of this Agreement, the Note, or any other agreement, certificate, instrument or
document contemplated hereby or thereby.
(e)
Entire Agreement; Amendments. The Transaction Documents contain the entire understanding of the parties with respect to the matters
covered herein and therein and, except as specifically set forth herein or therein, neither the Company nor the Buyer makes any representation,
warranty, covenant or undertaking with respect to such matters. No provision of this Agreement or any agreement or instrument contemplated
hereby may be waived or amended other than by an instrument in writing signed by the Buyer.
(f)
Notices. All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be
in writing and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified,
return receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted
by hand delivery, telegram, e-mail or facsimile, addressed as set forth below or to such other address as such party shall have specified
most recently by written notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective
(a) upon hand delivery or delivery by e-mail or facsimile, with accurate confirmation generated by the transmitting facsimile machine,
at the address or number designated below (if delivered on a Business Day during normal business hours where such notice is to be received),
or the first Business Day following such delivery (if delivered other than on a Business Day during normal business hours where such
notice is to be received) or (b) on the second Business Day following the date of mailing by express courier service, fully prepaid,
addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses for such communications
shall be:
If
to the Company, to:
CAN
B̅ CORP.
960
South Broadway, Suite 120
Hicksville,
NY 11801
Attention:
Marco Alfonsi
e-mail:
info@canbiola.com
If
to the Buyer:
As
provided on the signature page hereto
(g)
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
assigns. The Company shall not assign this Agreement or any rights or obligations hereunder without the prior written consent of the
Buyer. The Buyer may assign its rights hereunder to any “accredited investor” (as defined in Rule 501(a) of the 1933 Act)
in a private transaction from the Buyer or to any of its “affiliates,” as that term is defined under the 1934 Act, without
the consent of the Company.
(h)
Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted successors
and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other person.
(i)
Survival. The representations and warranties of the Company and the agreements and covenants set forth in this Agreement shall
survive the closing hereunder notwithstanding any due diligence investigation conducted by or on behalf of the Buyer. The Company agrees
to indemnify and hold harmless the Buyer and all their officers, directors, employees and agents for loss or damage arising as a result
of or related to any breach or alleged breach by the Company of any of its representations, warranties and covenants set forth in this
Agreement or any of its covenants and obligations under this Agreement, including advancement of expenses as they are incurred.
(j)
Publicity. The Company, and the Buyer shall have the right to review a reasonable period of time before issuance of any press
releases, SEC, Principal Market or FINRA filings, or any other public statements with respect to the transactions contemplated hereby;
provided, however, that the Company shall be entitled, without the prior approval of the Buyer, to make any press release
or SEC, Principal Market (or other applicable trading market) or FINRA filings with respect to such transactions as is required by applicable
law and regulations (although the Buyer shall be consulted by the Company in connection with any such press release prior to its release
and shall be provided with a copy thereof and be given an opportunity to comment thereon).
(k)
Further Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and
shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request
in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated
hereby.
(l)
No Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against any party.
(m)
Indemnification. In consideration of the Buyer’s execution and delivery of this Agreement and acquiring the Securities hereunder,
and in addition to all of the Company’s other obligations under this Agreement or the Note, the Company shall defend, protect,
indemnify and hold harmless the Buyer and its stockholders, partners, members, officers, directors, employees and direct or indirect
investors and any of the foregoing persons’ agents or other representatives (including, without limitation, those retained in connection
with the transactions contemplated by this Agreement) (collectively, the “Indemnitees”) from and against any and all
actions, causes of action, suits, claims, losses, costs, penalties, fees, liabilities and damages, and expenses in connection therewith
(irrespective of whether any such Indemnitee is a party to the action for which indemnification hereunder is sought), and including reasonable
attorneys’ fees and disbursements (the “Indemnified Liabilities”), incurred by any Indemnitee as a result of,
or arising out of, or relating to (i) any misrepresentation or breach of any representation or warranty made by the Company in the Transaction
Documents, (ii) any breach of any covenant, agreement or obligation of the Company contained in the Transaction Documents or (iii) any
cause of action, suit or claim brought or made against such Indemnitee by a third party (including for these purposes a derivative action
brought on behalf of the Company) and arising out of or resulting from (A) the execution, delivery, performance or enforcement of the
Transaction Documents, (B) any transaction financed or to be financed in whole or in part, directly or indirectly, with the proceeds
of the issuance of the Securities, or (C) the status of the Buyer or holder of the Securities as an investor in the Company pursuant
to the transactions contemplated by this Agreement. To the extent that the foregoing undertaking by the Company may be unenforceable
for any reason, the Company shall make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities
that is permissible under applicable law.
(n)
Remedies. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Buyer by
vitiating the intent and purpose of the transaction contemplated hereby. Accordingly, the Company acknowledges that the remedy at law
for a breach of its obligations under this Agreement, the Note or any other agreement, certificate, instrument or document contemplated
hereby or thereby will be inadequate and agrees, in the event of a breach or threatened breach by the Company of the provisions of this
Agreement, the Note, or any other agreement, certificate, instrument or document contemplated hereby or thereby, that the Buyer shall
be entitled, in addition to all other available remedies at law or in equity, and in addition to the penalties assessable herein, to
an injunction or injunctions restraining, preventing or curing any breach of this Agreement, the Note or any other agreement, certificate,
instrument or document contemplated hereby or thereby, and to enforce specifically the terms and provisions hereof and thereof, without
the necessity of showing economic loss and without any bond or other security being required.
(o)
Payment Set Aside. To the extent that the (i) Company makes a payment or payments to the Buyer hereunder, pursuant to the Note
or pursuant to any other agreement, certificate, instrument or document contemplated hereby or thereby, or (ii) the Buyer enforces or
exercises its rights hereunder, pursuant to the Note, or pursuant to any other agreement, certificate, instrument or document contemplated
hereby or thereby, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof (including but not
limited to the sale of the Securities) are for any reason (A) subsequently invalidated, declared to be fraudulent or preferential, set
aside, recovered from, or disgorged by the Buyer, or (B) are required to be refunded, repaid or otherwise restored to the Company, a
trustee, receiver or any other person or entity under any law (including, without limitation, any bankruptcy law, foreign, state or federal
law, common law or equitable cause of action), then (1) to the extent of any such restoration the obligation or part thereof originally
intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement
or setoff had not occurred and (2) the Company shall immediately pay to the Buyer a dollar amount equal to the amount that was for any
reason (x) subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, or disgorged by the Buyer,
or (y) required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other person or entity under
any law (including, without limitation, any bankruptcy law, foreign, state or federal law, common law or equitable cause of action).
(p)
Failure or Indulgence Not Waiver. No failure or delay on the part of the Buyer in the exercise of any power, right or privilege
hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude
other or further exercise thereof or of any other right, power or privileges. All rights and remedies of the Buyer existing hereunder
are cumulative to, and not exclusive of, any rights or remedies otherwise available.
[Signature
Page Follows]
IN
WITNESS WHEREOF, the undersigned Buyer and the Company have caused this Agreement to be duly executed as of the date first above written.
COMPANY:
CAN
B̅ CORP.
By:
|
/s/ MARCO ALFONSI |
|
Name: |
MARCO ALFONSI |
|
Title: |
CHIEF EXECUTIVE OFFICER |
|
BUYER:
Walleye
Opportunities Master Fund Ltd
By: |
/s/ William England |
|
Name: |
William England |
|
Title: |
Chief Executive Officer of the Manager |
|
Address
for Notice: 2800 Niagara Lane North, Plymouth, MN 55447
E-mail
for Notice: legal@walleyecapital.com
Exhibit
A
FORM
OF NOTE
(omitted)
Exhibit
B
FORM
OF DISTRIBUTION AND ASSIGNMENT AGREEMENT
(omitted)
Exhibit
C
PIGGY-BACK
REGISTRATION RIGHTS
All
of the Conversion Shares shall be deemed “Registrable Securities” subject to the provisions of this Exhibit C. All
capitalized terms used but not defined in this Exhibit C shall have the meanings ascribed to such terms in the Securities Purchase Agreement
to which this Exhibit is attached.
| 1. | Piggy-Back
Registration. |
1.1
Piggy-Back Rights. If, at any time on or after the date of the Closing, the Company proposes to file any Registration Statement
under the 1933 Act (a “Registration Statement”) with respect to any offering of equity securities, or securities or
other obligations exercisable or exchangeable for, or convertible into, equity securities, by the Company for its own account or for
shareholders of the Company for their account (or by the Company and by shareholders of the Company), other than a Registration Statement
(i) filed in connection with any employee stock option or other benefit plan on Form S-8, (ii) for a dividend reinvestment plan, (iii)
in connection with a merger or acquisition, or (iv) for the Uplist Offering, then the Company shall (x) give written notice of such proposed
filing to the holders of Registrable Securities appearing on the books and records of the Company as such a holder as soon as practicable
but in no event less than ten (10) days before the anticipated filing date of the Registration Statement, which notice shall describe
the amount and type of securities to be included in such Registration Statement, the intended method(s) of distribution, and the name
of the proposed managing underwriter or underwriters, if any, of the offering, and (y) offer to the holders of Registrable Securities
in such notice the opportunity to register the sale of such number of Registrable Securities as such holders may request in writing within
three (3) days following receipt of such notice (a “Piggy-Back Registration”). The Company shall cause such Registrable
Securities to be included in such registration, subject in the case of an underwritten offering to customary underwriter cutback provisions,
and shall cause the managing underwriter or underwriters of a proposed underwritten offering to permit the Registrable Securities requested
to be included in a Piggy-Back Registration on the same terms and conditions as any similar securities of the Company and to permit the
sale or other disposition of such Registrable Securities in accordance with the intended method(s) of distribution thereof (with the
understanding that the Company shall file the initial prospectus covering the Buyer’s sale of the Registrable Securities at prevailing
market prices on the same date that the Registration Statement is declared effective by the SEC).
1.2
Withdrawal. Any holder of Registrable Securities may elect to withdraw such holder’s request for inclusion of Registrable
Securities in any Piggy-Back Registration by giving written notice to the Company of such request to withdraw prior to the effectiveness
of the Registration Statement. The Company (whether on its own determination or as the result of a withdrawal by persons making a demand
pursuant to written contractual obligations) may withdraw a Registration Statement at any time prior to the effectiveness of such Registration
Statement. Notwithstanding any such withdrawal, the Company shall pay all expenses incurred by the holders of Registrable Securities
in connection with such Piggy-Back Registration as provided in Section 1.5 below.
1.3
The Company shall notify the holders of Registrable Securities at any time when a prospectus relating to such holder’s Registrable
Securities is required to be delivered under the 1933 Act, upon discovery that, or upon the happening of any event as a result of which,
the prospectus included in such Registration Statement, as then in effect, includes an untrue statement of a material fact or omits to
state any material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances
then existing. At the request of such holder, the Company shall also prepare, file and furnish to such holder a reasonable number of
copies of a supplement to or an amendment of such prospectus as may be necessary so that, as thereafter delivered to the purchasers of
the Registrable Securities, such prospectus shall not include an untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing.
The holders of Registrable Securities shall not to offer or sell any Registrable Securities covered by the Registration Statement after
receipt of such notification until the receipt of such supplement or amendment.
1.4
The Company may request a holder of Registrable Securities to furnish the Company such information with respect to such holder and such
holder’s proposed distribution of the Registrable Securities pursuant to the Registration Statement as the Company may from time
to time reasonably request in writing or as shall be required by law or by the SEC in connection therewith, and such holders shall furnish
the Company with such information.
1.5
All fees and expenses incident to the performance of or compliance with this Exhibit C by the Company shall be borne by the Company whether
or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred to in the foregoing sentence
shall include, without limitation,(i) all registration and filing fees
(including, without limitation, fees and expenses of the Company’s counsel and independent registered public accountants) (A) with
respect to filings made with the SEC, (B) with respect to filings required to be made with any trading market on which the Common Stock
is then listed for trading, (C) in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the Company in
writing (including, without limitation, fees and disbursements of counsel for the Company in connection with Blue Sky qualifications
or exemptions of the Registrable Securities) and (D) with respect to any filing that may be required to be made by any broker through
which a holder of Registrable Securities intends to make sales of Registrable Securities with the FINRA, (ii) printing expenses, (iii)
messenger, telephone and delivery expenses, (iv) fees and disbursements of counsel for the Company, (v) 1933 Act liability insurance,
if the Company so desires such insurance, (vi) fees and expenses of all other persons or entities retained by the Company in connection
with the consummation of the transactions contemplated by this Exhibit C and (vii) reasonable fees and disbursements of a single special
counsel for the holders of Registrable Securities (selected by holders of the majority of the Registrable Securities requesting such
registration). In addition, the Company shall be responsible for all of its internal expenses incurred in connection with the consummation
of the transactions contemplated by this Agreement (including, without limitation, all salaries and expenses of its officers and employees
performing legal or accounting duties), the expense of any annual audit and the fees and expenses incurred in connection with the listing
of the Registrable Securities on any securities exchange as required hereunder. In no event shall the Company be responsible for any
broker or similar commissions of any holder of Registrable Securities.
1.6
The Company and its successors and assigns shall indemnify and hold harmless the Buyer, each holder of Registrable Securities, the officers,
directors, members, partners, agents and employees (and any other individuals or entities with a functionally equivalent role of a person
holding such titles, notwithstanding a lack of such title or any other title) of each of them, each individual or entity who controls
the Buyer or any such holder of Registrable Securities (within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act)
and the officers, directors, members, stockholders, partners, agents and employees (and any other individuals or entities with a functionally
equivalent role of a person holding such titles, notwithstanding a lack of such title or any other title) of each such controlling individual
or entity (each, an “Indemnified Party”), to the fullest extent permitted by applicable law, from and against any
and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable attorneys’ fees) and expenses (collectively,
“Losses”), as incurred, arising out of or relating to (1) any untrue or alleged untrue statement of a material fact
contained in a Registration Statement, any related prospectus or any form of prospectus or in any amendment or supplement thereto or
in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated
therein or necessary to make the statements therein (in the case of any such prospectus or supplement thereto, in light of the circumstances
under which they were made) not misleading or (2) any violation or alleged violation by the Company of the 1933 Act, the 1934 Act or
any state securities law, or any rule or regulation thereunder, in connection with the performance of its obligations under this Exhibit
C, except to the extent, but only to the extent, that (i) such untrue statements or omissions are based upon information regarding the
Buyer or such holder of Registrable Securities furnished to the Company by such party for use therein. The Company shall notify the Buyer
and each holder of Registrable Securities promptly of the institution, threat or assertion of any proceeding arising from or in connection
with the transactions contemplated by this Exhibit C of which the Company is aware.
1.7
If the indemnification under Section 1.6 is unavailable to an Indemnified Party or insufficient to hold an Indemnified Party harmless
for any Losses, then the Company shall contribute to the amount paid or payable by such Indemnified Party, in such proportion as is appropriate
to reflect the relative fault of the Company and Indemnified Party in connection with the actions, statements or omissions that resulted
in such Losses as well as any other relevant equitable considerations. The relative fault of the Company and Indemnified Party shall
be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of
a material fact or omission or alleged omission of a material fact, has been taken or made by, or relates to information supplied by,
the Company or the Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity to correct
or prevent such action, statement or omission. The amount paid or payable by a party as a result of any Losses shall be deemed to include
any reasonable attorneys’ or other fees or expenses incurred by such party in connection with any proceeding to the extent such
party would have been indemnified for such fees or expenses if the indemnification provided for in Section 1.6 was available to such
party in accordance with its terms. It is agreed that it would not be just and equitable if contribution pursuant to this Section 1.7
were determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations
referred to in the immediately preceding sentence. Notwithstanding the provisions of this Section 1.7, neither the Buyer nor any holder
of Registrable Securities shall be required to contribute, in the aggregate, any amount in excess of the amount by which the net proceeds
actually received by such party from the sale of all of their Registrable Securities pursuant to such Registration Statement or related
prospectus exceeds the amount of any damages that such party has otherwise been required to pay by reason of such untrue or alleged untrue
statement or omission or alleged omission.
[End
of Exhibit C]
Exhibit
D
FORM
OF REGISTRATION RIGHTS AGREEMENT
(omitted)
Exhibit
E
FORM
OF CONSOLIDATED AMENDED AND RESTATED WALLEYE NOTE
(omitted)
Exhibit
9.2
NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED
FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH MAY BE THE LEGAL COUNSEL OPINION (AS DEFINED IN THE SPA)), IN A GENERALLY
ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144, RULE 144A OR REGULATION S
UNDER SAID ACT OR OTHER APPLICABLE EXEMPTION. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA
FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.
Principal
Amount: $156,250 |
Issue
Date: October 27, 2023 |
Actual
Amount of Purchase Price: $125,000 |
|
PROMISSORY
NOTE (this “Note”)
FOR
VALUE RECEIVED, CAN B̅ CORP., a Florida corporation (hereinafter called the “Borrower”) (Trading Symbol:
CANB), hereby promises to pay to the order of Walleye Opportunities Master Fund Ltd, a Cayman Islands exempted company with limited liability,
or its registered assigns (the “Holder”), in the form of lawful money of the United States of America, the principal
sum of $156,250.00 (the “Principal Amount”), of which $125,000 is the actual amount of the purchase price (the “Consideration”)
hereof plus an original issue discount in the amount of $31,250 (the “OID”) (subject to adjustment herein) on the
date the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise, as further provided herein.
The entire Principal Amount, together with any accrued and unpaid Default Interest and any other unpaid fees or other amounts outstanding
under this Note shall be due and payable on October 27, 2024 (the “Maturity Date”), or on such earlier date as all
or any portion of the Principal Amount, any such accrued and unpaid Default Interest and/or any such other unpaid fees and/or other amounts
outstanding under this Note may be due and payable in accordance with the terms of this Note, whether upon acceleration or otherwise
in accordance with the terms of this Note.
This
Note may not be prepaid or repaid in whole or in part except as otherwise explicitly set forth herein.
All
payments due hereunder (to the extent not converted into shares of common stock, nil par value per share, of the Borrower (the “Common
Stock”) in accordance with the terms hereof) shall be made in lawful money of the United States of America. As used herein,
“$” or “Dollars” means United States Dollars. All payments shall be made at such address as the
Holder shall hereafter give to the Borrower by written notice made in accordance with the provisions of this Note. Whenever any amount
expressed to be due by the terms of this Note is due on any day which is not a Business day, the same shall instead be due on the next
succeeding day which is a Business day.
Each
capitalized term used herein, and not otherwise defined, shall have the meaning ascribed thereto in that certain Securities Purchase
Agreement, dated as of October 26, 2023, by and between the Borrower and the Holder, and pursuant to which this Note is being issued
(as amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “SPA”). As
used in this Note, the term “Issue Date” means October 27, 2023 (i.e. the date first written above). As used in this
Note, the term “Business Day” shall mean any day other than a Saturday, Sunday or a day on which commercial banks
in the city of New York, New York are authorized or required by law or executive order to remain closed; provided, for the avoidance
of doubt, that no such commercial banks shall be considered to be authorized or required by law or executive order to remain closed as
a result of “stay at home”, “shelter-in-place”, “non-essential employee” or other similar orders
or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic
funds transfer systems (including for wire transfers) of such commercial banks are generally open for sue by customers on such day. As
used herein, the term “Trading Day” means any day that shares of Common Stock are listed for trading or quotation
on the Principal Market, provided, however, that if the Common Stock is not then listed or quoted on any Principal Market, then any calendar
day. “Principal Market” shall mean the principal securities exchange or trading market where the Common Stock is listed
or traded, including but not limited to any tier of the OTC Markets, any tier of the NASDAQ Stock Market (including NASDAQ Capital Market),
or the NYSE American, or any successor to such markets.
This
Note is free from all taxes, liens, claims and encumbrances with respect to the issue thereof and shall not be subject to preemptive
rights or other similar rights of shareholders of the Borrower and will not impose personal liability upon the holder thereof.
The
following terms shall also apply to this Note:
ARTICLE
I. CONVERSION RIGHTS
1.1
Conversions.
(a)
At any time after the Issue Date until this Note is no longer outstanding, this Note (including the outstanding Principal Amount of this
Note, any accrued and unpaid Default Interest and any other obligation of the Borrower payable under Section 3.2(a) the payment
of which the Holder elects to accept in Common Stock) shall be convertible, in whole or in part, into shares of Common Stock at the option
of the Holder, at any time and from time to time (subject to the conversion limitations set forth in this Article I). The Holder
shall effect such conversions (“Conversions”) by delivering to the Borrower or the Borrower’s transfer agent
a notice of conversion, (i) in the case of any Conversion effected prior to the occurrence of any Event of Default, the form of which
is attached hereto as Annex A-1, specifying therein the principal amount of this Note to be converted and the date on which such
Conversion shall be effected (such date, the “Conversion Date”), or in the case of any Conversion effected upon or
after the occurrence of any Event of Default, the form of which is attached hereto as Annex A-2, specifying therein the principal
amount of this Note to be converted (including any principal amount of this Note included in any Default Amount of this Note to be so
converted), any accrued and unpaid Default Interest and any other obligation of the Borrower payable under Section 3.2(a) the
payment of which the Holder elects to accept in Common Stock to be converted, and the Conversion Date on which such Conversion shall
be effected (each such notice of conversion described under either of the foregoing clauses (i) or (ii) of this sentence, a “Notice
of Conversion”), and which Notice of Conversion shall be delivered to the Borrower or the Borrower’s transfer agent in
the manner set forth in Section 1.4(a); provided, notwithstanding anything to the contrary set forth herein, the Conversion
Date with respect to any Conversion effected pursuant to delivery of any Notice of Conversion (including any Notice of Conversion specifying
a particular Conversion Date and any Notice of Conversion that does not specify a Conversion Date) shall be determined in accordance
with Section 1.4(a). No ink-original Notice of Conversion shall be required, nor shall any medallion guarantee (or other type
of guarantee or notarization) of any Notice of Conversion form be required. Conversions hereunder, (i) in the case of any Conversion
effected prior to the occurrence of any Event of Default, shall have the effect of lowering the amount of outstanding principal amount
of this Note in an amount equal to the applicable principal amount so converted, or (ii) in the case of any Conversion effected upon
or after the occurrence of any Event of Default, shall have the effect of lowering the amount of outstanding obligation(s) of the Borrower
payable under Section 3.2(a) by an amount equal to the applicable amount of any outstanding obligation(s) of the Borrower payable
under Section 3.2(a) the payment of which the Holder elects to accept in Common Stock.
(b)
Conversion Price. Conversions of this Note pursuant to this Section 1.1 and/or Section 3.2(a) shall be effected
at a conversion price equal to the Conversion Price. As used in this Note, the term “Conversion Price” means, with
respect to any Conversion, a price per share of the Borrower’s Common Stock, equal to 90% of the lowest daily VWAP of the Common
Stock during the fifteen (15) Trading Day period prior to the Conversion Date with respect to such Conversion; provided; notwithstanding
anything to the contrary set forth in this Section 1.1, the Conversion Price shall be subject to adjustment in accordance with
the terms and conditions of this Note, including without limitation upon the occurrence of an Event of Default as set forth in Section
3.2(a) and upon the occurrence of certain events as set forth in Section 1.6. Subject to Section 1.4(f), the number
of shares of Common Stock issuable to the Holder upon any Conversion pursuant to this Section 1.1 and/or Section 3.2(a)
as applicable, shall be equal to the ratio calculated by dividing (A) the amount in Dollars of the outstanding obligations of the Borrower
under this Note elected by the Holder to be converted (which for the avoidance of doubt, shall (i) in the case of any Conversion effected
prior to the occurrence of any Event of Default, be limited to the outstanding Principal Amount under this Note at the time of such Conversion,
and (ii) in the case of any Conversion effected upon or after the occurrence of any Event of Default, may include any obligation of the
Borrower payable under Section 3.2(a) the payment of which the Holder elects to accept in Common Stock, including without limitation
the Default Amount) by (B) the Conversion Price.
“VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (i) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (ii) if the Common Stock is not then listed or quoted for trading on OTCQB
or OTCQX or any other Trading Market, and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (iii)
in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith
by the Holder and reasonably acceptable to the Borrower, the fees and expenses of which shall be paid by the Borrower. “Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).
1.2
Conversion Schedule; Records. The Holder and the Borrower shall maintain a Conversion Schedule showing the principal amount(s)
converted (and as applicable, any other obligations of the Borrower under this Note converted, including without limitation, the amount
of any accrued and unpaid Default Interest and any other obligation of the Borrower payable under Section 3.2(a) the payment of
which the Holder elects to accept in Common Stock) and the date of any and all Conversion(s) effected. The Borrower may deliver an objection
to any Notice of Conversion within one (1) Business Day of delivery by the Holder of such Notice of Conversion. In the event of any dispute
or discrepancy, the records of the Holder shall be controlling and determinative in the absence of manifest error.
1.3
Authorized and Reserved Shares. The Borrower covenants that at all times until the Note is satisfied in full, the Borrower will
reserve from its authorized and unissued Common Stock a sufficient number of shares, free from preemptive rights, to provide for the
issuance of a number of Conversion Shares equal to the product calculated by multiplying (A) the sum of the number of Conversion Shares
issuable upon the full conversion of this Note (assuming no payment of Principal Amount or interest) at the time of such calculation
(taking into consideration any adjustments to the Conversion Price as provided in this Note) by (B) three (3) (the “Reserved
Amount”). The Borrower represents that upon issuance, the Conversion Shares will be duly and validly issued, fully paid and
non-assessable. The Borrower (i) acknowledges that it has irrevocably instructed its transfer agent to issue certificates for the Conversion
Shares or instructions to have the Conversion Shares issued as contemplated by Section 1.4(e) hereof, and (ii) agrees that its
issuance of this Note shall constitute full authority to its officers and agents who are charged with the duty of executing stock certificates
or cause the Borrower to electronically issue shares of Common Stock to execute and issue the necessary certificates for the Conversion
Shares or cause the Conversion Shares to be issued as contemplated by Section 1.4(e) hereof in accordance with the terms and conditions
of this Note.
If,
at any time the Borrower does not maintain the Reserved Amount it will be considered an Event of Default (as defined in this Note) under
Section 3.1(c) of this Note. If, on any date, the number of authorized but unissued (and
otherwise unreserved) shares of Common Stock is less than the Reserved Amount on such date, then the board of directors of the Borrower
shall use commercially reasonable efforts to amend the Borrower’s certificate or articles of incorporation to increase the number
of authorized but unissued shares of Common Stock to at least the Reserved Amount at such time, as soon as possible and in any event
not later than the 90th day after such date. The Borrower shall, if applicable: (A) in the time and manner required by the Principal
Market, prepare and file with such Principal Market an additional shares listing application covering a number of shares of Common Stock,
equal to or greater than the Reserved Amount if such application is made within 45 days of the Issue Date, (B) take all steps necessary
to cause such shares of Common Stock to be approved for listing or quotation on such Principal Market as soon as possible thereafter,
(C) provide to the Holder evidence of such listing or quotation and (D) maintain the listing or quotation of a number of shares of such
Common Stock on such Principal Market or another Principal Market on any date equal to or greater than the Reserved Amount if such date
is within 45 days of the Issue Date. The Borrower agrees to maintain the eligibility of the Common Stock for electronic transfer through
the DTC or another established clearing corporation, including, without limitation, by timely payment of fees to the DTC or such other
established clearing corporation in connection with such electronic transfer.
1.4
Method of Conversion.
(a)
Mechanics of Conversion. Conversions of this Note may be effected by the Holder pursuant to Section 1.1 and/or Section
3.2(a) by Holder’s submission to the Borrower or the Borrower’s transfer agent of a Notice of Conversion sent via by
facsimile, e-mail or other reasonable means of communication. The Conversion Date specified in the Notice of Conversion shall be the
Conversion Date with respect to the applicable Conversion so long as the Notice of Conversion is sent to the Borrower or the Borrower’s
transfer via by facsimile, e-mail or other reasonable means of communication before 5:30 p.m. (New York City time), on such date specified
in the Notice of Conversion. Any Notice of Conversion submitted after 5:30 p.m. (New York City time) on any given date shall be deemed
to have been delivered and received on the next Trading Day, which date shall be deemed to be the Conversion Date with respect to the
applicable Conversion effected pursuant to such Notice of Conversion regardless of the Conversion Date specified in the Notice of Conversion.
If no Conversion Date is specified in a Notice of Conversion, the Conversion Date with respect to the applicable Conversion shall be
deemed to be (i) the date that such Notice of Conversion is sent to the Borrower or the Borrower’s transfer via by facsimile, e-mail
or other reasonable means of communication, if such Notice of Conversion is sent to the Borrower or the Borrower’s transfer via
by facsimile, e-mail or other reasonable means of communication before 5:30 p.m. (New York City time) on such date or (ii) the next Trading
Day immediately following the date that such Notice of Conversion is sent to the Borrower or the Borrower’s transfer via by facsimile,
e-mail or other reasonable means of communication, if such Notice of Conversion is sent to the Borrower or the Borrower’s transfer
via by facsimile, e-mail or other reasonable means of communication after 5:30 p.m. (New York City time) on such date.
(b)
Surrender of Note Upon Conversion. Notwithstanding anything to the contrary set forth herein, upon conversion of this Note in
accordance with the terms hereof, the Holder shall not be required to physically surrender this Note to the Borrower unless the entire
unpaid Principal Amount of this Note (together with any accrued and unpaid Default Interest, and any other obligation of the Borrower
payable under Section 3.2(a) the payment of which the Holder elects to accept in Common Stock, and any other fee or other amount
permitted to be converted pursuant to this Note) has been so converted and all obligations of the Borrower owing under this Note have
been paid in full, including without limitation any accrued and unpaid Default Interest and any other fees and/or other amounts owing
by the Borrower under this Note. The Holder and the Borrower shall maintain records showing the Principal Amount (and, as applicable,
the amount of any accrued and unpaid Default Interest, any other obligation of the Borrower payable under Section 3.2(a) the payment
of which the Holder elects to accept in Common Stock, and any other fee or other amount permitted to be converted pursuant to this Note)
so converted and the dates of such conversions or shall use such other method, reasonably satisfactory to the Holder and the Borrower,
so as not to require physical surrender of this Note upon each such conversion. In the event of any dispute or discrepancy, such records
of the Holder shall be controlling and determinative in the absence of manifest error. Notwithstanding the foregoing, if any portion
of this Note is converted as aforesaid, the Holder may not transfer this Note unless the Holder first physically surrenders this Note
to the Borrower, whereupon the Borrower will forthwith issue and deliver upon the order of the Holder a new Note of like tenor, registered
as the Holder (upon payment by the Holder of any applicable transfer taxes) may request, representing in the aggregate the remaining
unpaid Principal Amount of this Note (together with any accrued and unpaid Default Interest and any other obligations of the Borrower
then owing under this Note, including without limitation any fees and/or other amounts then owing by the Borrower under this Note). The
Holder and any assignee, by acceptance of this Note, acknowledge and agree that, by reason of the provisions of this paragraph, following
conversion of a portion of this Note, the unpaid and unconverted Principal Amount of this Note represented by this Note may be less than
the amount stated on the face hereof.
(c)
Payment of Taxes and Expenses. The Borrower shall not be required to pay any tax which may be payable in respect of any transfer
involved in the issue and delivery of shares of Common Stock or other securities or property on conversion of this Note in a name other
than that of the Holder (or in street name), and the Borrower shall not be required to issue or deliver any such shares or other securities
or property unless and until the person or persons (other than the Holder or the custodian in whose street name such shares are to be
held for the Holder’s account) requesting the issuance thereof shall have paid to the Borrower the amount of any such tax or shall
have established to the satisfaction of the Borrower that such tax has been paid. Notwithstanding the foregoing, the issuance of Conversion
Shares on conversion of this Note shall be made without charge to the Holder for any documentary stamp or similar taxes that may be payable
in respect of the issue or delivery of such Conversion Shares. The Borrower shall pay all transfer agent fees required for same-day processing
of any Notice of Conversion and all fees to the DTC (or another established clearing corporation performing similar functions) required
for same-day electronic delivery of the Conversion Shares. The Borrower shall pay all attorney fees required for the issuance of attorney
legal opinions for removal of restrictive legends on Conversion Shares.
(d)
Delivery of Common Stock Upon Conversion. Upon receipt by the Borrower or the Borrower’s transfer agent from the Holder
of any Notice of Conversion submitted in accordance with Section 1.4(a) and otherwise meeting the requirements for conversion
as provided in this Section 1.4, the Borrower shall issue and deliver or cause to be issued and delivered to or upon the order
of the Holder certificates for the applicable Conversion Shares (or cause the electronic delivery of such Conversion Shares as contemplated
by Section 1.4(f) hereof) within one (1) Trading Day after such receipt (any such date, a “Deadline”). If the
Borrower shall fail for any reason or for no reason to issue to the Holder on or prior to the applicable Deadline a certificate for the
number of Conversion Shares or to which the Holder is entitled hereunder and register such Conversion Shares on the Borrower’s
share register or to credit the Holder’s balance account with DTC (as defined below) for such number of Conversion Shares to which
the Holder is entitled upon any Conversion of this Note (a “Conversion Failure”), then, in addition to all other remedies
available to the Holder, (i) the Borrower shall pay in cash to the Holder on each day after such Deadline and during such Conversion
Failure an amount equal to 2.0% of the product of (A) the sum of the number of Conversion Shares not issued to the Holder on or prior
to the applicable Deadline and to which the Holder is entitled and (B) the VWAP of the Common Stock on the Trading Day immediately preceding
the last possible date which the Borrower could have issued such Conversion Shares to the Holder without violating this Section 1.5(d);
and (ii) upon written notice to the Borrower, the Holder may void all or any portion of the Notice of Conversion submitted by the Holder
to effect such Conversion; provided that the voiding of all or any portion of any Notice of Conversion shall not affect the Borrower’s
obligations to make any payments which have accrued prior to the date of such notice. In addition to the foregoing, if on or prior to
the applicable Deadline, the Borrower shall fail to issue and deliver a certificate to the Holder and register such Conversion Shares
on the Borrower’s share register or credit the Holder’s balance account with DTC for the number of Conversion Shares to which
the Holder is entitled upon any Conversion of this Note or pursuant to the Borrower’s obligation pursuant to clause (ii) below,
and if on or after such Trading Day the Holder purchases (in an open market transaction or otherwise) shares of Common Stock to deliver
in satisfaction of a sale by the Holder of shares of Common Stock issuable upon such Conversion of this Note that the Holder anticipated
receiving from the Borrower, then the Borrower shall, within two (2) Trading Days after the Holder’s request and in the Holder’s
discretion, either (i) pay cash to the Holder in an amount equal to the Holder’s total purchase price (including brokerage commissions
and other reasonable and customary out-of-pocket expenses, if any) for the shares of Common Stock so purchased (the “Buy-In
Price”), at which point the Borrower’s obligation to deliver such certificate (and to issue such Conversion Shares) or
credit such Holder’s balance account with DTC for such Conversion Shares shall terminate, or (ii) promptly honor its obligation
to deliver to the Holder a certificate or certificates representing such Conversion Shares or credit such Holder’s balance account
with DTC and pay cash to the Holder in an amount equal to the excess (if any) of the Buy-In Price over the product of (A) such number
of shares of Common Stock multiplied by (B) the closing sales price of the Common Stock on the date of applicable Deadline. Nothing
shall limit the Holder’s right to pursue any other remedies available to it hereunder, at law or in equity, including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Borrower’s failure to timely deliver
certificates representing the Conversion Shares (or to electronically deliver such Conversion Shares) upon the conversion of this Note
as required pursuant to the terms hereof.
(e)
Obligation to Deliver Common Stock. Upon receipt by the Borrower or the Borrower’s transfer agent from the Holder of any
Notice of Conversion submitted in accordance with Section 1.4(a) and otherwise meeting the requirements for conversion as provided
in this Section 1.4, the Holder shall be deemed to be the holder of record of the Conversion Shares issuable upon the Conversion
of the Principal Amount (and, as applicable any accrued and unpaid Default Interest and any other obligation of the Borrower payable
under Section 3.2(a) the payment of which the Holder elects to accept in Common Stock pursuant to such Conversion) effected pursuant
to the submission of such Notice of Conversion, the outstanding Principal Amount under this Note (and, as applicable, any accrued and
unpaid Default Interest and any other obligation of the Borrower payable under Section 3.2(a) the payment of which the Holder
elects to accept in Common Stock pursuant to such Conversion) shall be reduced to reflect such Conversion in accordance with Section
1.1, and, unless the Borrower defaults on any of its obligations under this Article I (including without limitation, delivery
of the Conversion Shares with respect to such Conversion by the applicable Deadline with respect to such Conversion), all rights with
respect to the portion of the Principal Amount of this Note (and, as applicable, any accrued and unpaid Default Interest and any other
obligation of the Borrower payable under Section 3.2(a) the payment of which the Holder elects to accept in Common Stock pursuant
to such Conversion) being so converted shall forthwith terminate except the right of the Holder to receive the Common Stock or other
securities, cash or other assets, as herein provided, on such Conversion. If the Holder shall have submitted a Notice of Conversion as
provided herein, the Borrower’s obligation to issue and deliver the certificates for the Conversion Shares (or cause the electronic
delivery of the Conversion Shares as contemplated by Section 1.4(f) hereof) shall be absolute and unconditional, irrespective
of the absence of any action by the Holder to enforce the same, any waiver or consent with respect to any provision thereof, the recovery
of any judgment against any person or any action to enforce the same, any failure or delay in the enforcement of any other obligation
of the Borrower to the holder of record, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged
breach by the Holder of any obligation to the Borrower, and irrespective of any other circumstance which might otherwise limit such obligation
of the Borrower to the Holder in connection with such conversion. The Conversion Date with respect to any Conversion shall be determined
in accordance with Section 1.4(a) hereof.
(ii)
Delivery of Conversion Shares by Electronic Transfer. Not later than the applicable Deadline with respect to any Conversion Shares
issuable upon any Conversion of this Note, upon request of the Holder and its compliance with the provisions contained in (i) this Section
1.4 and (ii) Section 1.1 (with respect to any Conversion effected pursuant to Section 1.1 and/or Section 3.2(a),
the Borrower shall cause the Conversion Shares required to be issued hereunder pursuant to such Conversion to be electronically transmitted
by the Borrower’s transfer agent to the Holder by crediting the account of the Holder’s or its designee’s balance account
with the Depository Trust Company (“DTC”) through its Deposit Withdrawal Agent Commission, provided the Borrower is
participating in the DTC’s Fast Automated Securities Transfer or Deposit/Withdrawal at Custodian programs and either (A) there
is an effective registration statement permitting the issuance of the Conversion Shares to or resale of the Conversion Shares by the
Holder or (B) the requisite holding period provided by Rule 144 for the resale of the Conversion Shares by the Holder has been satisfied,
and otherwise by delivery of a certificate, registered in the Borrower’s share register in the name of the Holder or its designee.
(f)
Fractional Shares. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of this Note.
As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such conversion, the Borrower shall at its
election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Conversion
Price or round up to the next whole share.
1.5
Concerning the Shares. The Conversion Shares issuable upon conversion of this Note may not be sold or transferred unless (i) such
shares are sold pursuant to an effective registration statement under the 1933 Act or (ii) the Borrower or its transfer agent shall have
been furnished with an opinion of counsel (which opinion shall be the Legal Counsel Opinion (as defined in the SPA)) to the effect that
the shares to be sold or transferred may be sold or transferred pursuant to an exemption from such registration or (iii) such shares
are sold or transferred pursuant to Rule 144, Rule 144A, Regulation S, or other applicable exemption, or (iv) such shares are transferred
to an “affiliate” (as defined in Rule 144) of the Borrower who agrees to sell or otherwise transfer the shares only in accordance
with this Section 1.5 and who is an Accredited Investor (as defined in the SPA). Except as otherwise provided in the SPA (and
subject to the removal provisions set forth below), until such time as the Conversion Shares have been registered under the 1933 Act
or otherwise may be sold pursuant to Rule 144, Rule 144A, Regulation S, or other applicable exemption without any restriction as to the
number of securities as of a particular date that can then be immediately sold, each certificate for the Conversion Shares that has not
been so included in an effective registration statement or that has not been sold pursuant to an effective registration statement or
an exemption that permits removal of the legend, shall bear a legend substantially in the following form, as appropriate:
“NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED
FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH MAY BE THE LEGAL COUNSEL OPINION (AS DEFINED IN THE SPA)), IN A GENERALLY
ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144, RULE 144A, REGULATION S UNDER
SAID ACT, OR OTHER APPLICABLE EXEMPTION. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE
MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.”
The
legend set forth above shall be removed and the Borrower shall issue to the Holder a certificate for the applicable Conversion Shares
without such legend upon which it is stamped or (as requested by the Holder) issue the applicable Conversion Shares by electronic delivery
by crediting the account of such holder’s broker with DTC, if, unless otherwise required by applicable state securities laws: (a)
such Conversion Shares are registered for sale under an effective registration statement filed under the 1933 Act or otherwise may be
sold pursuant to Rule 144, Rule 144A, Regulation S, or other applicable exemption without any restriction as to the number of securities
as of a particular date that can then be immediately sold, or (b) the Borrower or the Holder provides the Legal Counsel Opinion (as contemplated
by and in accordance with Section 4(n) of the SPA) to the effect that a public sale or transfer of such Conversion Shares may be made
without registration under the 1933 Act, which opinion shall be accepted by the Borrower so that the sale or transfer is effected. The
Borrower shall be responsible for the fees of its transfer agent and all DTC fees associated with any such issuance. The Holder agrees
to sell all Conversion Shares, including those represented by a certificate(s) from which the legend has been removed, in compliance
with applicable prospectus delivery requirements, if any. In the event that the Borrower does not accept the opinion of counsel provided
by the Holder with respect to the transfer of Conversion Shares pursuant to an exemption from registration, such as Rule 144, Rule 144A,
Regulation S, or other applicable exemption, at any Deadline, notwithstanding that the conditions of Rule 144, Rule 144A, Regulation
S, or other applicable exemption, as applicable, have been met, it will be considered an Event of Default under Section 3.1(c)
of this Note.
1.6
Effect of Certain Events.
(a)
Effect of Merger, Consolidation, Etc. At the option of the Holder, the sale, conveyance or disposition of all or substantially
all of the assets of the Borrower, or the consolidation, merger or other business combination of the Borrower with or into any other
Person (as defined below) or Persons whereby the Borrower is not the survivor shall either: (i) be deemed to be an Event of Default pursuant
to which the Borrower shall be required to pay to the Holder upon the consummation of and as a condition to such transaction an amount
equal to the Default Amount (as defined in this Note) or (ii) be treated pursuant to Section 1.6(b) hereof. “Person”
shall mean any individual, corporation, limited liability company, partnership, association, trust or other entity or organization.
(b)
Adjustment Due to Merger, Consolidation, Etc. If, at any time when this Note is issued and outstanding and prior to conversion
of all of this Note, there shall be any merger, consolidation, exchange of shares, recapitalization, reorganization, or other similar
event, as a result of which shares of Common Stock of the Borrower shall be changed into the same or a different number of shares of
another class or classes of stock or securities of the Borrower or another entity, or in case of any sale or conveyance of all or substantially
all of the assets of the Borrower other than in connection with a plan of complete liquidation of the Borrower, then the Holder of this
Note shall thereafter have the right to receive upon conversion of this Note, upon the basis and upon the terms and conditions specified
herein and in lieu of the shares of Common Stock immediately theretofore issuable upon conversion, such stock, securities or assets which
the Holder would have been entitled to receive in such transaction had this Note been converted in full immediately prior to such transaction
(without regard to any limitations on conversion set forth herein), and in any such case appropriate provisions shall be made with respect
to the rights and interests of the Holder of this Note to the end that the provisions hereof (including, without limitation, provisions
for adjustment of the Conversion Price and of the number of shares issuable upon conversion of the Note) shall thereafter be applicable,
as nearly as may be practicable in relation to any securities or assets thereafter deliverable upon the conversion hereof. The Borrower
shall not effectuate any transaction described in this Section 1.6(b) unless (a) it first gives, to the extent practicable, at
least thirty (30) days prior written notice (but in any event at least fifteen (15) days prior written notice) of the record date of
the special meeting of shareholders to approve, or if there is no such record date, the consummation of, such merger, consolidation,
exchange of shares, recapitalization, reorganization or other similar event or sale of assets (during which time the Holder shall be
entitled to convert this Note) and (b) the resulting successor or acquiring entity (if not the Borrower) assumes by written instrument
the obligations of this Section 1.6(b). The above provisions shall similarly apply to successive consolidations, mergers, sales,
transfers or share exchanges.
(c)
Adjustment Due to Distribution. If the Borrower shall declare or make any distribution of its assets (or rights to acquire its
assets) to holders of Common Stock as a dividend, stock repurchase, by way of return of capital or otherwise (including any dividend
or distribution to the Borrower’s shareholders in cash or shares (or rights to acquire shares) of capital stock of a Subsidiary
(i.e., a spin-off)) (a “Distribution”), then the Holder of this Note shall be entitled, upon any conversion of this
Note after the date of record for determining shareholders entitled to such Distribution, to receive the amount of such assets which
would have been payable to the Holder with respect to the shares of Common Stock issuable upon such conversion had such Holder been the
holder of such shares of Common Stock on the record date for the determination of shareholders entitled to such Distribution.
(d)
Purchase Rights. If, at any time when all or any portion of this Note is issued and outstanding, the Borrower issues any convertible
securities or rights to purchase stock, warrants, securities or other property (the “Purchase Rights”) pro rata to
the record holders of any class of Common Stock, then the Holder of this Note will be entitled to acquire, upon the terms applicable
to such Purchase Rights, the aggregate Purchase Rights which such Holder could have acquired if such Holder had held the number of shares
of Common Stock acquirable upon complete conversion of this Note (without regard to any limitations on conversion contained herein) immediately
before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights or, if no such record is taken, the
date as of which the record holders of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights.
(e)
Dilutive Issuance. If the Borrower, at any time while this Note or any amounts due hereunder are outstanding, issues, sells or
grants (or has issued, sold or granted as of the Issue Date, as the case may be) any option to purchase, or sells or grants any right
to reprice, or otherwise disposes of, or issues (or has sold or issued, as the case may be, or announces any sale, grant or any option
to purchase or other disposition), any Common Stock or other securities convertible into, exercisable for, or otherwise entitle any person
or entity the right to acquire, shares of Common Stock (including, without limitation, upon conversion of this Note, and any convertible
notes or warrants outstanding as of or following the Issue Date), in each or any case at an effective price per share that is lower than
the then Conversion Price (such lower price, the “Base Conversion Price” and such issuances, collectively, a “Dilutive
Issuance”) (it being agreed that if the holder of the Common Stock or other securities so issued shall at any time, whether
by operation of purchase price adjustments, reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to
warrants, options or rights per share which are issued in connection with such issuance, be entitled to receive shares of Common Stock
at an effective price per share that is lower than the Conversion Price, such issuance shall be deemed to have occurred for less than
the Conversion Price on such date of the Dilutive Issuance), then the Conversion Price shall be reduced, at the option of the Holder,
to a price equal to the Base Conversion Price. Such adjustment shall be made whenever such Common Stock or other securities are issued.
By way of example, and for the avoidance of doubt, if the Borrower issues a convertible promissory note (including but not limited to
a Variable Rate Transaction), and the holder of such convertible promissory note has the right to convert it into Common Stock at an
effective price per share that is lower than the then Conversion Price (including but not limited to a conversion price with a discount
that varies with the trading prices of or quotations for the Common Stock), then the Holder has the right to reduce the Conversion Price
to such Base Conversion Price (including but not limited to a conversion price with a discount that varies with the trading prices of
or quotations for the Common Stock) in perpetuity regardless of whether the holder of such convertible promissory note ever effectuated
a conversion at the Base Conversion Price. In the event of an issuance of securities involving multiple tranches or closings, any adjustment
pursuant to this Section 1.6(e) shall be calculated as if all such securities were issued at the initial closing. Notwithstanding
the foregoing, the Holder may only enforce its rights under this Section 1.6(e) after the date that is one hundred eighty (180)
calendar days after the Issue Date, provided, however, that at such time the Holder may enforce its rights to all adjustments hereunder
that apply even if the Dilutive Issuance occurred prior to the date that is one hundred eighty (180) calendar days after the Issue Date.
(f)
Notice of Adjustments. Upon the occurrence of each adjustment or readjustment of the Conversion Price as a result of the events
described in this Section 1.6, the Borrower shall, at its expense and within one (1) calendar day after the occurrence of each
respective adjustment or readjustment of the Conversion Price, compute such adjustment or readjustment and prepare and furnish to the
Holder a certificate setting forth (i) the Conversion Price in effect at such time based upon the Dilutive Issuance, (ii) the number
of shares of Common Stock and the amount, if any, of other securities or property which at the time would be received upon conversion
of the Note, (iii) the detailed facts upon which such adjustment or readjustment is based, and (iv) copies of the documentation (including
but not limited to relevant transaction documents) that evidences the adjustment or readjustment. In addition, the Borrower shall, within
one (1) calendar day after each written request from the Holder, furnish to such Holder a like certificate setting forth (i) the Conversion
Price in effect at such time based upon the Dilutive Issuance, (ii) the number of shares of Common Stock and the amount, if any, of other
securities or property which at the time would be received upon conversion of the Note, (iii) the detailed facts upon which such adjustment
or readjustment is based, and (iv) copies of the documentation (including but not limited to relevant transaction documents) that evidences
the adjustment or readjustment. For the avoidance of doubt, each adjustment or readjustment of the Conversion Price as a result of the
events described in this Section 1.6 shall occur without any action by the Holder and regardless of whether the Borrower complied
with the notification provisions in this Section 1.6. To the extent that any notice provided hereunder constitutes, or contains,
material, non-public information regarding the Borrower or any of the Subsidiaries, the Borrower shall simultaneously file such notice
with the SEC pursuant to a Current Report on Form 8-K.
1.7
Holder’s Conversion Limitations. The Borrower shall not effect any conversion of this Note, and the Holder shall not have
the right to convert any portion of this Note, to the extent that after giving effect to the conversion set forth on the applicable Notice
of Conversion, the Holder (together with the Holder’s Affiliates, and any other Persons acting as a group together with the Holder
or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)) would beneficially own in excess of
the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock
beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable
upon conversion of this Note with respect to which such determination is being made, but shall exclude the number of shares of Common
Stock which are issuable upon (i) conversion of the remaining, unconverted principal amount of this Note beneficially owned by the Holder
or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or unconverted portion of any other
securities of the Borrower subject to a limitation on conversion or exercise analogous to the limitation contained herein (including,
without limitation, any other convertible notes or any Warrant) beneficially owned by the Holder or any of its Affiliates or Attribution
Parties. Except as set forth in the preceding sentence, for purposes of this Section 1.7, beneficial ownership shall be calculated
in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. To the extent that the limitation
contained in this Section 1.7 applies, the determination of whether this Note is convertible (in relation to other securities
owned by the Holder together with any Affiliates and Attribution Parties) and of which principal amount of this Note is convertible shall
be in the sole discretion of the Holder, and the submission of a Notice of Conversion shall be deemed to be the Holder’s determination
of whether this Note may be converted (in relation to other securities owned by the Holder together with any Affiliates or Attribution
Parties) and which principal amount of this Note is convertible, in each case subject to the Beneficial Ownership Limitation. To ensure
compliance with this restriction, the Holder will be deemed to represent to the Borrower each time it delivers a Notice of Conversion
that such Notice of Conversion has not violated the restrictions set forth in this paragraph and the Borrower shall have no obligation
to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall
be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes
of this Section 1.7, in determining the number of outstanding shares of Common Stock, the Holder may rely on the number of outstanding
shares of Common Stock as stated in the most recent of the following: (i) the Borrower’s most recent periodic or annual report
filed with the Commission, as the case may be, (ii) a more recent public announcement by the Borrower, or (iii) a more recent written
notice by the Borrower or the Borrower’s transfer agent setting forth the number of shares of Common Stock outstanding. Upon the
written or oral request of a Holder, the Borrower shall within one (1) Trading Day confirm orally and in writing to the Holder the number
of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving
effect to the conversion or exercise of securities of the Borrower, including this Note, by the Holder or its Affiliates since the date
as of which such number of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation”
shall be 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common
Stock issuable upon conversion of this Note held by the Holder. The Beneficial Ownership Limitation provisions of this paragraph shall
be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 1.7 to correct this
paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation contained
herein or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained
in this paragraph shall apply to a successor holder of this Note.
1.8
Status as Shareholder. Upon submission of a Notice of Conversion by a Holder, (i) the Conversion Shares covered thereby (other
than the Conversion Shares, if any, which cannot be issued because their issuance would exceed such Holder’s allocated portion
of the Reserved Amount) shall be deemed converted into shares of Common Stock and (ii) the Holder’s rights as a Holder of such
converted portion of this Note shall cease and terminate, excepting only the right to receive certificates for such shares of Common
Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Borrower
to comply with the terms of this Note. Notwithstanding the foregoing, if a Holder has not received certificates for all shares of Common
Stock prior to the tenth (10th) Business Day after the expiration of the applicable Deadline with respect to a conversion of any portion
of this Note for any reason, then (unless the Holder otherwise elects to retain its status as a holder of Common Stock by so notifying
the Borrower) the Holder shall regain the rights of a Holder of this Note with respect to such unconverted portions of this Note and
the Borrower shall, as soon as practicable, return such unconverted Note to the Holder or, if the Note has not been surrendered, adjust
its records to reflect that such portion of this Note has not been converted. In all cases, the Holder shall retain all of its rights
and remedies for the Borrower’s failure to convert this Note.
1.9
Note Obligations Independent from Distribution Obligations. The obligations of the Borrower to pay the Holder all principal, interest
and other amounts owing to the Holder under this Note shall be in addition to, and not in substitution for, any obligations of the Borrower
and Nascent Pharma, LLC, a Nevada limited liability company (“Nascent”) to pay Distributions (as defined in the Distribution
and Assignment Agreement) to the Holder under the Distribution and Assignment Agreement, and any such Distributions (as defined in the
Distribution and Assignment Agreement) paid to the Holder pursuant to the Distribution and Assignment Agreement shall be applied towards
the Additional Consideration Obligation (as defined in the Distribution and Assignment Agreement) and not to reduce the principal balance
or any other obligations of the Borrower outstanding under this Note, or any other promissory note or other instrument issued by the
Borrower to the Holder. As used herein, the term “Distribution and Assignment Agreement” means that certain Distribution
and Assignment Agreement dated as of October 27, 2023, by and among Nascent, the Borrower and the Holder (as amended, amended and restated,
supplemented or otherwise modified from time to time).
ARTICLE
II. NEGATIVE COVENANTS
2.1
Other Indebtedness. So long as the Borrower shall have any obligation under this Note, the Borrower shall not incur or suffer
to exist or guarantee any indebtedness that is senior to or pari passu in right or priority of payment to the obligations of the Borrower
under this Note, or otherwise secured by any assets of the Borrower or any of its Subsidiaries, other than Permitted Indebtedness. As
used herein, the term “Permitted Indebtedness” (i) means any indebtedness incurred under or contemplated by the Arena
Notes (used herein as defined in the Arena-Walleye Intercreditor Agreement) or any other Arena Transaction Document (used herein
as defined in the Arena-Walleye Intercreditor Agreement), which Permitted Indebtedness is subject to terms and provisions of that certain
letter agreement, dated as of February 27, 2023, by and among the Borrower, Walleye Opportunities Master Fund Ltd., Arena Special Opportunities
Partners I, LP, a Delaware limited partnership (“ASOP I”), Arena Special Opportunities Fund, LP, a Delaware limited
partnership (“ASOF”, and together with ASOP I, collectively, the “Arena Purchasers”), and Arena
Investors, LP, a Delaware limited partnership (as amended, restated, amended and restated, supplemented or otherwise modified from time
to time, the “Arena-Walleye Intercreditor Agreement”), (ii) indebtedness of the Borrower owing to the Holder under
that certain Promissory Note of the Borrower in the original principal amount of $1,823,529, dated as of February 27, 2023, issued by
the Borrower to Walleye Opportunities Master Fund Ltd (the “February 2023 Secured Walleye Note”), (iii) indebtedness
of the Borrower under any other Note (as such term is defined in the SPA) issued under the SPA or under the Consolidated Amended and
Restated Walleye Note (as defined in the SPA), and (iv) indebtedness of the Borrower owing to the Holder under the Distribution and Assignment
Agreement and/or owing to any other parties joined to the Distribution and Assignment Agreement from time to time as additional assignees
in accordance with the terms of the Distribution and Assignment Agreement and the SPA.
2.2
Reserved.
2.3
Distributions on Capital Stock. So long as the Borrower shall have any obligation under this Note, the Borrower shall not without
the Holder’s written consent (a) pay, declare or set apart for such payment, any dividend or other distribution (whether in cash,
property or other securities) on shares of capital stock other than dividends on shares of Common Stock solely in the form of additional
shares of Common Stock or (b) directly or indirectly or through any Subsidiary make any other payment or distribution in respect of its
capital stock.
2.4
Restriction on Stock Repurchases and Debt Repayments. So long as the Borrower shall have any obligation under this Note, the Borrower
shall not without the Holder’s written consent redeem, repurchase or otherwise acquire (whether for cash or in exchange for property
or other securities or otherwise) in any one transaction or series of related transactions any shares of capital stock of the Borrower
or any warrants, rights or options to purchase or acquire any such shares, or repay any indebtedness of Borrower (other than the indebtedness
of the Borrower owing under this Note, any other Note (as such term is defined in the SPA) issued under the SPA, the Consolidated Amended
and Restated Walleye Note (as defined in the SPA), the Distribution and Assignment Agreement or under any other Transaction Documents)
except for (i) pursuant to the terms of the February 2023 Secured Walleye Note, (ii) pursuant to the terms of the Arena Notes as in effect
as of February 27, 2023 in accordance with the Walleye-Arena Intercreditor Agreement, (ii) pursuant to the terms of that certain Promissory
Note held by Blue Lake dated as of March 22, 2022 (as amended by that certain Amendment #2 to Promissory Note, Amendment to Securities
Purchase Agreement, Consent and Waiver Agreement dated as of February 23, 2023 by and between Blue Lake and the Borrower) as in effect
as of February 27, 2023, (iii) pursuant to the terms of that certain Promissory Note held by Mast Hill dated as of March 22, 2022 (as
amended by that certain Amendment #2 to Promissory Note, Amendment to Securities Purchase Agreement, Consent and Waiver Agreement dated
as of February 23, 2023 by and between Mast Hill and the Borrower) as in effect as of February 27, 2023, (iv) regularly scheduled payments
of interest and principal with respect to the other indebtedness of the Borrower outstanding as of October 26, 2023 pursuant to the terms
of the documents evidencing such indebtedness listed on Schedule 4(y) of the SPA as in effect on October 26, 2023, or (v) pursuant to
any provision of any document listed on Schedule 4(y) of the SPA as in effect on October 26, 2023, evidencing indebtedness of the Borrower
outstanding as of October 26, 2023 providing for the conversion of such indebtedness into shares of the Borrower’s Common Stock.
2.5
Sale of Assets. So long as the Borrower shall have any obligation under this Note, the Borrower shall not, without the Holder’s
written consent, sell, lease or otherwise dispose of any significant portion of its assets outside the ordinary course of business. Any
consent by the Holder to the disposition of any assets may be conditioned on a specified use of the proceeds of disposition.
2.6
Advances and Loans; Affiliate Transactions. So long as the Borrower shall have any obligation under this Note, the Borrower shall
not, without the Holder’s written consent, lend money, give credit, make advances to or enter into any transaction with any person,
firm, joint venture or corporation, including, without limitation, officers, directors, employees, Subsidiaries and affiliates of the
Borrower, except loans, credits or advances (a) in existence or committed on the Issue Date and of which the Borrower has informed Holder
in writing prior to the Issue Date, (b) in regard to transactions with unaffiliated third parties, made in the ordinary course of business
or (c) in regard to transactions with unaffiliated third parties, not in excess of $100,000 in the aggregate of all such transactions.
So long as the Borrower shall have any obligation under this Note, the Borrower shall not, without the Holder’s written consent,
repay any affiliate (as defined in Rule 144) of the Borrower in connection with any indebtedness or accrued amounts owed to any such
party.
2.7
3(a)(10) Transaction. So long as this Note is outstanding, the Borrower shall not enter into any transaction or arrangement structured
in accordance with, based upon, or related or pursuant to, in whole or in part, Section 3(a)(10) of the Securities Act (a “3(a)(10)
Transaction”). In the event that the Borrower does enter into, or makes any issuance of Common Stock related to a 3(a)(10)
Transaction while this Note is outstanding, a liquidated damages charge of 25% of the outstanding principal balance of this Note, but
not less than $25,000, will be assessed and will become immediately due and payable to the Holder at its election in the form of a cash
payment or added to the balance of this Note (under Holder’s and Borrower’s expectation that this amount will tack back to
the Issue Date).
2.8
Preservation of Business and Existence, etc. So long as the Borrower shall have any obligation under this Note, the Borrower shall
not, without the Holder’s written consent, (a) change the nature of its business; (b) sell, divest, change the structure of any
material assets other than in the ordinary course of business; (c) enter into a Variable Rate Transaction; or (d) enter into any merchant
cash advance transactions. In addition, so long as the Borrower shall have any obligation under this Note, the Borrower shall maintain
and preserve, and cause each of its Subsidiaries to maintain and preserve, its existence, rights and privileges, and become or remain,
and cause each of its Subsidiaries (other than dormant Subsidiaries that have no or minimum assets) to become or remain, duly qualified
and in good standing in each jurisdiction in which the character of the properties owned or leased by it or in which the transaction
of its business makes such qualification necessary.
2.9
Noncircumvention. The Borrower hereby covenants and agrees that the Borrower will not, by amendment of its Certificate or Articles
of Incorporation or Bylaws, or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution,
issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms
of this Note, and will at all times in good faith carry out all the provisions of this Note and take all action as may be required to
protect the rights of the Holder.
2.10
Lost, Stolen or Mutilated Note. Upon receipt by the Borrower of evidence reasonably satisfactory to the Borrower of the loss,
theft, destruction or mutilation of this Note, and, in the case of loss, theft or destruction, of any indemnification undertaking by
the Holder to the Borrower in customary form and, in the case of mutilation, upon surrender and cancellation of this Note, the Borrower
shall execute and deliver to the Holder a new Note.
ARTICLE
III. EVENTS OF DEFAULT
3.1
Events of Default. It shall be considered an event of default if any of the following events listed in this Article III
(each, an “Event of Default”) shall occur (whatever the reason for such event and whether such event shall be voluntary
or involuntary or effected by operation of law or pursuant to any judgment, decree or order of any court, or any order, rule or regulation
of any administrative or governmental body):
(a)
Failure to Pay Principal or Interest. The Borrower fails to pay any Principal Amount hereof and/or interest thereon, in each case
when such payment becomes due under this Note, whether at the Maturity Date, upon acceleration or otherwise in accordance with the terms
of this Note.
(b)
Conversion and the Shares. The Borrower (i) fails to issue Conversion Shares to the Holder (or announces or threatens in writing
that it will not honor its obligation to do so) upon exercise by the Holder of the conversion rights of the Holder in accordance with
the terms of this Note, (ii) fails to transfer or cause its transfer agent to transfer (issue) (electronically or in certificated form)
any certificate for the Conversion Shares issuable to the Holder upon conversion of or otherwise pursuant to this Note as and when required
by this Note, (iii) fails to reserve the Reserved Amount at all times, (iv) the Borrower directs its transfer agent not to transfer or
delays, impairs, and/or hinders its transfer agent in transferring (or issuing) (electronically or in certificated form) any certificate
for the Conversion Shares issuable to the Holder upon conversion of or otherwise pursuant to this Note as and when required by this Note,
or fails to remove (or directs its transfer agent not to remove or impairs, delays, and/or hinders its transfer agent from removing)
any restrictive legend (or to withdraw any stop transfer instructions in respect thereof) on any certificate for any Conversion Shares
issued to the Holder upon conversion of or otherwise pursuant to this Note as and when required by this Note (or makes any written announcement,
statement or threat that it does not intend to honor the obligations described in this paragraph) and any such failure shall continue
uncured (or any written announcement, statement or threat not to honor its obligations shall not be rescinded in writing) for two (2)
Trading Days after the Holder shall have delivered a Notice of Conversion, and/or (v) fails to remain current in its obligations to its
transfer agent (including but not limited to payment obligations to its transfer agent). It shall be an Event of Default of this Note,
if a conversion of this Note is delayed, hindered or frustrated due to a balance owed by the Borrower to its transfer agent. If at the
option of the Holder, the Holder advances any funds to the Borrower’s transfer agent in order to process a conversion, such advanced
funds shall be added to the principal balance of the Note.
(c)
Breach of Agreements and Covenants. The Borrower or Nascent breaches any covenant, agreement, or other term or condition contained
in the SPA, this Note, any other Note (as such term is defined in the SPA), the Consolidated Amended and Restated Walleye Note, the Distribution
and Assignment Agreement, any RRA, or in any other Transaction Document or in any agreement, statement or certificate given in writing
pursuant hereto or thereto or in connection herewith or therewith.
(d)
Breach of Representations and Warranties. Any representation or warranty of the Borrower or Nascent made in the SPA, this Note,
any other Note (as such term is defined in the SPA), the Consolidated Amended and Restated Walleye Note, the Distribution and Assignment
Agreement, or in any other Transaction Document, or in any agreement, statement or certificate given in writing pursuant hereto or in
connection herewith or therewith shall be false or misleading in any material respect when made and the breach of which has (or with
the passage of time will have) a material adverse effect on the rights of the Holder with respect to this Note, any other Note (as such
term is defined in the SPA), the Consolidated Amended and Restated Walleye Note, the SPA, the Distribution and Assignment Agreement or
any RRA.
(e)
Receiver or Trustee. The Borrower, Nascent or any Subsidiary of the Borrower shall make an assignment for the benefit of creditors,
or apply for or consent to the appointment of a receiver or trustee for it or for a substantial part of its property or business, or
such a receiver or trustee shall otherwise be appointed.
(f)
Judgments. Any money judgment, writ or similar process shall be entered or filed against the Borrower, Nascent or any Subsidiary
of the Borrower or any of its property or other assets for more than $100,000, and shall remain unvacated, unbonded or unstayed for a
period of twenty (20) days unless otherwise consented to by the Holder, which consent will not be unreasonably withheld.
(g)
Bankruptcy. Bankruptcy, insolvency, reorganization or liquidation proceedings or other proceedings, voluntary or involuntary,
for relief under any bankruptcy law or any law for the relief of debtors shall be instituted by or against the Borrower, Nascent or any
Subsidiary of the Borrower.
(h)
Failure to Comply with the 1934 Act. At any time after the Issue Date, the Borrower shall fail to comply with the reporting requirements
of the 1934 Act and/or the Borrower shall cease to be subject to the reporting requirements of the 1934 Act.
(i)
Liquidation. Any dissolution, liquidation, or winding up of Borrower, Nascent or any Subsidiary of the Borrower or any substantial
portion of its business.
(j)
Cessation of Operations. Any cessation of operations by Borrower, Nascent or any Subsidiary of the Borrower or any admission by
the Borrower, Nascent or any of Subsidiary of the Borrower that it is otherwise generally unable to pay its debts as such debts become
due, provided, however, that any disclosure of the Borrower’s, Nascent’s or any of the Borrower’s Subsidiaries’
ability to continue as a “going concern” shall not be an admission that the Borrower (or any such Subsidiary of the Borrower)
cannot pay its debts as they become due.
(k)
Maintenance of Assets. The failure by Borrower or Nascent to maintain any material intellectual property rights, personal, real
property or other assets which are necessary to conduct its business (whether now or in the future).
(l)
Financial Statement Restatement. The restatement of any financial statements filed by the Borrower with the SEC for any date or
period from two years prior to the Issue Date of this Note and until this Note is no longer outstanding.
(m)
Replacement of Transfer Agent. In the event that the Borrower proposes to replace its transfer agent, the Borrower fails to provide,
prior to the effective date of such replacement, a fully executed Irrevocable Transfer Agent Instructions in a form as initially delivered
pursuant to the SPA, signed by the successor transfer agent to Borrower and the Borrower.
(n)
Cross-Default. The declaration of an event of default by any lender or other extender of credit to the Borrower under any notes,
loans, agreements or other instruments of the Borrower evidencing any indebtedness of the Borrower (including those filed as exhibits
to or described in the Borrower’s filings with the SEC), after the passage of all applicable notice and cure or grace periods.
(o)
Variable Rate Transactions. The Borrower consummates a Variable Rate Transaction at any time on or after the Issue Date without
the prior written consent of the Holder.
(p)
Inside Information. Any attempt by the Borrower or its officers, directors, and/or affiliates to transmit, convey, disclose, or
any actual transmittal, conveyance, or disclosure by the Borrower or its officers, directors, and/or affiliates of, material non-public
information concerning the Borrower, to the Holder or its successors and assigns, which is not immediately cured by Borrower’s
filing of a Form 8-K pursuant to Regulation FD on that same date.
(q)
Unavailability of Rule 144. If, at any time on or after the date that is six (6) calendar months after the Issue Date, the Holder
is unable to (i) obtain a standard “144 legal opinion letter” from an attorney reasonably acceptable to the Holder, the Holder’s
brokerage firm (and respective clearing firm), and the Borrower’s transfer agent in order to facilitate the Holder’s conversion
of any portion of the Note into free trading shares of the Borrower’s Common Stock pursuant to Rule 144, and/or (ii) thereupon
deposit such shares into the Holder’s brokerage account.
(r)
Delisting, Suspension, or Quotation of Trading of Common Stock. If, at any time on or after the Issue Date, the Borrower’s
Common Stock (i) is suspended from trading, (ii) halted from trading, and/or (iii) fails to be quoted or listed (as applicable) on a
Principal Market.
(s)
Registration Statement Failures. The Borrower fails to comply with any term or provision set forth in any RRA delivered pursuant
to the SPA.
(t)
Asset Sales; Fundamental Transactions. Any (i) sale, conveyance or disposition of all or substantially all of the assets of the
Borrower, or (ii) consolidation, merger or other business combination of the Borrower with or into any other Person or Persons whereby
the Borrower is not the survivor (any such transaction a “Section 1.6 Transaction”), which Section 1.6 Transaction
is deemed by the Holder at its option to be an Event of Default pursuant to Section 1.6 of this Note.
3.2
Rights and Remedies Upon an Event of Default.
(a)
Upon the occurrence of any Event of Default specified in this Article III, this Note shall become immediately due and payable,
and the Borrower shall pay to the Holder, in full satisfaction of its obligations hereunder, an amount equal to the product calculated
by multiplying (a) the sum of the Principal Amount then outstanding plus accrued Default Interest through the date of full repayment
by (b) 135% (collectively the “Default Amount”), as well as all costs, including, without limitation, legal fees and
expenses, of collection, all without demand, presentment or notice, all of which hereby are expressly waived by the Borrower in cash;
provided, notwithstanding anything to the contrary set forth herein, that the Holder may, in its sole discretion, determine to
accept payment of any obligation of the Borrower payable under this Section 3.2(a) in Common Stock (using the Conversion Price
as adjusted pursuant the last sentence of this Section 3.2(a)) or in cash, or in a combination of both Common Stock and cash.
The Holder shall be entitled to exercise all other rights and remedies available at law or in equity. Commencing upon the occurrence
of any Event of Default, the Principal Amount then outstanding shall bear interest at the rate of the lesser of (i) eighteen percent
(18%) per annum and (ii) the maximum amount permitted by law from the due date thereof until the same is paid (“Default Interest”).
Default Interest accrued hereunder shall be paid either in cash or in Common Stock, as determined by the Holder in its sole discretion,
and shall be computed on the basis of a 365-day year for the actual number of days elapsed. Upon the payment in full of the Default Amount,
as well as all costs, including, without limitation, legal fees and expenses, of collection, the Holder shall promptly surrender this
Note to or as directed by the Borrower. In connection with such acceleration described herein, the Holder need not provide, and the Borrower
hereby waives, any presentment, demand, protest or other notice of any kind, and the Holder may immediately and without expiration of
any grace period enforce any and all of its rights and remedies hereunder and all other remedies available to it under applicable law.
Such acceleration may be rescinded and annulled by Holder at any time prior to payment hereunder and the Holder shall have all rights
as a holder of the Note until such time, if any, as the Holder receives full payment pursuant to this Section 3.2. No such rescission
or annulment shall affect any subsequent Event of Default or impair any right consequent thereon. For the avoidance of doubt, subject
to Section 1.6(f), the number of shares of Common Stock issuable to the Holder upon any election of the Holder to accept payment
of any obligation of the Borrower payable under this Section 3.2(a) in Common Stock shall be equal to the ratio calculated by
dividing (A) the amount in Dollars of such obligation of the Borrower payable under this Section 3.2(a) the payment of which the
Holder has elected to accept in Common Stock by (B) the Conversion Price. Additionally, upon the occurrence and continuance of an Event
of Default, the Conversion Price shall be adjusted to the lower of (i) the Conversion Price on the date of the Event of Default or (ii)
60% discount to the lowest VWAP of the Borrower’s Common Stock during the five (5) Trading Day period immediately prior to the
Conversion Date.
(b)
In case any one or more Events of Default shall occur and be continuing, Holder may proceed to protect and enforce its rights by an action
at law, suit in equity or other appropriate proceeding, whether for the specific performance of any agreement contained herein or for
an injunction against a violation of any of the terms hereof, or in aid of the exercise of any power granted hereby or thereby or by
law or otherwise. In case of a default in the payment of any portion of the Principal Amount, or any interest or other fees due and payable
on this Note, Borrower will pay to Holder such further amount as shall be sufficient to cover the reasonable cost and expenses of collection,
including, without limitation, reasonable attorneys’ fees, expenses and disbursements. No course of dealing and no delay on the
part of Holder in exercising any right, power or remedy shall operate as a waiver thereof or otherwise prejudice Holder’s rights,
powers or remedies. No right, power or remedy conferred by this Note upon Holder shall be exclusive of any other right, power or remedy
referred to herein or therein or now or hereafter available at law, in equity, by statute or otherwise.
ARTICLE
IV. MISCELLANEOUS
4.1
Failure or Indulgence Not Waiver. No failure or delay on the part of the Holder in the exercise of any power, right or privilege
hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude
other or further exercise thereof or of any other right, power or privileges. All rights and remedies of the Holder existing hereunder
are cumulative to, and not exclusive of, any rights or remedies otherwise available.
4.2
Notices. All notices, requests, demands, and other communications provided for hereunder must be in writing and will be deemed
to have been duly given and effective on the earliest of: (a) the date of transmission, if such notice or communication is delivered
via e-mail prior to 5:30 p.m. (New York City time) on any Business Day; (b) the next Business Day after the date of transmission, if
such notice or communication is delivered via e-mail on a day that is not a Business Day or later than 5:30 p.m. (New York City time)
on any Business Day; (c) the second Business Day following the date of mailing, if sent by U.S. nationally recognized overnight courier
service or (d) upon actual receipt by the party to whom such notice is required to be given, addressed as follows:
|
CAN
B̅ CORP. |
|
960
South Broadway, Suite 120 |
|
Hicksville,
NY 11801 |
|
Attention:
Marco Alfonsi |
|
e-mail:
info@canbiola.com |
|
Walleye
Opportunities Master Fund Ltd |
|
2800
Niagara Lane N. |
|
Plymouth,
MN 55447 |
|
Attention:
William England |
|
e-mail:
wengland@walleyecapital.com |
or
as to the Borrower or the Holder, at such other address as shall be designated by such party in a written notice to the other party delivered
in accordance with this Section 4.2.
4.3
Amendments. This Note and any provision hereof may only be amended by an instrument in writing signed by the Borrower and the
Holder. The term “Note” and all reference thereto, as used throughout this instrument, shall mean this instrument
as originally executed, or if later amended or supplemented, then as so amended or supplemented.
4.4
Assignability. This Note shall be binding upon the Borrower and its successors and assigns, and shall inure to be the benefit
of the Holder and its successors and assigns. The Borrower shall not assign this Note or any rights or obligations hereunder without
the prior written consent of the Holder. The Holder may assign its rights hereunder to any “accredited investor” (as defined
in Rule 501(a) of the 1933 Act) in a private transaction from the Holder or to any of its “affiliates”, as that term is defined
under the 1934 Act, without the consent of the Borrower. Notwithstanding anything in this Note to the contrary, this Note may be pledged
as collateral in connection with a bona fide margin account or other lending arrangement. The Holder and any assignee, by acceptance
of this Note, acknowledge and agree that following conversion of a portion of this Note, the unpaid and unconverted principal amount
of this Note represented by this Note may be less than the amount stated on the face hereof.
4.5
Holder Fees and Expenses. Borrower agrees to pay to Holder, immediately upon written notice from Holder, all actual costs, expenses,
disbursements, and legal fees and expenses incurred by Holder in connection with: (a) the collection, attempted collection, or negotiation
and documentation of any settlement or workout of any payment due hereunder, and (b) any suit or proceeding whatsoever in regard to this
Note or the protection or enforcement of the lien of any instrument securing this Note, including, without limitation, in connection
with any litigation, mediation, bankruptcy or administrative proceeding, and including any appellate proceeding or judicial or non-judicial
foreclosure proceeding in connection therewith.
4.6
Governing Law; Venue; Waiver of Jury Trial; Attorneys’ Fees. This Note shall be governed by and construed in accordance
with the laws of the State of Delaware without regard to principles of conflicts of laws. Any action brought by either party against
the other concerning the transactions contemplated by this Note or any other agreement, certificate, instrument or document contemplated
hereby shall be brought only in the Court of Chancery of the State of Delaware or, to the extent such court does not have subject matter
jurisdiction, the United States District Court for the District of Delaware or, to the extent that neither of the foregoing courts has
jurisdiction, the Superior Court of the State of Delaware. The Borrower hereby irrevocably waives any objection to jurisdiction and venue
of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non
conveniens. THE BORROWER HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION
OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS NOTE OR ANY TRANSACTIONS CONTEMPLATED HEREBY. Each party hereby
irrevocably waives personal service of process and consents to process being served in any suit, action or proceeding in connection with
this Note or any other agreement, certificate, instrument or document contemplated hereby or thereby by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Note and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. The prevailing party in any action
or dispute brought in connection with this the Note or any other agreement, certificate, instrument or document contemplated hereby or
thereby shall be entitled to recover from the other party its reasonable attorneys’ fees and costs.
4.7
Certain Amounts. At any time pursuant to this Note the Borrower is required to pay an amount in excess of the outstanding Principal
Amount (or the remaining portion thereof required to be paid at such time pursuant to this Note) plus Default Interest thereon, the Borrower
and the Holder agree that the actual damages to the Holder from the receipt of cash payment on this Note may be difficult to determine
and the amount to be so paid by the Borrower represents stipulated damages and not a penalty and is intended to compensate the Holder
in part for loss of the opportunity to convert this Note and to earn a return from the sale of shares of Common Stock acquired upon conversion
of this Note at a price in excess of the price paid for such shares pursuant to this Note. The Borrower and the Holder hereby agree that
such amount of stipulated damages is not plainly disproportionate to the possible loss to the Holder from the receipt of a cash payment
without the opportunity to convert this Note into shares of Common Stock.
4.8
Purchase Agreement. The Borrower and the Holder shall be bound by the applicable terms of the SPA and the documents entered into
in connection herewith and therewith.
4.9
Notice of Corporate Events. Except as otherwise provided below, the Holder of this Note shall have no rights as a Holder of Common
Stock unless and only to the extent that it converts this Note into Common Stock. The Borrower shall provide the Holder with prior notification
of any meeting of the Borrower’s shareholders (and copies of proxy materials and other information sent to shareholders). In the
event of any taking by the Borrower of a record of its shareholders for the purpose of determining shareholders who are entitled to receive
payment of any dividend or other distribution, any right to subscribe for, purchase or otherwise acquire (including by way of merger,
consolidation, reclassification or recapitalization) any share of any class or any other securities or property, or to receive any other
right, or for the purpose of determining shareholders who are entitled to vote in connection with any change in control or any proposed
liquidation, dissolution or winding up of the Borrower, the Borrower shall mail a notice to the Holder, at least twenty (20) days prior
to the record date specified therein (or thirty (30) days prior to the consummation of the transaction or event, whichever is earlier),
of the date on which any such record is to be taken for the purpose of such dividend, distribution, right or other event, and a brief
statement regarding the amount and character of such dividend, distribution, right or other event to the extent known at such time. The
Borrower shall make a public announcement of any event requiring notification to the Holder hereunder substantially simultaneously with
the notification to the Holder in accordance with the terms of this Section 4.9.
4.10
Remedies. The Borrower acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder,
by vitiating the intent and purpose of the transaction contemplated hereby. Accordingly, the Borrower acknowledges that the remedy at
law for a breach of its obligations under this Note will be inadequate and agrees, in the event of a breach or threatened breach by the
Borrower of the provisions of this Note, that the Holder shall be entitled, in addition to all other available remedies at law or in
equity, and in addition to the penalties assessable herein, to an injunction or injunctions restraining, preventing or curing any breach
of this Note and to enforce specifically the terms and provisions thereof, without the necessity of showing economic loss and without
any bond or other security being required.
4.11
Construction; Headings. This Note shall be deemed to be jointly drafted by the Borrower and all the Holder and shall not be construed
against any person as the drafter hereof. The headings of this Note are for convenience of reference and shall not form part of, or affect
the interpretation of, this Note.
4.12
Usury. To the extent it may lawfully do so, the Borrower hereby agrees not to insist upon or plead or in any manner whatsoever
claim, and will resist any and all efforts to be compelled to take the benefit or advantage of, usury laws wherever enacted, now or at
any time hereafter in force, in connection with any action or proceeding that may be brought by the Holder in order to enforce any right
or remedy under this Note. Notwithstanding any provision to the contrary contained in this Note, it is expressly agreed and provided
that the total liability of the Borrower under this Note for payments which under the applicable law are in the nature of interest shall
not exceed the maximum lawful rate authorized under applicable law (the “Maximum Rate”), and, without limiting the
foregoing, in no event shall any rate of interest or default interest, or both of them, when aggregated with any other sums which under
the applicable law in the nature of interest that the Borrower may be obligated to pay under this Note exceed such Maximum Rate. It is
agreed that if the maximum contract rate of interest allowed by applicable law and applicable to this Note is increased or decreased
by statute or any official governmental action subsequent to the Issue Date, the new maximum contract rate of interest allowed by law
will be the Maximum Rate applicable to this Note from the effective date thereof forward, unless such application is precluded by applicable
law. If under any circumstances whatsoever, interest in excess of the Maximum Rate is paid by the Borrower to the Holder with respect
to indebtedness evidenced by this the Note, such excess shall be applied by the Holder to the unpaid principal balance of any such indebtedness
or be refunded to the Borrower, the manner of handling such excess to be at the Holder’s election.
4.13
Severability. In the event that any provision of this Note is invalid or unenforceable under any applicable statute or rule of
law (including any judicial ruling), then such provision shall be deemed inoperative to the extent that it may conflict therewith and
shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable under
any law shall not affect the validity or enforceability of any other provision of this Note.
4.14
Terms of Future Financings. So long as this Note is outstanding, upon any issuance by the Borrower or any of its subsidiaries
of any security, or amendment to a security that was originally issued before the Issue Date, with any term that the Holder reasonably
believes is more favorable to the holder of such security or with a term in favor of the holder of such security that the Holder reasonably
believes was not similarly provided to the Holder in this Note, then (i) the Borrower shall notify the Holder of such additional or more
favorable term within one (1) Business Day of the issuance and/or amendment (as applicable) of the respective security, and (ii) such
term, at Holder’s option, shall become a part of the transaction documents with the Holder (regardless of whether the Borrower
complied with the notification provision of this Section 4.14). The types of terms contained in another security that may be more
favorable to the holder of such security include, but are not limited to, terms addressing prepayment rate, interest rates, and original
issue discounts. Notwithstanding the foregoing, the Holder may only enforce its rights under this Section 4.14 after the date
that is one hundred eighty (180) calendar days after the Issue Date, provided, however, that at such time the Holder may enforce its
rights to all adjustments hereunder that apply even if such adjustment was triggered or such issuance occurred prior to the date that
is one hundred eighty (180) calendar days after the Issue Date.
4.15
Right of First Refusal. If at any time while this Note is outstanding, the Borrower has a bona fide offer of capital or financing
from any third party that the Borrower intends to act upon, then the Borrower must offer such opportunity on the same terms as such third
party’s terms by providing written notice of the offer (an “Offer Notice”) concurrently to the Holder, the Arena
Purchasers, Mast Hill Fund, L.P., a Delaware limited partnership (“Mast Hill”), Blue Lake Partners, LLC, a Delaware
limited liability company (“Blue Lake”), and Fourth Man, LLC, a Nevada limited liability company (“Fourth
Man”), subject to the terms of this Section 4.15. As used in this Section 4.15, the term “Offerees”
shall mean, collectively, (i) the Holder, (ii) the Arena Purchasers (jointly), (iii) Mast Hill, (iv) Blue Lake and (v) Fourth Man, and,
each individually an “Offeree”; provided for the avoidance of doubt that for purposes of this Section 4.15,
the Arena Purchasers shall be considered to be a single Offeree. Within five (5) Business Days after receipt of an Offer Notice by any
Offeree (the “Offer Response Period”), such Offeree shall notify the Borrower in writing (an “Offer Response
Notice”) of such Offeree’s election to either (A) provide such capital or financing to the Borrower on the same terms
as such third party’s terms (including without limitation matching the aggregate principal amount of such capital or financing
proposed to be provided to the Borrower by such third party) or (B) waive such Offeree’s right to provide such capital or financing
to the Borrower on the same terms as such third party’s terms. If any Offeree fails to deliver an Offer Response Notice to the
Borrower prior to the end of the Offer Response Period, time being of the essence, then such Offeree shall be deemed to have elected
option (B) above. In the event (x) more than one Offeree elects to provide such capital or financing to the Borrower on the same terms
as such third party’s terms pursuant to Offer Response Notices sent by each such Offeree to the Borrower within the Offer Response
Period, then each such Offeree shall provide a portion of such capital or financing to the Borrower pro rata in proportion to the respective
ROFR Units (as defined below) of such Offerees, and in all other respects on the same terms as such third party’s terms, (y) only
one Offeree elects to provide such capital or financing to the Borrower on the same terms as such third party’s terms pursuant
to an Offer Response Notice sent by such Offeree to the Borrower within the Offer Response Period, then such Offeree shall provide (and
none of the other Offerees shall have the right to provide) such capital or financing to the Borrower on the same terms as such third
party’s terms (including without limitation matching the aggregate principal amount of such capital or financing proposed to be
provided to the Borrower by such third party), or (z) none of the Offerees elect to provide such capital or financing to the Borrower
on the same terms as such third party’s terms pursuant to an Offer Response Notice sent to the Borrower within the Offer Response
Period, then the Borrower may obtain such capital or financing from such third party, provided the Borrower obtains such capital or financing
from such third party upon the exact same terms and conditions set forth in the Offer Notice. If none of the Offerees elects to provide
such capital or financing to the Borrower on the same terms as such third party’s terms pursuant to an Offer Response Notice sent
to the Borrower within the Offer Response Period, and the Borrower does not receive the capital or financing from such third party in
accordance with the foregoing clause (z) within thirty (30) days after the date of the last Offer Notice, so long as this Note remains
outstanding at such time, the Borrower must again offer the capital or financing opportunity on the same terms as such third party’s
terms by providing written notice of the offer concurrently to each of the Offerees pursuant to a further Offer Notice as described above,
and the process detailed above shall be repeated. All Offer Notices required to be sent to the Holder under this Section 4.15
must be sent via electronic mail to wengland@walleyecapital.com. For purposes of allocating the opportunity to provide the capital
or financing to the Borrower on the same terms as the applicable third party’s terms to the applicable Offerees under clause (x)
of the fourth sentence of this Section 4.15, the Offerees shall be and hereby are allocated units (with respect to each Offeree,
such Offeree’s “ROFR Units”) representing the Offerees’ respective rights in connection with any such
allocation of the opportunity, with such ROFR Units being allocated to the Offerees in the following amounts: (i) to the Holder, 2,149,706
ROFR Units, (ii) to the Arena Purchasers (as a single Offeree), 3,900,000 ROFR Units, (iii) to Mast Hill, 367,500 ROFR Units, (iv) to
Blue Lake, 262,500 ROFR Units, and (v) to Fourth Man, 156,525 ROFR Units.
4.16
Dispute Resolution. In the case of a dispute as to the determination of the Conversion Price, the number of Conversion Shares
issuable upon any Conversion, any prepayment amount or Default Amount, the closing bid price, or fair market value (as the case may be)
or the arithmetic calculation of the Conversion Price, the number of Conversion Shares issuable upon any Conversion, the applicable prepayment
amount(s) or Default Amount (as the case may be), the Borrower or the Holder shall submit the disputed determinations or arithmetic calculations
via facsimile (i) within one (1) Trading Day after receipt of the applicable notice giving rise to such dispute to the Borrower or the
Holder or (ii) if no notice gave rise to such dispute, at any time after the Holder learned of the circumstances giving rise to such
dispute. If the Holder and the Borrower are unable to agree upon such determination or calculation within one (1) Trading Day of such
disputed determination or arithmetic calculation (as the case may be) being submitted to the Borrower or the Holder, then the Borrower
shall, within one (1) Trading Day, submit (a) the disputed determination of the Conversion Price, the closing bid price, or fair market
value (as the case may be) to an independent, reputable investment bank selected by the Borrower and approved by the Holder or (b) the
disputed arithmetic calculation of the Conversion Price, the number of Conversion Shares issuable upon any Conversion or any prepayment
amount or Default Amount, to an independent, outside accountant selected by the Holder that is reasonably acceptable to the Borrower.
The Borrower shall cause at its expense the investment bank or the accountant to perform the determinations or calculations and notify
the Borrower and the Holder of the results no later than one (1) Trading Day from the time it receives such disputed determinations or
calculations. Such investment bank’s or accountant’s determination or calculation shall be binding upon all parties absent
demonstrable error.
4.17
Remedies, Characterizations, Other Obligations, Breaches, and Injunctive Relief. The remedies provided in this Note shall
be cumulative and in addition to all other remedies available under this Note at law or in equity (including a decree of specific performance
and/or other injunctive relief), and nothing herein shall limit the Holder’s right to pursue actual and consequential damages for
any failure by the Borrower to comply with the terms of this Note. The Borrower covenants to the Holder that there shall be no characterization
concerning this instrument other than as expressly provided herein. Amounts set forth or provided for herein with respect to payments
and the like (and the computation thereof) shall be the amounts to be received by the Holder and shall not, except as expressly provided
herein, be subject to any other obligation of the Borrower (or the performance thereof). The Borrower acknowledges that a breach by it
of its obligations hereunder will cause irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate.
The Borrower therefore agrees that, in the event of any such breach or threatened breach, the Holder shall be entitled, in addition to
all other available remedies, to an injunction restraining any such breach or any such threatened breach, without the necessity of showing
economic loss and without any bond or other security being required. The Borrower shall provide all information and documentation to
the Holder that is reasonably requested by the Holder to enable the Holder to confirm the Borrower’s compliance with the terms
and conditions of this Note.
4.18
Disclosure. Upon receipt or delivery by the Borrower of any notice in accordance with the terms of this Note, unless the Borrower
has in good faith determined that the matters relating to such notice do not constitute material, nonpublic information relating to the
Borrower or its subsidiaries, the Borrower shall (i) within two (2) Business Days following any such receipt of a notice by the Borrower
hereunder or (ii) immediately upon any such delivery of a notice by the Borrower hereunder, publicly disclose such material, nonpublic
information on a Current Report on Form 8-K pursuant to Regulation FD. In the event that the Borrower believes that any such notice contains
material, non-public information relating to the Borrower or its subsidiaries, the Borrower so shall indicate to the Holder contemporaneously
with delivery of such notice, and in the absence of any such indication, the Holder shall be allowed to presume that all matters relating
to such notice do not constitute material, nonpublic information relating to the Borrower or its subsidiaries.
[signature
page follows]
IN
WITNESS WHEREOF, the Borrower has caused this Note to be signed in its name by its duly authorized officer as of the date first written
above.
|
CAN
B̅ CORP. |
|
|
|
|
By: |
/s/
Marco Alfonsi |
|
Name: |
Marco
Alfonsi |
|
Title: |
Chief
Executive Officer |
ANNEX
A-1 - NOTICE OF CONVERSION
The
undersigned hereby elects to convert $______________ in outstanding principal amount of the Note (defined below) into that number of
shares of Common Stock to be issued pursuant to the conversion of the Note (“Common Stock”) as set forth below, of
CAN B̅ CORP., a Florida corporation (the “Borrower”), according to the conditions of the promissory note
of the Borrower dated as of October 27, 2023 (the “Note”), as of the Conversion Date set forth below. No fee will
be charged to the Holder for any conversion, except for transfer taxes, if any. Capitalized terms used but not defined herein shall have
the meaning given to such terms in the Note.
Box
Checked as to applicable instructions:
|
☐ |
The
Borrower shall electronically transmit the Common Stock issuable pursuant to this Notice of Conversion to the account of the undersigned
or its nominee with DTC through its Deposit Withdrawal Agent Commission system (“DWAC Transfer”). |
|
|
|
|
|
Name
of DTC Prime Broker: |
|
|
Account
Number: |
|
|
|
|
☐ |
The
undersigned hereby requests that the Borrower issue a certificate or certificates for the number of shares of Common Stock set forth
below (which numbers are based on the Holder’s calculation attached hereto) in the name(s) specified immediately below or,
if additional space is necessary, on an attachment hereto: |
|
Conversion
Date: |
____________________________ |
|
|
|
|
Converted
Principal Amount
|
|
|
(set
forth above): |
$____________________________ |
|
Applicable
Conversion Price: |
$____________________________ |
|
Number
of Shares of Common Stock to be |
|
|
issued
pursuant to this Conversion of the |
|
|
Note: |
_____________________________ |
|
Principal
Amount due remaining under the |
|
|
Note
after this Conversion: |
$____________________________ |
[Signature
Page to Annex A-1 – Notice of Conversion]
ANNEX
A-2 - NOTICE OF CONVERSION
Reference
is made to that certain Promissory Note dated as of October 27, 2023 (the “Note”) of CAN B̅ CORP., a Florida
corporation (the “Borrower”). Capitalized terms used but not defined herein shall have the meaning given to such terms
in the Note. No fee will be charged to the Holder for any conversion of the Note, except for transfer taxes, if any. The undersigned
hereby elects to convert, by Conversion as of the Conversion Date set forth below, $_____________ (such amount, the “Total Default
Obligations Converted Amount”) in obligations outstanding of the Borrower under Section 3.2(a) of the Note consisting of:
|
(a)
Default Amount being converted: |
|
$___________________ |
|
Principal
Amount of Note being converted (included in calculation of Default Amount being converted: |
|
$___________________ |
|
Default
Interest to be converted (included in calculation of Default Amount being converted): |
|
$___________________ |
|
(b)
Costs, including without limitation legal fees and expenses, of collection, being converted: |
|
$___________________ |
|
|
|
|
|
Total
Default Obligations Converted Amount
(add
lines (a) and (b) above): |
|
$___________________ |
|
Conversion
Date: |
__________________________ |
|
Total
Default Obligations Converted Amount
(set
forth above): |
|
$___________________ |
|
Applicable
Conversion Price: |
|
$___________________ |
|
Number
of Shares of Common Stock to be issued pursuant to this Conversion of the Total Default Obligations Converted Amount: |
|
___________________ |
|
|
|
___________________ |
|
(a)
Default Amount due remaining under the Note after this Conversion: |
|
$___________________ |
|
Principal
Amount due remaining under the Note after this Conversion (included in calculation of Default Amount remaining due under the Note
after this Conversion): |
|
$___________________ |
|
Default
Interest due remaining under the Note after this Conversion (included in calculation of Default Amount remaining due under the Note
after this Conversion): |
|
$___________________ |
|
(b)
Costs, including without limitation legal fees and expenses, of collection, due remaining under the Note after this Conversion: |
|
$___________________ |
|
Total
obligations of the Borrower under Section 3.2(a) of the Note due remaining due after this Conversion (add lines (a) and (b) above): |
|
$___________________ |
[form
continues on following page]
[Signature
Page to Annex A-2 – Notice of Conversion]
Box
Checked as to applicable instructions:
|
☐ |
The
Borrower shall electronically transmit the Common Stock issuable pursuant to this Notice of Conversion to the account of the undersigned
or its nominee with DTC through its Deposit Withdrawal Agent Commission system (“DWAC Transfer”). |
|
|
|
|
|
Name
of DTC Prime Broker: |
|
|
Account
Number: |
|
|
|
|
☐ |
The
undersigned hereby requests that the Borrower issue a certificate or certificates for the number of shares of Common Stock set forth
below (which numbers are based on the Holder’s calculation attached hereto) in the name(s) specified immediately below or,
if additional space is necessary, on an attachment hereto: |
[Signature
Page to Annex A-2 – Notice of Conversion]
Exhibit
9.3
NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE CONVERTIBLE
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED
FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH MAY BE THE LEGAL COUNSEL OPINION (AS DEFINED IN THE SPA)), IN A GENERALLY
ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144, RULE 144A OR REGULATION S
UNDER SAID ACT OR OTHER APPLICABLE EXEMPTION. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA
FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.
Principal
Amount: $1,354,210 |
Effective
Date: October 27, 2023 |
Actual
Amount of Purchase Price: $1,083,368 |
|
CONSOLIDATED
AMENDED AND RESTATED PROMISSORY NOTE (this “Note”)
FOR
VALUE RECEIVED, CAN B̅ CORP., a Florida corporation (hereinafter called the “Borrower”) (Trading Symbol:
CANB), hereby promises to pay to the order of Walleye Opportunities Master Fund Ltd, a Cayman Islands exempted company with limited liability,
or its registered assigns (the “Holder”), in the form of lawful money of the United States of America, the principal
sum of $1,354,210.00 (the “Principal Amount”), of which $1,083,368 is the actual amount of the purchase price (the
“Consideration”) hereof plus an original issue discount in the amount of $270,842 (the “OID”) (subject
to adjustment herein) on the date the same becomes due and payable, whether at maturity or upon acceleration or by prepayment or otherwise,
as further provided herein. The entire Principal Amount, together with any accrued and unpaid Default Interest and any other unpaid fees
or other amounts outstanding under this Note shall be due and payable on October 27, 2024 (the “Maturity Date”), or
on such earlier date as all or any portion of the Principal Amount, any such accrued and unpaid Default Interest and/or any such other
unpaid fees and/or other amounts outstanding under this Note may be due and payable in accordance with the terms of this Note, whether
upon acceleration or otherwise in accordance with the terms of this Note.
Reference
is made to that certain Securities Purchase Agreement, dated as of October 26, 2023, by and between the Borrower and the Holder (as amended,
restated, amended and restated, supplemented or otherwise modified from time to time, the “SPA”), pursuant to which
the Borrower and the Holder have agreed, among other things, on the terms and subject to the conditions set forth therein, to (a) consolidate
(i) that certain promissory note of the Borrower dated as of August 30, 2022 in the original principal amount of $385,000, issued by
the Borrower in favor of the Holder (the “$385,000 Walleye Note”), (ii) that certain 20% Original Issue Discount Promissory
Note of the Borrower dated as of May 17, 2023 in the original principal amount of $437,500, issued by the Borrower in favor of the Holder
(the “$437,500 Walleye Note”), (iii) that certain $100,000 Unsecured Promissory Note of the Borrower dated as of August
5, 2022, by and between the Borrower as borrower and Emergent Health Corp., a Wyoming corporation (“Emergent”) as
lender (the “$100,000 Walleye Note”), which $100,000 Walleye Note was purchased by the Holder from Emergent pursuant
to that certain Note Purchase Agreement, dated as of August 3, 2023, by and between Emergent as seller and the Holder as purchaser (the
“Emergent NPA”), and (iv) that certain $250,000 Unsecured Promissory Note of the Borrower dated as of August 18, 2022,
by and between the Borrower as borrower and Emergent as lender, which $250,000 Unsecured Promissory Note was purchased by the Holder
from Emergent pursuant to the Emergent NPA (the “$250,000 Walleye Note”, together with the $385,000 Walleye Note,
the $437,500 Walleye Note and the $100,000 Walleye Note, each as amended, restated, amended and restated, supplemented or otherwise modified
from time to time, collectively, the “Original Notes”), and the indebtedness evidenced by the Original Notes, to form
a single note evidencing a principal indebtedness of $1,354,210 (reflecting the aggregate outstanding principal of the Original Notes
and accrued interest thereon as of the Effective Date), and (b) to amend and restate such Original Notes, as so consolidated, on the
terms and conditions hereinafter set forth. This Note consolidates, amends, restates and supersedes in their entirety the Original Notes.
The Borrower and the Holder hereby confirm and agree that (i) upon execution and delivery of this Note, the Original Notes shall have
no further force or effect and (ii) the principal amount outstanding under this Note as of the Effective Date is the Principal Amount
set forth in the introductory paragraph of this Note.
This
Note may not be prepaid or repaid in whole or in part except as otherwise explicitly set forth herein.
All
payments due hereunder (to the extent not converted into shares of common stock, nil par value per share, of the Borrower (the “Common
Stock”) in accordance with the terms hereof) shall be made in lawful money of the United States of America. As used herein,
“$” or “Dollars” means United States Dollars. All payments shall be made at such address as the
Holder shall hereafter give to the Borrower by written notice made in accordance with the provisions of this Note. Whenever any amount
expressed to be due by the terms of this Note is due on any day which is not a Business day, the same shall instead be due on the next
succeeding day which is a Business day.
Each
capitalized term used herein, and not otherwise defined, shall have the meaning ascribed thereto in the SPA. As used in this Note, the
term “Effective Date” means October 27, 2023 (i.e. the date first written above). As used in this Note, the term “Business
Day” shall mean any day other than a Saturday, Sunday or a day on which commercial banks in the city of New York, New York
are authorized or required by law or executive order to remain closed; provided, for the avoidance of doubt, that no such commercial
banks shall be considered to be authorized or required by law or executive order to remain closed as a result of “stay at home”,
“shelter-in-place”, “non-essential employee” or other similar orders or restrictions or the closure of any physical
branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire
transfers) of such commercial banks are generally open for sue by customers on such day. As used herein, the term “Trading Day”
means any day that shares of Common Stock are listed for trading or quotation on the Principal Market, provided, however, that if the
Common Stock is not then listed or quoted on any Principal Market, then any calendar day. “Principal Market” shall
mean the principal securities exchange or trading market where the Common Stock is listed or traded, including but not limited to any
tier of the OTC Markets, any tier of the NASDAQ Stock Market (including NASDAQ Capital Market), or the NYSE American, or any successor
to such markets.
This
Note is free from all taxes, liens, claims and encumbrances with respect to the issue thereof and shall not be subject to preemptive
rights or other similar rights of shareholders of the Borrower and will not impose personal liability upon the holder thereof.
The
following terms shall also apply to this Note:
ARTICLE
I. CONVERSION RIGHTS
1.1
Conversions.
(a)
At any time after the Effective Date until this Note is no longer outstanding, this Note (including the outstanding Principal Amount
of this Note, any accrued and unpaid Default Interest and any other obligation of the Borrower payable under Section 3.2(a) the
payment of which the Holder elects to accept in Common Stock) shall be convertible, in whole or in part, into shares of Common Stock
at the option of the Holder, at any time and from time to time (subject to the conversion limitations set forth in this Article I).
The Holder shall effect such conversions (“Conversions”) by delivering to the Borrower or the Borrower’s transfer
agent a notice of conversion, (i) in the case of any Conversion effected prior to the occurrence of any Event of Default, the form of
which is attached hereto as Annex A-1, specifying therein the principal amount of this Note to be converted and the date on which
such Conversion shall be effected (such date, the “Conversion Date”), or in the case of any Conversion effected upon
or after the occurrence of any Event of Default, the form of which is attached hereto as Annex A-2, specifying therein the principal
amount of this Note to be converted (including any principal amount of this Note included in any Default Amount of this Note to be so
converted), any accrued and unpaid Default Interest and any other obligation of the Borrower payable under Section 3.2(a) the
payment of which the Holder elects to accept in Common Stock to be converted, and the Conversion Date on which such Conversion shall
be effected (each such notice of conversion described under either of the foregoing clauses (i) or (ii) of this sentence, a “Notice
of Conversion”), and which Notice of Conversion shall be delivered to the Borrower or the Borrower’s transfer agent in
the manner set forth in Section 1.4(a); provided, notwithstanding anything to the contrary set forth herein, the Conversion
Date with respect to any Conversion effected pursuant to delivery of any Notice of Conversion (including any Notice of Conversion specifying
a particular Conversion Date and any Notice of Conversion that does not specify a Conversion Date) shall be determined in accordance
with Section 1.4(a). No ink-original Notice of Conversion shall be required, nor shall any medallion guarantee (or other type
of guarantee or notarization) of any Notice of Conversion form be required. Conversions hereunder, (i) in the case of any Conversion
effected prior to the occurrence of any Event of Default, shall have the effect of lowering the amount of outstanding principal amount
of this Note in an amount equal to the applicable principal amount so converted, or (ii) in the case of any Conversion effected upon
or after the occurrence of any Event of Default, shall have the effect of lowering the amount of outstanding obligation(s) of the Borrower
payable under Section 3.2(a) by an amount equal to the applicable amount of any outstanding obligation(s) of the Borrower payable
under Section 3.2(a) the payment of which the Holder elects to accept in Common Stock.
(b)
Conversion Price. Conversions of this Note pursuant to this Section 1.1 and/or Section 3.2(a) shall be effected
at a conversion price equal to the Conversion Price. As used in this Note, the term “Conversion Price” means, with
respect to any Conversion, a price per share of the Borrower’s Common Stock, equal to 90% of the lowest daily VWAP of the Common
Stock during the fifteen (15) Trading Day period prior to the Conversion Date with respect to such Conversion; provided; notwithstanding
anything to the contrary set forth in this Section 1.1, the Conversion Price shall be subject to adjustment in accordance with
the terms and conditions of this Note, including without limitation upon the occurrence of an Event of Default as set forth in Section
3.2(a) and upon the occurrence of certain events as set forth in Section 1.6. Subject to Section 1.4(f), the number
of shares of Common Stock issuable to the Holder upon any Conversion pursuant to this Section 1.1 and/or Section 3.2(a)
as applicable, shall be equal to the ratio calculated by dividing (A) the amount in Dollars of the outstanding obligations of the Borrower
under this Note elected by the Holder to be converted (which for the avoidance of doubt, shall (i) in the case of any Conversion effected
prior to the occurrence of any Event of Default, be limited to the outstanding Principal Amount under this Note at the time of such Conversion,
and (ii) in the case of any Conversion effected upon or after the occurrence of any Event of Default, may include any obligation of the
Borrower payable under Section 3.2(a) the payment of which the Holder elects to accept in Common Stock, including without limitation
the Default Amount) by (B) the Conversion Price.
“VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (i) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (ii) if the Common Stock is not then listed or quoted for trading on OTCQB
or OTCQX or any other Trading Market, and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (iii)
in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith
by the Holder and reasonably acceptable to the Borrower, the fees and expenses of which shall be paid by the Borrower. “Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).
1.2
Conversion Schedule; Records. The Holder and the Borrower shall maintain a Conversion Schedule showing the principal amount(s)
converted (and as applicable, any other obligations of the Borrower under this Note converted, including without limitation, the amount
of any accrued and unpaid Default Interest and any other obligation of the Borrower payable under Section 3.2(a) the payment of
which the Holder elects to accept in Common Stock) and the date of any and all Conversion(s) effected. The Borrower may deliver an objection
to any Notice of Conversion within one (1) Business Day of delivery by the Holder of such Notice of Conversion. In the event of any dispute
or discrepancy, the records of the Holder shall be controlling and determinative in the absence of manifest error.
1.3
Authorized and Reserved Shares. The Borrower covenants that at all times until the Note is satisfied in full, the Borrower will
reserve from its authorized and unissued Common Stock a sufficient number of shares, free from preemptive rights, to provide for the
issuance of a number of Conversion Shares equal to the product calculated by multiplying (A) the sum of the number of Conversion Shares
issuable upon the full conversion of this Note (assuming no payment of Principal Amount or interest) at the time of such calculation
(taking into consideration any adjustments to the Conversion Price as provided in this Note) by (B) three (3) (the “Reserved
Amount”). The Borrower represents that upon issuance, the Conversion Shares will be duly and validly issued, fully paid and
non-assessable. The Borrower (i) acknowledges that it has irrevocably instructed its transfer agent to issue certificates for the Conversion
Shares or instructions to have the Conversion Shares issued as contemplated by Section 1.4(e) hereof, and (ii) agrees that its
issuance of this Note shall constitute full authority to its officers and agents who are charged with the duty of executing stock certificates
or cause the Borrower to electronically issue shares of Common Stock to execute and issue the necessary certificates for the Conversion
Shares or cause the Conversion Shares to be issued as contemplated by Section 1.4(e) hereof in accordance with the terms and conditions
of this Note.
If,
at any time the Borrower does not maintain the Reserved Amount it will be considered an Event of Default (as defined in this Note) under
Section 3.1(c) of this Note. If, on any date, the number of authorized but unissued (and
otherwise unreserved) shares of Common Stock is less than the Reserved Amount on such date, then the board of directors of the Borrower
shall use commercially reasonable efforts to amend the Borrower’s certificate or articles of incorporation to increase the number
of authorized but unissued shares of Common Stock to at least the Reserved Amount at such time, as soon as possible and in any event
not later than the 90th day after such date. The Borrower shall, if applicable: (A) in the time and manner required by the Principal
Market, prepare and file with such Principal Market an additional shares listing application covering a number of shares of Common Stock,
equal to or greater than the Reserved Amount if such application is made within 45 days of the Effective Date, (B) take all steps necessary
to cause such shares of Common Stock to be approved for listing or quotation on such Principal Market as soon as possible thereafter,
(C) provide to the Holder evidence of such listing or quotation and (D) maintain the listing or quotation of a number of shares of such
Common Stock on such Principal Market or another Principal Market on any date equal to or greater than the Reserved Amount if such date
is within 45 days of the Effective Date. The Borrower agrees to maintain the eligibility of the Common Stock for electronic transfer
through the DTC or another established clearing corporation, including, without limitation, by timely payment of fees to the DTC or such
other established clearing corporation in connection with such electronic transfer.
1.4
Method of Conversion.
(a)
Mechanics of Conversion. Conversions of this Note may be effected by the Holder pursuant to Section 1.1 and/or Section
3.2(a) by Holder’s submission to the Borrower or the Borrower’s transfer agent of a Notice of Conversion sent via by
facsimile, e-mail or other reasonable means of communication. The Conversion Date specified in the Notice of Conversion shall be the
Conversion Date with respect to the applicable Conversion so long as the Notice of Conversion is sent to the Borrower or the Borrower’s
transfer via by facsimile, e-mail or other reasonable means of communication before 5:30 p.m. (New York City time), on such date specified
in the Notice of Conversion. Any Notice of Conversion submitted after 5:30 p.m. (New York City time) on any given date shall be deemed
to have been delivered and received on the next Trading Day, which date shall be deemed to be the Conversion Date with respect to the
applicable Conversion effected pursuant to such Notice of Conversion regardless of the Conversion Date specified in the Notice of Conversion.
If no Conversion Date is specified in a Notice of Conversion, the Conversion Date with respect to the applicable Conversion shall be
deemed to be (i) the date that such Notice of Conversion is sent to the Borrower or the Borrower’s transfer via by facsimile, e-mail
or other reasonable means of communication, if such Notice of Conversion is sent to the Borrower or the Borrower’s transfer via
by facsimile, e-mail or other reasonable means of communication before 5:30 p.m. (New York City time) on such date or (ii) the next Trading
Day immediately following the date that such Notice of Conversion is sent to the Borrower or the Borrower’s transfer via by facsimile,
e-mail or other reasonable means of communication, if such Notice of Conversion is sent to the Borrower or the Borrower’s transfer
via by facsimile, e-mail or other reasonable means of communication after 5:30 p.m. (New York City time) on such date.
(b)
Surrender of Note Upon Conversion. Notwithstanding anything to the contrary set forth herein, upon conversion of this Note in
accordance with the terms hereof, the Holder shall not be required to physically surrender this Note to the Borrower unless the entire
unpaid Principal Amount of this Note (together with any accrued and unpaid Default Interest, and any other obligation of the Borrower
payable under Section 3.2(a) the payment of which the Holder elects to accept in Common Stock, and any other fee or other amount
permitted to be converted pursuant to this Note) has been so converted and all obligations of the Borrower owing under this Note have
been paid in full, including without limitation any accrued and unpaid Default Interest and any other fees and/or other amounts owing
by the Borrower under this Note. The Holder and the Borrower shall maintain records showing the Principal Amount (and, as applicable,
the amount of any accrued and unpaid Default Interest, any other obligation of the Borrower payable under Section 3.2(a) the payment
of which the Holder elects to accept in Common Stock, and any other fee or other amount permitted to be converted pursuant to this Note)
so converted and the dates of such conversions or shall use such other method, reasonably satisfactory to the Holder and the Borrower,
so as not to require physical surrender of this Note upon each such conversion. In the event of any dispute or discrepancy, such records
of the Holder shall be controlling and determinative in the absence of manifest error. Notwithstanding the foregoing, if any portion
of this Note is converted as aforesaid, the Holder may not transfer this Note unless the Holder first physically surrenders this Note
to the Borrower, whereupon the Borrower will forthwith issue and deliver upon the order of the Holder a new Note of like tenor, registered
as the Holder (upon payment by the Holder of any applicable transfer taxes) may request, representing in the aggregate the remaining
unpaid Principal Amount of this Note (together with any accrued and unpaid Default Interest and any other obligations of the Borrower
then owing under this Note, including without limitation any fees and/or other amounts then owing by the Borrower under this Note). The
Holder and any assignee, by acceptance of this Note, acknowledge and agree that, by reason of the provisions of this paragraph, following
conversion of a portion of this Note, the unpaid and unconverted Principal Amount of this Note represented by this Note may be less than
the amount stated on the face hereof.
(c)
Payment of Taxes and Expenses. The Borrower shall not be required to pay any tax which may be payable in respect of any transfer
involved in the issue and delivery of shares of Common Stock or other securities or property on conversion of this Note in a name other
than that of the Holder (or in street name), and the Borrower shall not be required to issue or deliver any such shares or other securities
or property unless and until the person or persons (other than the Holder or the custodian in whose street name such shares are to be
held for the Holder’s account) requesting the issuance thereof shall have paid to the Borrower the amount of any such tax or shall
have established to the satisfaction of the Borrower that such tax has been paid. Notwithstanding the foregoing, the issuance of Conversion
Shares on conversion of this Note shall be made without charge to the Holder for any documentary stamp or similar taxes that may be payable
in respect of the issue or delivery of such Conversion Shares. The Borrower shall pay all transfer agent fees required for same-day processing
of any Notice of Conversion and all fees to the DTC (or another established clearing corporation performing similar functions) required
for same-day electronic delivery of the Conversion Shares. The Borrower shall pay all attorney fees required for the issuance of attorney
legal opinions for removal of restrictive legends on Conversion Shares.
(d)
Delivery of Common Stock Upon Conversion. Upon receipt by the Borrower or the Borrower’s transfer agent from the Holder
of any Notice of Conversion submitted in accordance with Section 1.4(a) and otherwise meeting the requirements for conversion
as provided in this Section 1.4, the Borrower shall issue and deliver or cause to be issued and delivered to or upon the order
of the Holder certificates for the applicable Conversion Shares (or cause the electronic delivery of such Conversion Shares as contemplated
by Section 1.4(f) hereof) within one (1) Trading Day after such receipt (any such date, a “Deadline”). If the
Borrower shall fail for any reason or for no reason to issue to the Holder on or prior to the applicable Deadline a certificate for the
number of Conversion Shares or to which the Holder is entitled hereunder and register such Conversion Shares on the Borrower’s
share register or to credit the Holder’s balance account with DTC (as defined below) for such number of Conversion Shares to which
the Holder is entitled upon any Conversion of this Note (a “Conversion Failure”), then, in addition to all other remedies
available to the Holder, (i) the Borrower shall pay in cash to the Holder on each day after such Deadline and during such Conversion
Failure an amount equal to 2.0% of the product of (A) the sum of the number of Conversion Shares not issued to the Holder on or prior
to the applicable Deadline and to which the Holder is entitled and (B) the VWAP of the Common Stock on the Trading Day immediately preceding
the last possible date which the Borrower could have issued such Conversion Shares to the Holder without violating this Section 1.5(d);
and (ii) upon written notice to the Borrower, the Holder may void all or any portion of the Notice of Conversion submitted by the Holder
to effect such Conversion; provided that the voiding of all or any portion of any Notice of Conversion shall not affect the Borrower’s
obligations to make any payments which have accrued prior to the date of such notice. In addition to the foregoing, if on or prior to
the applicable Deadline, the Borrower shall fail to issue and deliver a certificate to the Holder and register such Conversion Shares
on the Borrower’s share register or credit the Holder’s balance account with DTC for the number of Conversion Shares to which
the Holder is entitled upon any Conversion of this Note or pursuant to the Borrower’s obligation pursuant to clause (ii) below,
and if on or after such Trading Day the Holder purchases (in an open market transaction or otherwise) shares of Common Stock to deliver
in satisfaction of a sale by the Holder of shares of Common Stock issuable upon such Conversion of this Note that the Holder anticipated
receiving from the Borrower, then the Borrower shall, within two (2) Trading Days after the Holder’s request and in the Holder’s
discretion, either (i) pay cash to the Holder in an amount equal to the Holder’s total purchase price (including brokerage commissions
and other reasonable and customary out-of-pocket expenses, if any) for the shares of Common Stock so purchased (the “Buy-In
Price”), at which point the Borrower’s obligation to deliver such certificate (and to issue such Conversion Shares) or
credit such Holder’s balance account with DTC for such Conversion Shares shall terminate, or (ii) promptly honor its obligation
to deliver to the Holder a certificate or certificates representing such Conversion Shares or credit such Holder’s balance account
with DTC and pay cash to the Holder in an amount equal to the excess (if any) of the Buy-In Price over the product of (A) such number
of shares of Common Stock multiplied by (B) the closing sales price of the Common Stock on the date of applicable Deadline. Nothing
shall limit the Holder’s right to pursue any other remedies available to it hereunder, at law or in equity, including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Borrower’s failure to timely deliver
certificates representing the Conversion Shares (or to electronically deliver such Conversion Shares) upon the conversion of this Note
as required pursuant to the terms hereof.
(e)
Obligation to Deliver Common Stock. Upon receipt by the Borrower or the Borrower’s transfer agent from the Holder of any
Notice of Conversion submitted in accordance with Section 1.4(a) and otherwise meeting the requirements for conversion as provided
in this Section 1.4, the Holder shall be deemed to be the holder of record of the Conversion Shares issuable upon the Conversion
of the Principal Amount (and, as applicable any accrued and unpaid Default Interest and any other obligation of the Borrower payable
under Section 3.2(a) the payment of which the Holder elects to accept in Common Stock pursuant to such Conversion) effected pursuant
to the submission of such Notice of Conversion, the outstanding Principal Amount under this Note (and, as applicable, any accrued and
unpaid Default Interest and any other obligation of the Borrower payable under Section 3.2(a) the payment of which the Holder
elects to accept in Common Stock pursuant to such Conversion) shall be reduced to reflect such Conversion in accordance with Section
1.1, and, unless the Borrower defaults on any of its obligations under this Article I (including without limitation, delivery
of the Conversion Shares with respect to such Conversion by the applicable Deadline with respect to such Conversion), all rights with
respect to the portion of the Principal Amount of this Note (and, as applicable, any accrued and unpaid Default Interest and any other
obligation of the Borrower payable under Section 3.2(a) the payment of which the Holder elects to accept in Common Stock pursuant
to such Conversion) being so converted shall forthwith terminate except the right of the Holder to receive the Common Stock or other
securities, cash or other assets, as herein provided, on such Conversion. If the Holder shall have submitted a Notice of Conversion as
provided herein, the Borrower’s obligation to issue and deliver the certificates for the Conversion Shares (or cause the electronic
delivery of the Conversion Shares as contemplated by Section 1.4(f) hereof) shall be absolute and unconditional, irrespective
of the absence of any action by the Holder to enforce the same, any waiver or consent with respect to any provision thereof, the recovery
of any judgment against any person or any action to enforce the same, any failure or delay in the enforcement of any other obligation
of the Borrower to the holder of record, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged
breach by the Holder of any obligation to the Borrower, and irrespective of any other circumstance which might otherwise limit such obligation
of the Borrower to the Holder in connection with such conversion. The Conversion Date with respect to any Conversion shall be determined
in accordance with Section 1.4(a) hereof.
(ii)
Delivery of Conversion Shares by Electronic Transfer. Not later than the applicable Deadline with respect to any Conversion Shares
issuable upon any Conversion of this Note, upon request of the Holder and its compliance with the provisions contained in (i) this Section
1.4 and (ii) Section 1.1 (with respect to any Conversion effected pursuant to Section 1.1 and/or Section 3.2(a),
the Borrower shall cause the Conversion Shares required to be issued hereunder pursuant to such Conversion to be electronically transmitted
by the Borrower’s transfer agent to the Holder by crediting the account of the Holder’s or its designee’s balance account
with the Depository Trust Company (“DTC”) through its Deposit Withdrawal Agent Commission, provided the Borrower is
participating in the DTC’s Fast Automated Securities Transfer or Deposit/Withdrawal at Custodian programs and either (A) there
is an effective registration statement permitting the issuance of the Conversion Shares to or resale of the Conversion Shares by the
Holder or (B) the requisite holding period provided by Rule 144 for the resale of the Conversion Shares by the Holder has been satisfied,
and otherwise by delivery of a certificate, registered in the Borrower’s share register in the name of the Holder or its designee.
(f)
Fractional Shares. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of this Note.
As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such conversion, the Borrower shall at its
election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Conversion
Price or round up to the next whole share.
1.5
Concerning the Shares. The Conversion Shares issuable upon conversion of this Note may not be sold or transferred unless (i) such
shares are sold pursuant to an effective registration statement under the 1933 Act or (ii) the Borrower or its transfer agent shall have
been furnished with an opinion of counsel (which opinion shall be the Legal Counsel Opinion (as defined in the SPA)) to the effect that
the shares to be sold or transferred may be sold or transferred pursuant to an exemption from such registration or (iii) such shares
are sold or transferred pursuant to Rule 144, Rule 144A, Regulation S, or other applicable exemption, or (iv) such shares are transferred
to an “affiliate” (as defined in Rule 144) of the Borrower who agrees to sell or otherwise transfer the shares only in accordance
with this Section 1.5 and who is an Accredited Investor (as defined in the SPA). Except as otherwise provided in the SPA (and
subject to the removal provisions set forth below), until such time as the Conversion Shares have been registered under the 1933 Act
or otherwise may be sold pursuant to Rule 144, Rule 144A, Regulation S, or other applicable exemption without any restriction as to the
number of securities as of a particular date that can then be immediately sold, each certificate for the Conversion Shares that has not
been so included in an effective registration statement or that has not been sold pursuant to an effective registration statement or
an exemption that permits removal of the legend, shall bear a legend substantially in the following form, as appropriate:
“NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED
FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH MAY BE THE LEGAL COUNSEL OPINION (AS DEFINED IN THE SPA)), IN A GENERALLY
ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144, RULE 144A, REGULATION S UNDER
SAID ACT, OR OTHER APPLICABLE EXEMPTION. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE
MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.”
The
legend set forth above shall be removed and the Borrower shall issue to the Holder a certificate for the applicable Conversion Shares
without such legend upon which it is stamped or (as requested by the Holder) issue the applicable Conversion Shares by electronic delivery
by crediting the account of such holder’s broker with DTC, if, unless otherwise required by applicable state securities laws: (a)
such Conversion Shares are registered for sale under an effective registration statement filed under the 1933 Act or otherwise may be
sold pursuant to Rule 144, Rule 144A, Regulation S, or other applicable exemption without any restriction as to the number of securities
as of a particular date that can then be immediately sold, or (b) the Borrower or the Holder provides the Legal Counsel Opinion (as contemplated
by and in accordance with Section 4(n) of the SPA) to the effect that a public sale or transfer of such Conversion Shares may be made
without registration under the 1933 Act, which opinion shall be accepted by the Borrower so that the sale or transfer is effected. The
Borrower shall be responsible for the fees of its transfer agent and all DTC fees associated with any such issuance. The Holder agrees
to sell all Conversion Shares, including those represented by a certificate(s) from which the legend has been removed, in compliance
with applicable prospectus delivery requirements, if any. In the event that the Borrower does not accept the opinion of counsel provided
by the Holder with respect to the transfer of Conversion Shares pursuant to an exemption from registration, such as Rule 144, Rule 144A,
Regulation S, or other applicable exemption, at any Deadline, notwithstanding that the conditions of Rule 144, Rule 144A, Regulation
S, or other applicable exemption, as applicable, have been met, it will be considered an Event of Default under Section 3.1(c)
of this Note.
1.6
Effect of Certain Events.
(a)
Effect of Merger, Consolidation, Etc. At the option of the Holder, the sale, conveyance or disposition of all or substantially
all of the assets of the Borrower, or the consolidation, merger or other business combination of the Borrower with or into any other
Person (as defined below) or Persons whereby the Borrower is not the survivor shall either: (i) be deemed to be an Event of Default pursuant
to which the Borrower shall be required to pay to the Holder upon the consummation of and as a condition to such transaction an amount
equal to the Default Amount (as defined in this Note) or (ii) be treated pursuant to Section 1.6(b) hereof. “Person”
shall mean any individual, corporation, limited liability company, partnership, association, trust or other entity or organization.
(b)
Adjustment Due to Merger, Consolidation, Etc. If, at any time when this Note is issued and outstanding and prior to conversion
of all of this Note, there shall be any merger, consolidation, exchange of shares, recapitalization, reorganization, or other similar
event, as a result of which shares of Common Stock of the Borrower shall be changed into the same or a different number of shares of
another class or classes of stock or securities of the Borrower or another entity, or in case of any sale or conveyance of all or substantially
all of the assets of the Borrower other than in connection with a plan of complete liquidation of the Borrower, then the Holder of this
Note shall thereafter have the right to receive upon conversion of this Note, upon the basis and upon the terms and conditions specified
herein and in lieu of the shares of Common Stock immediately theretofore issuable upon conversion, such stock, securities or assets which
the Holder would have been entitled to receive in such transaction had this Note been converted in full immediately prior to such transaction
(without regard to any limitations on conversion set forth herein), and in any such case appropriate provisions shall be made with respect
to the rights and interests of the Holder of this Note to the end that the provisions hereof (including, without limitation, provisions
for adjustment of the Conversion Price and of the number of shares issuable upon conversion of the Note) shall thereafter be applicable,
as nearly as may be practicable in relation to any securities or assets thereafter deliverable upon the conversion hereof. The Borrower
shall not effectuate any transaction described in this Section 1.6(b) unless (a) it first gives, to the extent practicable, at
least thirty (30) days prior written notice (but in any event at least fifteen (15) days prior written notice) of the record date of
the special meeting of shareholders to approve, or if there is no such record date, the consummation of, such merger, consolidation,
exchange of shares, recapitalization, reorganization or other similar event or sale of assets (during which time the Holder shall be
entitled to convert this Note) and (b) the resulting successor or acquiring entity (if not the Borrower) assumes by written instrument
the obligations of this Section 1.6(b). The above provisions shall similarly apply to successive consolidations, mergers, sales,
transfers or share exchanges.
(c)
Adjustment Due to Distribution. If the Borrower shall declare or make any distribution of its assets (or rights to acquire its
assets) to holders of Common Stock as a dividend, stock repurchase, by way of return of capital or otherwise (including any dividend
or distribution to the Borrower’s shareholders in cash or shares (or rights to acquire shares) of capital stock of a Subsidiary
(i.e., a spin-off)) (a “Distribution”), then the Holder of this Note shall be entitled, upon any conversion of this
Note after the date of record for determining shareholders entitled to such Distribution, to receive the amount of such assets which
would have been payable to the Holder with respect to the shares of Common Stock issuable upon such conversion had such Holder been the
holder of such shares of Common Stock on the record date for the determination of shareholders entitled to such Distribution.
(d)
Purchase Rights. If, at any time when all or any portion of this Note is issued and outstanding, the Borrower issues any convertible
securities or rights to purchase stock, warrants, securities or other property (the “Purchase Rights”) pro rata to
the record holders of any class of Common Stock, then the Holder of this Note will be entitled to acquire, upon the terms applicable
to such Purchase Rights, the aggregate Purchase Rights which such Holder could have acquired if such Holder had held the number of shares
of Common Stock acquirable upon complete conversion of this Note (without regard to any limitations on conversion contained herein) immediately
before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights or, if no such record is taken, the
date as of which the record holders of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights.
(e)
Dilutive Issuance. If the Borrower, at any time while this Note or any amounts due hereunder are outstanding, issues, sells or
grants (or has issued, sold or granted as of the Effective Date, as the case may be) any option to purchase, or sells or grants any right
to reprice, or otherwise disposes of, or issues (or has sold or issued, as the case may be, or announces any sale, grant or any option
to purchase or other disposition), any Common Stock or other securities convertible into, exercisable for, or otherwise entitle any person
or entity the right to acquire, shares of Common Stock (including, without limitation, upon conversion of this Note, and any convertible
notes or warrants outstanding as of or following the Effective Date), in each or any case at an effective price per share that is lower
than the then Conversion Price (such lower price, the “Base Conversion Price” and such issuances, collectively, a
“Dilutive Issuance”) (it being agreed that if the holder of the Common Stock or other securities so issued shall at
any time, whether by operation of purchase price adjustments, reset provisions, floating conversion, exercise or exchange prices or otherwise,
or due to warrants, options or rights per share which are issued in connection with such issuance, be entitled to receive shares of Common
Stock at an effective price per share that is lower than the Conversion Price, such issuance shall be deemed to have occurred for less
than the Conversion Price on such date of the Dilutive Issuance), then the Conversion Price shall be reduced, at the option of the Holder,
to a price equal to the Base Conversion Price. Such adjustment shall be made whenever such Common Stock or other securities are issued.
By way of example, and for the avoidance of doubt, if the Borrower issues a convertible promissory note (including but not limited to
a Variable Rate Transaction), and the holder of such convertible promissory note has the right to convert it into Common Stock at an
effective price per share that is lower than the then Conversion Price (including but not limited to a conversion price with a discount
that varies with the trading prices of or quotations for the Common Stock), then the Holder has the right to reduce the Conversion Price
to such Base Conversion Price (including but not limited to a conversion price with a discount that varies with the trading prices of
or quotations for the Common Stock) in perpetuity regardless of whether the holder of such convertible promissory note ever effectuated
a conversion at the Base Conversion Price. In the event of an issuance of securities involving multiple tranches or closings, any adjustment
pursuant to this Section 1.6(e) shall be calculated as if all such securities were issued at the initial closing. Notwithstanding
the foregoing, the Holder may only enforce its rights under this Section 1.6(e) after the date that is one hundred eighty (180)
calendar days after the Effective Date, provided, however, that at such time the Holder may enforce its rights to all adjustments hereunder
that apply even if the Dilutive Issuance occurred prior to the date that is one hundred eighty (180) calendar days after the Effective
Date.
(f)
Notice of Adjustments. Upon the occurrence of each adjustment or readjustment of the Conversion Price as a result of the events
described in this Section 1.6, the Borrower shall, at its expense and within one (1) calendar day after the occurrence of each
respective adjustment or readjustment of the Conversion Price, compute such adjustment or readjustment and prepare and furnish to the
Holder a certificate setting forth (i) the Conversion Price in effect at such time based upon the Dilutive Issuance, (ii) the number
of shares of Common Stock and the amount, if any, of other securities or property which at the time would be received upon conversion
of the Note, (iii) the detailed facts upon which such adjustment or readjustment is based, and (iv) copies of the documentation (including
but not limited to relevant transaction documents) that evidences the adjustment or readjustment. In addition, the Borrower shall, within
one (1) calendar day after each written request from the Holder, furnish to such Holder a like certificate setting forth (i) the Conversion
Price in effect at such time based upon the Dilutive Issuance, (ii) the number of shares of Common Stock and the amount, if any, of other
securities or property which at the time would be received upon conversion of the Note, (iii) the detailed facts upon which such adjustment
or readjustment is based, and (iv) copies of the documentation (including but not limited to relevant transaction documents) that evidences
the adjustment or readjustment. For the avoidance of doubt, each adjustment or readjustment of the Conversion Price as a result of the
events described in this Section 1.6 shall occur without any action by the Holder and regardless of whether the Borrower complied
with the notification provisions in this Section 1.6. To the extent that any notice provided hereunder constitutes, or contains,
material, non-public information regarding the Borrower or any of the Subsidiaries, the Borrower shall simultaneously file such notice
with the SEC pursuant to a Current Report on Form 8-K.
1.7
Holder’s Conversion Limitations. The Borrower shall not effect any conversion of this Note, and the Holder shall not have
the right to convert any portion of this Note, to the extent that after giving effect to the conversion set forth on the applicable Notice
of Conversion, the Holder (together with the Holder’s Affiliates, and any other Persons acting as a group together with the Holder
or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)) would beneficially own in excess of
the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock
beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable
upon conversion of this Note with respect to which such determination is being made, but shall exclude the number of shares of Common
Stock which are issuable upon (i) conversion of the remaining, unconverted principal amount of this Note beneficially owned by the Holder
or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or unconverted portion of any other
securities of the Borrower subject to a limitation on conversion or exercise analogous to the limitation contained herein (including,
without limitation, any other convertible notes or any warrant) beneficially owned by the Holder or any of its Affiliates or Attribution
Parties. Except as set forth in the preceding sentence, for purposes of this Section 1.7, beneficial ownership shall be calculated
in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. To the extent that the limitation
contained in this Section 1.7 applies, the determination of whether this Note is convertible (in relation to other securities
owned by the Holder together with any Affiliates and Attribution Parties) and of which principal amount of this Note is convertible shall
be in the sole discretion of the Holder, and the submission of a Notice of Conversion shall be deemed to be the Holder’s determination
of whether this Note may be converted (in relation to other securities owned by the Holder together with any Affiliates or Attribution
Parties) and which principal amount of this Note is convertible, in each case subject to the Beneficial Ownership Limitation. To ensure
compliance with this restriction, the Holder will be deemed to represent to the Borrower each time it delivers a Notice of Conversion
that such Notice of Conversion has not violated the restrictions set forth in this paragraph and the Borrower shall have no obligation
to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall
be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes
of this Section 1.7, in determining the number of outstanding shares of Common Stock, the Holder may rely on the number of outstanding
shares of Common Stock as stated in the most recent of the following: (i) the Borrower’s most recent periodic or annual report
filed with the Commission, as the case may be, (ii) a more recent public announcement by the Borrower, or (iii) a more recent written
notice by the Borrower or the Borrower’s transfer agent setting forth the number of shares of Common Stock outstanding. Upon the
written or oral request of a Holder, the Borrower shall within one (1) Trading Day confirm orally and in writing to the Holder the number
of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving
effect to the conversion or exercise of securities of the Borrower, including this Note, by the Holder or its Affiliates since the date
as of which such number of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation”
shall be 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common
Stock issuable upon conversion of this Note held by the Holder. The Beneficial Ownership Limitation provisions of this paragraph shall
be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 1.7 to correct this
paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation contained
herein or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained
in this paragraph shall apply to a successor holder of this Note.
1.8
Status as Shareholder. Upon submission of a Notice of Conversion by a Holder, (i) the Conversion Shares covered thereby (other
than the Conversion Shares, if any, which cannot be issued because their issuance would exceed such Holder’s allocated portion
of the Reserved Amount) shall be deemed converted into shares of Common Stock and (ii) the Holder’s rights as a Holder of such
converted portion of this Note shall cease and terminate, excepting only the right to receive certificates for such shares of Common
Stock and to any remedies provided herein or otherwise available at law or in equity to such Holder because of a failure by the Borrower
to comply with the terms of this Note. Notwithstanding the foregoing, if a Holder has not received certificates for all shares of Common
Stock prior to the tenth (10th) Business Day after the expiration of the applicable Deadline with respect to a conversion of any portion
of this Note for any reason, then (unless the Holder otherwise elects to retain its status as a holder of Common Stock by so notifying
the Borrower) the Holder shall regain the rights of a Holder of this Note with respect to such unconverted portions of this Note and
the Borrower shall, as soon as practicable, return such unconverted Note to the Holder or, if the Note has not been surrendered, adjust
its records to reflect that such portion of this Note has not been converted. In all cases, the Holder shall retain all of its rights
and remedies for the Borrower’s failure to convert this Note.
1.9
Note Obligations Independent from Distribution Obligations. The obligations of the Borrower to pay the Holder all principal, interest
and other amounts owing to the Holder under this Note shall be in addition to, and not in substitution for, any obligations of the Borrower
and Nascent Pharma, LLC, a Nevada limited liability company (“Nascent”) to pay Distributions (as defined in the Distribution
and Assignment Agreement) to the Holder under the Distribution and Assignment Agreement, and any such Distributions (as defined in the
Distribution and Assignment Agreement) paid to the Holder pursuant to the Distribution and Assignment Agreement shall be applied towards
the Additional Consideration Obligation (as defined in the Distribution and Assignment Agreement) and not to reduce the principal balance
or any other obligations of the Borrower outstanding under this Note, or any other promissory note or other instrument issued by the
Borrower to the Holder. As used herein, the term “Distribution and Assignment Agreement” means that certain Distribution
and Assignment Agreement dated as of October 27, 2023, by and among Nascent, the Borrower and the Holder (as amended, amended and restated,
supplemented or otherwise modified from time to time).
ARTICLE
II. NEGATIVE COVENANTS
2.1
Other Indebtedness. So long as the Borrower shall have any obligation under this Note, the Borrower shall not incur or suffer
to exist or guarantee any indebtedness that is senior to or pari passu in right or priority of payment to the obligations of the Borrower
under this Note, or otherwise secured by any assets of the Borrower or any of its Subsidiaries, other than Permitted Indebtedness. As
used herein, the term “Permitted Indebtedness” (i) means any indebtedness incurred under or contemplated by the Arena
Notes (used herein as defined in the Arena-Walleye Intercreditor Agreement) or any other Arena Transaction Document (used herein
as defined in the Arena-Walleye Intercreditor Agreement), which Permitted Indebtedness is subject to terms and provisions of that certain
letter agreement, dated as of February 27, 2023, by and among the Borrower, Walleye Opportunities Master Fund Ltd, Arena Special Opportunities
Partners I, LP, a Delaware limited partnership (“ASOP I”), Arena Special Opportunities Fund, LP, a Delaware limited
partnership (“ASOF”, and together with ASOP I, collectively, the “Arena Purchasers”), and Arena
Investors, LP, a Delaware limited partnership (as amended, restated, amended and restated, supplemented or otherwise modified from time
to time, the “Arena-Walleye Intercreditor Agreement”), (ii) indebtedness of the Borrower owing to the Holder under
that certain Promissory Note of the Borrower in the original principal amount of $1,823,529, dated as of February 27, 2023, issued by
the Borrower to Walleye Opportunities Master Fund Ltd (the “February 2023 Secured Walleye Note”), (iii) indebtedness
of the Borrower under any Note (as such term is defined in the SPA) issued under the SPA, and (iv) indebtedness of the Borrower owing
to the Holder under the Distribution and Assignment Agreement and/or owing to any other parties joined to the Distribution and Assignment
Agreement from time to time as additional assignees in accordance with the terms of the Distribution and Assignment Agreement and the
SPA.
2.2
Reserved.
2.3
Distributions on Capital Stock. So long as the Borrower shall have any obligation under this Note, the Borrower shall not without
the Holder’s written consent (a) pay, declare or set apart for such payment, any dividend or other distribution (whether in cash,
property or other securities) on shares of capital stock other than dividends on shares of Common Stock solely in the form of additional
shares of Common Stock or (b) directly or indirectly or through any Subsidiary make any other payment or distribution in respect of its
capital stock.
2.4
Restriction on Stock Repurchases and Debt Repayments. So long as the Borrower shall have any obligation under this Note, the Borrower
shall not without the Holder’s written consent redeem, repurchase or otherwise acquire (whether for cash or in exchange for property
or other securities or otherwise) in any one transaction or series of related transactions any shares of capital stock of the Borrower
or any warrants, rights or options to purchase or acquire any such shares, or repay any indebtedness of Borrower (other than the indebtedness
of the Borrower owing under this Note, any Note (as such term is defined in the SPA) issued under the SPA, or under the Distribution
and Assignment Agreement or any other Transaction Documents) except for (i) pursuant to the terms of the February 2023 Secured Walleye
Note, (ii) pursuant to the terms of the Arena Notes as in effect as of February 27, 2023 in accordance with the Walleye-Arena Intercreditor
Agreement, (ii) pursuant to the terms of that certain Promissory Note held by Blue Lake dated as of March 22, 2022 (as amended by that
certain Amendment #2 to Promissory Note, Amendment to Securities Purchase Agreement, Consent and Waiver Agreement dated as of February
23, 2023 by and between Blue Lake and the Borrower) as in effect as of February 27, 2023, (iii) pursuant to the terms of that certain
Promissory Note held by Mast Hill dated as of March 22, 2022 (as amended by that certain Amendment #2 to Promissory Note, Amendment to
Securities Purchase Agreement, Consent and Waiver Agreement dated as of February 23, 2023 by and between Mast Hill and the Borrower)
as in effect as of February 27, 2023, (iv) regularly scheduled payments of interest and principal with respect to the other indebtedness
of the Borrower outstanding as of October 26, 2023 pursuant to the terms of the documents evidencing such indebtedness listed on Schedule
4(y) of the SPA as in effect on October 26, 2023, or (v) pursuant to any provision of any document listed on Schedule 4(y) of the SPA
as in effect on October 26, 2023, evidencing indebtedness of the Borrower outstanding as of October 26, 2023 providing for the conversion
of such indebtedness into shares of the Borrower’s Common Stock.
2.5
Sale of Assets. So long as the Borrower shall have any obligation under this Note, the Borrower shall not, without the Holder’s
written consent, sell, lease or otherwise dispose of any significant portion of its assets outside the ordinary course of business. Any
consent by the Holder to the disposition of any assets may be conditioned on a specified use of the proceeds of disposition.
2.6
Advances and Loans; Affiliate Transactions. So long as the Borrower shall have any obligation under this Note, the Borrower shall
not, without the Holder’s written consent, lend money, give credit, make advances to or enter into any transaction with any person,
firm, joint venture or corporation, including, without limitation, officers, directors, employees, Subsidiaries and affiliates of the
Borrower, except loans, credits or advances (a) in existence or committed on the Effective Date and of which the Borrower has informed
Holder in writing prior to the Effective Date, (b) in regard to transactions with unaffiliated third parties, made in the ordinary course
of business or (c) in regard to transactions with unaffiliated third parties, not in excess of $100,000 in the aggregate of all such
transactions. So long as the Borrower shall have any obligation under this Note, the Borrower shall not, without the Holder’s written
consent, repay any affiliate (as defined in Rule 144) of the Borrower in connection with any indebtedness or accrued amounts owed to
any such party.
2.7
3(a)(10) Transaction. So long as this Note is outstanding, the Borrower shall not enter into any transaction or arrangement structured
in accordance with, based upon, or related or pursuant to, in whole or in part, Section 3(a)(10) of the Securities Act (a “3(a)(10)
Transaction”). In the event that the Borrower does enter into, or makes any issuance of Common Stock related to a 3(a)(10)
Transaction while this Note is outstanding, a liquidated damages charge of 25% of the outstanding principal balance of this Note, but
not less than $25,000, will be assessed and will become immediately due and payable to the Holder at its election in the form of a cash
payment or added to the balance of this Note (under Holder’s and Borrower’s expectation that this amount will tack back to
the Effective Date).
2.8
Preservation of Business and Existence, etc. So long as the Borrower shall have any obligation under this Note, the Borrower shall
not, without the Holder’s written consent, (a) change the nature of its business; (b) sell, divest, change the structure of any
material assets other than in the ordinary course of business; (c) enter into a Variable Rate Transaction; or (d) enter into any merchant
cash advance transactions. In addition, so long as the Borrower shall have any obligation under this Note, the Borrower shall maintain
and preserve, and cause each of its Subsidiaries to maintain and preserve, its existence, rights and privileges, and become or remain,
and cause each of its Subsidiaries (other than dormant Subsidiaries that have no or minimum assets) to become or remain, duly qualified
and in good standing in each jurisdiction in which the character of the properties owned or leased by it or in which the transaction
of its business makes such qualification necessary.
2.9
Noncircumvention. The Borrower hereby covenants and agrees that the Borrower will not, by amendment of its Certificate or Articles
of Incorporation or Bylaws, or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement, dissolution,
issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms
of this Note, and will at all times in good faith carry out all the provisions of this Note and take all action as may be required to
protect the rights of the Holder.
2.10
Lost, Stolen or Mutilated Note. Upon receipt by the Borrower of evidence reasonably satisfactory to the Borrower of the loss,
theft, destruction or mutilation of this Note, and, in the case of loss, theft or destruction, of any indemnification undertaking by
the Holder to the Borrower in customary form and, in the case of mutilation, upon surrender and cancellation of this Note, the Borrower
shall execute and deliver to the Holder a new Note.
ARTICLE
III. EVENTS OF DEFAULT
3.1
Events of Default. It shall be considered an event of default if any of the following events listed in this Article III
(each, an “Event of Default”) shall occur (whatever the reason for such event and whether such event shall be voluntary
or involuntary or effected by operation of law or pursuant to any judgment, decree or order of any court, or any order, rule or regulation
of any administrative or governmental body):
(a)
Failure to Pay Principal or Interest. The Borrower fails to pay any Principal Amount hereof and/or interest thereon, in each case
when such payment becomes due under this Note, whether at the Maturity Date, upon acceleration or otherwise in accordance with the terms
of this Note.
(b)
Conversion and the Shares. The Borrower (i) fails to issue Conversion Shares to the Holder (or announces or threatens in writing
that it will not honor its obligation to do so) upon exercise by the Holder of the conversion rights of the Holder in accordance with
the terms of this Note, (ii) fails to transfer or cause its transfer agent to transfer (issue) (electronically or in certificated form)
any certificate for the Conversion Shares issuable to the Holder upon conversion of or otherwise pursuant to this Note as and when required
by this Note, (iii) fails to reserve the Reserved Amount at all times, (iv) the Borrower directs its transfer agent not to transfer or
delays, impairs, and/or hinders its transfer agent in transferring (or issuing) (electronically or in certificated form) any certificate
for the Conversion Shares issuable to the Holder upon conversion of or otherwise pursuant to this Note as and when required by this Note,
or fails to remove (or directs its transfer agent not to remove or impairs, delays, and/or hinders its transfer agent from removing)
any restrictive legend (or to withdraw any stop transfer instructions in respect thereof) on any certificate for any Conversion Shares
issued to the Holder upon conversion of or otherwise pursuant to this Note as and when required by this Note (or makes any written announcement,
statement or threat that it does not intend to honor the obligations described in this paragraph) and any such failure shall continue
uncured (or any written announcement, statement or threat not to honor its obligations shall not be rescinded in writing) for two (2)
Trading Days after the Holder shall have delivered a Notice of Conversion, and/or (v) fails to remain current in its obligations to its
transfer agent (including but not limited to payment obligations to its transfer agent). It shall be an Event of Default of this Note,
if a conversion of this Note is delayed, hindered or frustrated due to a balance owed by the Borrower to its transfer agent. If at the
option of the Holder, the Holder advances any funds to the Borrower’s transfer agent in order to process a conversion, such advanced
funds shall be added to the principal balance of the Note.
(c)
Breach of Agreements and Covenants. The Borrower or Nascent breaches any covenant, agreement, or other term or condition contained
in the SPA, this Note, any Note (as such term is defined in the SPA), the Distribution and Assignment Agreement, any RRA, or in any other
Transaction Document or in any agreement, statement or certificate given in writing pursuant hereto or thereto or in connection herewith
or therewith.
(d)
Breach of Representations and Warranties. Any representation or warranty of the Borrower or Nascent made in the SPA, this Note,
any Note (as such term is defined in the SPA), the Distribution and Assignment Agreement, or in any other Transaction Document, or in
any agreement, statement or certificate given in writing pursuant hereto or in connection herewith or therewith shall be false or misleading
in any material respect when made and the breach of which has (or with the passage of time will have) a material adverse effect on the
rights of the Holder with respect to this Note, any Note (as defined in the SPA), the SPA, the Distribution and Assignment Agreement
or any RRA.
(e)
Receiver or Trustee. The Borrower, Nascent or any Subsidiary of the Borrower shall make an assignment for the benefit of creditors,
or apply for or consent to the appointment of a receiver or trustee for it or for a substantial part of its property or business, or
such a receiver or trustee shall otherwise be appointed.
(f)
Judgments. Any money judgment, writ or similar process shall be entered or filed against the Borrower, Nascent or any Subsidiary
of the Borrower or any of its property or other assets for more than $100,000, and shall remain unvacated, unbonded or unstayed for a
period of twenty (20) days unless otherwise consented to by the Holder, which consent will not be unreasonably withheld.
(g)
Bankruptcy. Bankruptcy, insolvency, reorganization or liquidation proceedings or other proceedings, voluntary or involuntary,
for relief under any bankruptcy law or any law for the relief of debtors shall be instituted by or against the Borrower, Nascent or any
Subsidiary of the Borrower.
(h)
Failure to Comply with the 1934 Act. At any time after the Effective Date, the Borrower shall fail to comply with the reporting
requirements of the 1934 Act and/or the Borrower shall cease to be subject to the reporting requirements of the 1934 Act.
(i)
Liquidation. Any dissolution, liquidation, or winding up of Borrower, Nascent or any Subsidiary of the Borrower or any substantial
portion of its business.
(j)
Cessation of Operations. Any cessation of operations by Borrower, Nascent or any Subsidiary of the Borrower or any admission by
the Borrower, Nascent or any of Subsidiary of the Borrower that it is otherwise generally unable to pay its debts as such debts become
due, provided, however, that any disclosure of the Borrower’s, Nascent’s or any of the Borrower’s Subsidiaries’
ability to continue as a “going concern” shall not be an admission that the Borrower (or any such Subsidiary of the Borrower)
cannot pay its debts as they become due.
(k)
Maintenance of Assets. The failure by Borrower or Nascent to maintain any material intellectual property rights, personal, real
property or other assets which are necessary to conduct its business (whether now or in the future).
(l)
Financial Statement Restatement. The restatement of any financial statements filed by the Borrower with the SEC for any date or
period from two years prior to the Effective Date of this Note and until this Note is no longer outstanding.
(m)
Replacement of Transfer Agent. In the event that the Borrower proposes to replace its transfer agent, the Borrower fails to provide,
prior to the effective date of such replacement, a fully executed Irrevocable Transfer Agent Instructions in a form as initially delivered
pursuant to the SPA, signed by the successor transfer agent to Borrower and the Borrower.
(n)
Cross-Default. The declaration of an event of default by any lender or other extender of credit to the Borrower under any notes,
loans, agreements or other instruments of the Borrower evidencing any indebtedness of the Borrower (including those filed as exhibits
to or described in the Borrower’s filings with the SEC), after the passage of all applicable notice and cure or grace periods.
(o)
Variable Rate Transactions. The Borrower consummates a Variable Rate Transaction at any time on or after the Effective Date without
the prior written consent of the Holder.
(p)
Inside Information. Any attempt by the Borrower or its officers, directors, and/or affiliates to transmit, convey, disclose, or
any actual transmittal, conveyance, or disclosure by the Borrower or its officers, directors, and/or affiliates of, material non-public
information concerning the Borrower, to the Holder or its successors and assigns, which is not immediately cured by Borrower’s
filing of a Form 8-K pursuant to Regulation FD on that same date.
(q)
Unavailability of Rule 144. If, at any time on or after the date that is six (6) calendar months after the Effective Date, the
Holder is unable to (i) obtain a standard “144 legal opinion letter” from an attorney reasonably acceptable to the Holder,
the Holder’s brokerage firm (and respective clearing firm), and the Borrower’s transfer agent in order to facilitate the
Holder’s conversion of any portion of the Note into free trading shares of the Borrower’s Common Stock pursuant to Rule 144,
and/or (ii) thereupon deposit such shares into the Holder’s brokerage account.
(r)
Delisting, Suspension, or Quotation of Trading of Common Stock. If, at any time on or after the Effective Date, the Borrower’s
Common Stock (i) is suspended from trading, (ii) halted from trading, and/or (iii) fails to be quoted or listed (as applicable) on a
Principal Market.
(s)
Registration Statement Failures. The Borrower fails to comply with any term or provision set forth in any RRA delivered pursuant
to the SPA.
(t)
Asset Sales; Fundamental Transactions. Any (i) sale, conveyance or disposition of all or substantially all of the assets of the
Borrower, or (ii) consolidation, merger or other business combination of the Borrower with or into any other Person or Persons whereby
the Borrower is not the survivor (any such transaction a “Section 1.6 Transaction”), which Section 1.6 Transaction
is deemed by the Holder at its option to be an Event of Default pursuant to Section 1.6 of this Note.
3.2
Rights and Remedies Upon an Event of Default.
(a)
Upon the occurrence of any Event of Default specified in this Article III, this Note shall become immediately due and payable,
and the Borrower shall pay to the Holder, in full satisfaction of its obligations hereunder, an amount equal to the product calculated
by multiplying (a) the sum of the Principal Amount then outstanding plus accrued Default Interest through the date of full repayment
by (b) 135% (collectively the “Default Amount”), as well as all costs, including, without limitation, legal fees and
expenses, of collection, all without demand, presentment or notice, all of which hereby are expressly waived by the Borrower in cash;
provided, notwithstanding anything to the contrary set forth herein, that the Holder may, in its sole discretion, determine to
accept payment of any obligation of the Borrower payable under this Section 3.2(a) in Common Stock (using the Conversion Price
as adjusted pursuant the last sentence of this Section 3.2(a)) or in cash, or in a combination of both Common Stock and cash.
The Holder shall be entitled to exercise all other rights and remedies available at law or in equity. Commencing upon the occurrence
of any Event of Default, the Principal Amount then outstanding shall bear interest at the rate of the lesser of (i) eighteen percent
(18%) per annum and (ii) the maximum amount permitted by law from the due date thereof until the same is paid (“Default Interest”).
Default Interest accrued hereunder shall be paid either in cash or in Common Stock, as determined by the Holder in its sole discretion,
and shall be computed on the basis of a 365-day year for the actual number of days elapsed. Upon the payment in full of the Default Amount,
as well as all costs, including, without limitation, legal fees and expenses, of collection, the Holder shall promptly surrender this
Note to or as directed by the Borrower. In connection with such acceleration described herein, the Holder need not provide, and the Borrower
hereby waives, any presentment, demand, protest or other notice of any kind, and the Holder may immediately and without expiration of
any grace period enforce any and all of its rights and remedies hereunder and all other remedies available to it under applicable law.
Such acceleration may be rescinded and annulled by Holder at any time prior to payment hereunder and the Holder shall have all rights
as a holder of the Note until such time, if any, as the Holder receives full payment pursuant to this Section 3.2. No such rescission
or annulment shall affect any subsequent Event of Default or impair any right consequent thereon. For the avoidance of doubt, subject
to Section 1.6(f), the number of shares of Common Stock issuable to the Holder upon any election of the Holder to accept payment
of any obligation of the Borrower payable under this Section 3.2(a) in Common Stock shall be equal to the ratio calculated by
dividing (A) the amount in Dollars of such obligation of the Borrower payable under this Section 3.2(a) the payment of which the
Holder has elected to accept in Common Stock by (B) the Conversion Price. Additionally, upon the occurrence and continuance of an Event
of Default, the Conversion Price shall be adjusted to the lower of (i) the Conversion Price on the date of the Event of Default or (ii)
60% discount to the lowest VWAP of the Borrower’s Common Stock during the five (5) Trading Day period immediately prior to the
Conversion Date.
(b)
In case any one or more Events of Default shall occur and be continuing, Holder may proceed to protect and enforce its rights by an action
at law, suit in equity or other appropriate proceeding, whether for the specific performance of any agreement contained herein or for
an injunction against a violation of any of the terms hereof, or in aid of the exercise of any power granted hereby or thereby or by
law or otherwise. In case of a default in the payment of any portion of the Principal Amount, or any interest or other fees due and payable
on this Note, Borrower will pay to Holder such further amount as shall be sufficient to cover the reasonable cost and expenses of collection,
including, without limitation, reasonable attorneys’ fees, expenses and disbursements. No course of dealing and no delay on the
part of Holder in exercising any right, power or remedy shall operate as a waiver thereof or otherwise prejudice Holder’s rights,
powers or remedies. No right, power or remedy conferred by this Note upon Holder shall be exclusive of any other right, power or remedy
referred to herein or therein or now or hereafter available at law, in equity, by statute or otherwise.
ARTICLE
IV. MISCELLANEOUS
4.1
Failure or Indulgence Not Waiver. No failure or delay on the part of the Holder in the exercise of any power, right or privilege
hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude
other or further exercise thereof or of any other right, power or privileges. All rights and remedies of the Holder existing hereunder
are cumulative to, and not exclusive of, any rights or remedies otherwise available.
4.2
Notices. All notices, requests, demands, and other communications provided for hereunder must be in writing and will be deemed
to have been duly given and effective on the earliest of: (a) the date of transmission, if such notice or communication is delivered
via e-mail prior to 5:30 p.m. (New York City time) on any Business Day; (b) the next Business Day after the date of transmission, if
such notice or communication is delivered via e-mail on a day that is not a Business Day or later than 5:30 p.m. (New York City time)
on any Business Day; (c) the second Business Day following the date of mailing, if sent by U.S. nationally recognized overnight courier
service or (d) upon actual receipt by the party to whom such notice is required to be given, addressed as follows:
|
CAN
B̅ CORP. |
|
960
South Broadway, Suite 120 |
|
Hicksville,
NY 11801 |
|
Attention:
Marco Alfonsi |
|
e-mail:
info@canbiola.com |
|
Walleye
Opportunities Master Fund Ltd |
|
2800
Niagara Lane N. |
|
Plymouth,
MN 55447 |
|
Attention:
William England |
|
e-mail:
wengland@walleyecapital.com |
or
as to the Borrower or the Holder, at such other address as shall be designated by such party in a written notice to the other party delivered
in accordance with this Section 4.2.
4.3
Amendments. This Note and any provision hereof may only be amended by an instrument in writing signed by the Borrower and the
Holder. The term “Note” and all reference thereto, as used throughout this instrument, shall mean this instrument
as originally executed, or if later amended or supplemented, then as so amended or supplemented.
4.4
Assignability. This Note shall be binding upon the Borrower and its successors and assigns, and shall inure to be the benefit
of the Holder and its successors and assigns. The Borrower shall not assign this Note or any rights or obligations hereunder without
the prior written consent of the Holder. The Holder may assign its rights hereunder to any “accredited investor” (as defined
in Rule 501(a) of the 1933 Act) in a private transaction from the Holder or to any of its “affiliates”, as that term is defined
under the 1934 Act, without the consent of the Borrower. Notwithstanding anything in this Note to the contrary, this Note may be pledged
as collateral in connection with a bona fide margin account or other lending arrangement. The Holder and any assignee, by acceptance
of this Note, acknowledge and agree that following conversion of a portion of this Note, the unpaid and unconverted principal amount
of this Note represented by this Note may be less than the amount stated on the face hereof.
4.5
Holder Fees and Expenses. Borrower agrees to pay to Holder, immediately upon written notice from Holder, all actual costs, expenses,
disbursements, and legal fees and expenses incurred by Holder in connection with: (a) the collection, attempted collection, or negotiation
and documentation of any settlement or workout of any payment due hereunder, and (b) any suit or proceeding whatsoever in regard to this
Note or the protection or enforcement of the lien of any instrument securing this Note, including, without limitation, in connection
with any litigation, mediation, bankruptcy or administrative proceeding, and including any appellate proceeding or judicial or non-judicial
foreclosure proceeding in connection therewith.
4.6
Governing Law; Venue; Waiver of Jury Trial; Attorneys’ Fees. This Note shall be governed by and construed in accordance
with the laws of the State of Delaware without regard to principles of conflicts of laws. Any action brought by either party against
the other concerning the transactions contemplated by this Note or any other agreement, certificate, instrument or document contemplated
hereby shall be brought only in the Court of Chancery of the State of Delaware or, to the extent such court does not have subject matter
jurisdiction, the United States District Court for the District of Delaware or, to the extent that neither of the foregoing courts has
jurisdiction, the Superior Court of the State of Delaware. The Borrower hereby irrevocably waives any objection to jurisdiction and venue
of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non
conveniens. THE BORROWER HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION
OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS NOTE OR ANY TRANSACTIONS CONTEMPLATED HEREBY. Each party hereby
irrevocably waives personal service of process and consents to process being served in any suit, action or proceeding in connection with
this Note or any other agreement, certificate, instrument or document contemplated hereby or thereby by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Note and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. The prevailing party in any action
or dispute brought in connection with this the Note or any other agreement, certificate, instrument or document contemplated hereby or
thereby shall be entitled to recover from the other party its reasonable attorneys’ fees and costs.
4.7
Certain Amounts. At any time pursuant to this Note the Borrower is required to pay an amount in excess of the outstanding Principal
Amount (or the remaining portion thereof required to be paid at such time pursuant to this Note) plus Default Interest thereon, the Borrower
and the Holder agree that the actual damages to the Holder from the receipt of cash payment on this Note may be difficult to determine
and the amount to be so paid by the Borrower represents stipulated damages and not a penalty and is intended to compensate the Holder
in part for loss of the opportunity to convert this Note and to earn a return from the sale of shares of Common Stock acquired upon conversion
of this Note at a price in excess of the price paid for such shares pursuant to this Note. The Borrower and the Holder hereby agree that
such amount of stipulated damages is not plainly disproportionate to the possible loss to the Holder from the receipt of a cash payment
without the opportunity to convert this Note into shares of Common Stock.
4.8
Purchase Agreement. The Borrower and the Holder shall be bound by the applicable terms of the SPA and the documents entered into
in connection herewith and therewith.
4.9
Notice of Corporate Events. Except as otherwise provided below, the Holder of this Note shall have no rights as a Holder of Common
Stock unless and only to the extent that it converts this Note into Common Stock. The Borrower shall provide the Holder with prior notification
of any meeting of the Borrower’s shareholders (and copies of proxy materials and other information sent to shareholders). In the
event of any taking by the Borrower of a record of its shareholders for the purpose of determining shareholders who are entitled to receive
payment of any dividend or other distribution, any right to subscribe for, purchase or otherwise acquire (including by way of merger,
consolidation, reclassification or recapitalization) any share of any class or any other securities or property, or to receive any other
right, or for the purpose of determining shareholders who are entitled to vote in connection with any change in control or any proposed
liquidation, dissolution or winding up of the Borrower, the Borrower shall mail a notice to the Holder, at least twenty (20) days prior
to the record date specified therein (or thirty (30) days prior to the consummation of the transaction or event, whichever is earlier),
of the date on which any such record is to be taken for the purpose of such dividend, distribution, right or other event, and a brief
statement regarding the amount and character of such dividend, distribution, right or other event to the extent known at such time. The
Borrower shall make a public announcement of any event requiring notification to the Holder hereunder substantially simultaneously with
the notification to the Holder in accordance with the terms of this Section 4.9.
4.10
Remedies. The Borrower acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder,
by vitiating the intent and purpose of the transaction contemplated hereby. Accordingly, the Borrower acknowledges that the remedy at
law for a breach of its obligations under this Note will be inadequate and agrees, in the event of a breach or threatened breach by the
Borrower of the provisions of this Note, that the Holder shall be entitled, in addition to all other available remedies at law or in
equity, and in addition to the penalties assessable herein, to an injunction or injunctions restraining, preventing or curing any breach
of this Note and to enforce specifically the terms and provisions thereof, without the necessity of showing economic loss and without
any bond or other security being required.
4.11
Construction; Headings. This Note shall be deemed to be jointly drafted by the Borrower and all the Holder and shall not be construed
against any person as the drafter hereof. The headings of this Note are for convenience of reference and shall not form part of, or affect
the interpretation of, this Note.
4.12
Usury. To the extent it may lawfully do so, the Borrower hereby agrees not to insist upon or plead or in any manner whatsoever
claim, and will resist any and all efforts to be compelled to take the benefit or advantage of, usury laws wherever enacted, now or at
any time hereafter in force, in connection with any action or proceeding that may be brought by the Holder in order to enforce any right
or remedy under this Note. Notwithstanding any provision to the contrary contained in this Note, it is expressly agreed and provided
that the total liability of the Borrower under this Note for payments which under the applicable law are in the nature of interest shall
not exceed the maximum lawful rate authorized under applicable law (the “Maximum Rate”), and, without limiting the
foregoing, in no event shall any rate of interest or default interest, or both of them, when aggregated with any other sums which under
the applicable law in the nature of interest that the Borrower may be obligated to pay under this Note exceed such Maximum Rate. It is
agreed that if the maximum contract rate of interest allowed by applicable law and applicable to this Note is increased or decreased
by statute or any official governmental action subsequent to the Effective Date, the new maximum contract rate of interest allowed by
law will be the Maximum Rate applicable to this Note from the effective date thereof forward, unless such application is precluded by
applicable law. If under any circumstances whatsoever, interest in excess of the Maximum Rate is paid by the Borrower to the Holder with
respect to indebtedness evidenced by this the Note, such excess shall be applied by the Holder to the unpaid principal balance of any
such indebtedness or be refunded to the Borrower, the manner of handling such excess to be at the Holder’s election.
4.13
Severability. In the event that any provision of this Note is invalid or unenforceable under any applicable statute or rule of
law (including any judicial ruling), then such provision shall be deemed inoperative to the extent that it may conflict therewith and
shall be deemed modified to conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable under
any law shall not affect the validity or enforceability of any other provision of this Note.
4.14
Terms of Future Financings. So long as this Note is outstanding, upon any issuance by the Borrower or any of its subsidiaries
of any security, or amendment to a security that was originally issued before the Effective Date, with any term that the Holder reasonably
believes is more favorable to the holder of such security or with a term in favor of the holder of such security that the Holder reasonably
believes was not similarly provided to the Holder in this Note, then (i) the Borrower shall notify the Holder of such additional or more
favorable term within one (1) Business Day of the issuance and/or amendment (as applicable) of the respective security, and (ii) such
term, at Holder’s option, shall become a part of the transaction documents with the Holder (regardless of whether the Borrower
complied with the notification provision of this Section 4.14). The types of terms contained in another security that may be more
favorable to the holder of such security include, but are not limited to, terms addressing prepayment rate, interest rates, and original
issue discounts. Notwithstanding the foregoing, the Holder may only enforce its rights under this Section 4.14 after the date
that is one hundred eighty (180) calendar days after the Effective Date, provided, however, that at such time the Holder may enforce
its rights to all adjustments hereunder that apply even if such adjustment was triggered or such issuance occurred prior to the date
that is one hundred eighty (180) calendar days after the Effective Date.
4.15
Right of First Refusal. If at any time while this Note is outstanding, the Borrower has a bona fide offer of capital or financing
from any third party that the Borrower intends to act upon, then the Borrower must offer such opportunity on the same terms as such third
party’s terms by providing written notice of the offer (an “Offer Notice”) concurrently to the Holder, the Arena
Purchasers, Mast Hill Fund, L.P., a Delaware limited partnership (“Mast Hill”), Blue Lake Partners, LLC, a Delaware
limited liability company (“Blue Lake”), and Fourth Man, LLC, a Nevada limited liability company (“Fourth
Man”), subject to the terms of this Section 4.15. As used in this Section 4.15, the term “Offerees”
shall mean, collectively, (i) the Holder, (ii) the Arena Purchasers (jointly), (iii) Mast Hill, (iv) Blue Lake and (v) Fourth Man, and,
each individually an “Offeree”; provided for the avoidance of doubt that for purposes of this Section 4.15,
the Arena Purchasers shall be considered to be a single Offeree. Within five (5) Business Days after receipt of an Offer Notice by any
Offeree (the “Offer Response Period”), such Offeree shall notify the Borrower in writing (an “Offer Response
Notice”) of such Offeree’s election to either (A) provide such capital or financing to the Borrower on the same terms
as such third party’s terms (including without limitation matching the aggregate principal amount of such capital or financing
proposed to be provided to the Borrower by such third party) or (B) waive such Offeree’s right to provide such capital or financing
to the Borrower on the same terms as such third party’s terms. If any Offeree fails to deliver an Offer Response Notice to the
Borrower prior to the end of the Offer Response Period, time being of the essence, then such Offeree shall be deemed to have elected
option (B) above. In the event (x) more than one Offeree elects to provide such capital or financing to the Borrower on the same terms
as such third party’s terms pursuant to Offer Response Notices sent by each such Offeree to the Borrower within the Offer Response
Period, then each such Offeree shall provide a portion of such capital or financing to the Borrower pro rata in proportion to the respective
ROFR Units (as defined below) of such Offerees, and in all other respects on the same terms as such third party’s terms, (y) only
one Offeree elects to provide such capital or financing to the Borrower on the same terms as such third party’s terms pursuant
to an Offer Response Notice sent by such Offeree to the Borrower within the Offer Response Period, then such Offeree shall provide (and
none of the other Offerees shall have the right to provide) such capital or financing to the Borrower on the same terms as such third
party’s terms (including without limitation matching the aggregate principal amount of such capital or financing proposed to be
provided to the Borrower by such third party), or (z) none of the Offerees elect to provide such capital or financing to the Borrower
on the same terms as such third party’s terms pursuant to an Offer Response Notice sent to the Borrower within the Offer Response
Period, then the Borrower may obtain such capital or financing from such third party, provided the Borrower obtains such capital or financing
from such third party upon the exact same terms and conditions set forth in the Offer Notice. If none of the Offerees elects to provide
such capital or financing to the Borrower on the same terms as such third party’s terms pursuant to an Offer Response Notice sent
to the Borrower within the Offer Response Period, and the Borrower does not receive the capital or financing from such third party in
accordance with the foregoing clause (z) within thirty (30) days after the date of the last Offer Notice, so long as this Note remains
outstanding at such time, the Borrower must again offer the capital or financing opportunity on the same terms as such third party’s
terms by providing written notice of the offer concurrently to each of the Offerees pursuant to a further Offer Notice as described above,
and the process detailed above shall be repeated. All Offer Notices required to be sent to the Holder under this Section 4.15
must be sent via electronic mail to wengland@walleyecapital.com. For purposes of allocating the opportunity to provide the capital
or financing to the Borrower on the same terms as the applicable third party’s terms to the applicable Offerees under clause (x)
of the fourth sentence of this Section 4.15, the Offerees shall be and hereby are allocated units (with respect to each Offeree,
such Offeree’s “ROFR Units”) representing the Offerees’ respective rights in connection with any such
allocation of the opportunity, with such ROFR Units being allocated to the Offerees in the following amounts: (i) to the Holder, 2,149,706
ROFR Units, (ii) to the Arena Purchasers (as a single Offeree), 3,900,000 ROFR Units, (iii) to Mast Hill, 367,500 ROFR Units, (iv) to
Blue Lake, 262,500 ROFR Units, and (v) to Fourth Man, 156,525 ROFR Units.
4.16
Dispute Resolution. In the case of a dispute as to the determination of the Conversion Price, the number of Conversion Shares
issuable upon any Conversion, any prepayment amount or Default Amount, the closing bid price, or fair market value (as the case may be)
or the arithmetic calculation of the Conversion Price, the number of Conversion Shares issuable upon any Conversion, the applicable prepayment
amount(s) or Default Amount (as the case may be), the Borrower or the Holder shall submit the disputed determinations or arithmetic calculations
via facsimile (i) within one (1) Trading Day after receipt of the applicable notice giving rise to such dispute to the Borrower or the
Holder or (ii) if no notice gave rise to such dispute, at any time after the Holder learned of the circumstances giving rise to such
dispute. If the Holder and the Borrower are unable to agree upon such determination or calculation within one (1) Trading Day of such
disputed determination or arithmetic calculation (as the case may be) being submitted to the Borrower or the Holder, then the Borrower
shall, within one (1) Trading Day, submit (a) the disputed determination of the Conversion Price, the closing bid price, or fair market
value (as the case may be) to an independent, reputable investment bank selected by the Borrower and approved by the Holder or (b) the
disputed arithmetic calculation of the Conversion Price, the number of Conversion Shares issuable upon any Conversion or any prepayment
amount or Default Amount, to an independent, outside accountant selected by the Holder that is reasonably acceptable to the Borrower.
The Borrower shall cause at its expense the investment bank or the accountant to perform the determinations or calculations and notify
the Borrower and the Holder of the results no later than one (1) Trading Day from the time it receives such disputed determinations or
calculations. Such investment bank’s or accountant’s determination or calculation shall be binding upon all parties absent
demonstrable error.
4.17
Remedies, Characterizations, Other Obligations, Breaches, and Injunctive Relief. The remedies provided in this Note shall
be cumulative and in addition to all other remedies available under this Note at law or in equity (including a decree of specific performance
and/or other injunctive relief), and nothing herein shall limit the Holder’s right to pursue actual and consequential damages for
any failure by the Borrower to comply with the terms of this Note. The Borrower covenants to the Holder that there shall be no characterization
concerning this instrument other than as expressly provided herein. Amounts set forth or provided for herein with respect to payments
and the like (and the computation thereof) shall be the amounts to be received by the Holder and shall not, except as expressly provided
herein, be subject to any other obligation of the Borrower (or the performance thereof). The Borrower acknowledges that a breach by it
of its obligations hereunder will cause irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate.
The Borrower therefore agrees that, in the event of any such breach or threatened breach, the Holder shall be entitled, in addition to
all other available remedies, to an injunction restraining any such breach or any such threatened breach, without the necessity of showing
economic loss and without any bond or other security being required. The Borrower shall provide all information and documentation to
the Holder that is reasonably requested by the Holder to enable the Holder to confirm the Borrower’s compliance with the terms
and conditions of this Note.
4.18
Disclosure. Upon receipt or delivery by the Borrower of any notice in accordance with the terms of this Note, unless the Borrower
has in good faith determined that the matters relating to such notice do not constitute material, nonpublic information relating to the
Borrower or its subsidiaries, the Borrower shall (i) within two (2) Business Days following any such receipt of a notice by the Borrower
hereunder or (ii) immediately upon any such delivery of a notice by the Borrower hereunder, publicly disclose such material, nonpublic
information on a Current Report on Form 8-K pursuant to Regulation FD. In the event that the Borrower believes that any such notice contains
material, non-public information relating to the Borrower or its subsidiaries, the Borrower so shall indicate to the Holder contemporaneously
with delivery of such notice, and in the absence of any such indication, the Holder shall be allowed to presume that all matters relating
to such notice do not constitute material, nonpublic information relating to the Borrower or its subsidiaries.
[signature
page follows]
IN
WITNESS WHEREOF, the Borrower has caused this Consolidated Amended and Restated Promissory Note to be signed in its name by its duly
authorized officer as of the date first written above.
|
BORROWER: |
|
|
|
CAN
B̅ CORP. |
|
|
|
|
By: |
/s/
Marco Alfonsi |
|
Name: |
Marco
Alfonsi |
|
Title: |
Chief
Executive Officer |
Acknowledged
and agreed to as of
the
date first set forth above:
HOLDER: |
|
|
|
|
WALLEYE
OPPORTUNITIES MASTER FUND LTD |
|
|
|
By: |
/s/
William England |
|
Name: |
William
England |
|
Title: |
Chief
Executive Officer of the Manager |
|
ANNEX
A-1 - NOTICE OF CONVERSION
The
undersigned hereby elects to convert $______________ in outstanding principal amount of the Note (defined below) into that number of
shares of Common Stock to be issued pursuant to the conversion of the Note (“Common Stock”) as set forth below, of
CAN B̅ CORP., a Florida corporation (the “Borrower”), according to the conditions of the Consolidated
Amended and Restated Promissory Note of the Borrower dated as of October 27, 2023 (the “Note”), as of the Conversion
Date set forth below. No fee will be charged to the Holder for any conversion, except for transfer taxes, if any. Capitalized terms used
but not defined herein shall have the meaning given to such terms in the Note.
Box
Checked as to applicable instructions:
|
☐ |
The
Borrower shall electronically transmit the Common Stock issuable pursuant to this Notice of Conversion to the account of the undersigned
or its nominee with DTC through its Deposit Withdrawal Agent Commission system (“DWAC Transfer”). |
|
|
|
|
|
Name
of DTC Prime Broker: |
|
|
Account
Number: |
|
|
|
|
☐ |
The
undersigned hereby requests that the Borrower issue a certificate or certificates for the number of shares of Common Stock set forth
below (which numbers are based on the Holder’s calculation attached hereto) in the name(s) specified immediately below or,
if additional space is necessary, on an attachment hereto: |
|
Conversion
Date: |
________________________ |
|
|
|
|
Converted
Principal Amount
(set
forth above): |
$________________________ |
|
Applicable
Conversion Price: |
$________________________ |
|
Number
of Shares of Common Stock to be |
|
|
issued
pursuant to this Conversion of the |
|
|
Note: |
________________________ |
|
Principal
Amount due remaining under the |
|
|
Note
after this Conversion: |
$________________________ |
[Signature
Page to Annex A-1 – Notice of Conversion]
ANNEX
A-2 - NOTICE OF CONVERSION
Reference
is made to that certain Consolidated Amended and Restated Promissory Note dated as of October 27, 2023 (the “Note”)
of CAN B̅ CORP., a Florida corporation (the “Borrower”). Capitalized terms used but not defined herein
shall have the meaning given to such terms in the Note. No fee will be charged to the Holder for any conversion of the Note, except for
transfer taxes, if any. The undersigned hereby elects to convert, by Conversion as of the Conversion Date set forth below, $_____________
(such amount, the “Total Default Obligations Converted Amount”) in obligations outstanding of the Borrower under Section
3.2(a) of the Note consisting of:
|
(a)
Default Amount being converted: |
|
$___________________ |
|
Principal
Amount of Note being converted (included in calculation of Default Amount being converted: |
|
$___________________ |
|
Default
Interest to be converted (included in calculation of Default Amount being converted): |
|
$___________________ |
|
(b)
Costs, including without limitation legal fees and expenses, of collection, being converted: |
|
$___________________ |
|
|
|
|
|
Total
Default Obligations Converted Amount
(add
lines (a) and (b) above): |
|
$___________________ |
|
Conversion
Date: |
______________________ |
|
Total
Default Obligations Converted Amount
(set
forth above): |
|
$___________________ |
|
Applicable
Conversion Price: |
|
$___________________ |
|
Number
of Shares of Common Stock to be issued pursuant to this Conversion of the Total Default Obligations Converted Amount: |
|
___________________ |
|
|
|
___________________ |
|
(a)
Default Amount due remaining under the Note after this Conversion: |
|
$___________________ |
|
Principal
Amount due remaining under the Note after this Conversion (included in calculation of Default Amount remaining due under the Note
after this Conversion): |
|
$___________________ |
|
Default
Interest due remaining under the Note after this Conversion (included in calculation of Default Amount remaining due under the Note
after this Conversion): |
|
$___________________ |
|
(b)
Costs, including without limitation legal fees and expenses, of collection, due remaining under the Note after this Conversion: |
|
$___________________ |
|
Total
obligations of the Borrower under Section 3.2(a) of the Note due remaining due after this Conversion (add lines (a) and (b) above): |
|
$___________________ |
[form
continues on following page]
[Signature
Page to Annex A-2 – Notice of Conversion]
Box
Checked as to applicable instructions:
|
☐ |
The
Borrower shall electronically transmit the Common Stock issuable pursuant to this Notice of Conversion to the account of the undersigned
or its nominee with DTC through its Deposit Withdrawal Agent Commission system (“DWAC Transfer”). |
|
|
|
|
|
Name
of DTC Prime Broker: |
|
|
Account
Number: |
|
|
|
|
☐ |
The
undersigned hereby requests that the Borrower issue a certificate or certificates for the number of shares of Common Stock set forth
below (which numbers are based on the Holder’s calculation attached hereto) in the name(s) specified immediately below or,
if additional space is necessary, on an attachment hereto: |
[Signature
Page to Annex A-2 – Notice of Conversion]
Exhibit
9.4
DISTRIBUTION
AND ASSIGNMENT AGREEMENT
THIS
DISTRIBUTION AND ASSIGNMENT AGREEMENT (as amended, restated, supplemented or otherwise modified from time to time in accordance with
its terms, this “Agreement”), is made and entered into as of October 27, 2023 (the “Effective Date”),
by and among, NASCENT PHARMA, LLC, a Nevada limited liability company (“Nascent”), CAN B̅ CORP.,
a Florida corporation (the “Company”), and WALLEYE OPPORTUNITIES MASTER FUND LTD, a Cayman Islands exempted
company with limited liability (“Assignee”, and together with Nascent and the Company, collectively, the “Parties”,
and each, individually, a “Party”). Capitalized terms used but not defined herein shall have the meaning given to
such terms in the Purchase Agreement (as defined below).
WITNESSETH:
WHEREAS,
the Company and Assignee entered into that certain Securities Purchase Agreement dated as of October 26, 2023 by and between the Company
and Assignee in its capacity as the Buyer (as the same may be amended, supplemented or otherwise modified from time to time in accordance
with the terms thereof, the “Purchase Agreement”), pursuant to which the Company agreed, among other things, that
as additional consideration for Assignee’s purchase of one or more Notes of the Company in the aggregate principal amount of up
to $1,875,000 (the “Maximum Offered Amount”), to cause Nascent to pay Assignee a certain portion of the distributions
and proceeds that the Company would otherwise be entitled to receive from Nascent pursuant to the Nascent Operating Agreement (as defined
below) and/or the Proposed UCANN Distribution Agreement (as defined below);
WHEREAS,
immediately prior to the execution of this Agreement, Assignee held each of the following promissory notes of the Company: (i) that certain
Promissory Note, dated August 30, 2022, in the original principal amount of $385,000 (the “$385,000 Walleye Note”),
(ii) that certain 20% Original Issue Discount Promissory Note, dated May 16, 2023, in the original principal amount of $437,500 (the
“$437,500 Walleye Note”), (iii) that certain $100,000 Unsecured Promissory Note of the Borrower dated as of August
5, 2022, by and between the Company as borrower and Emergent Health Corp., a Wyoming corporation (“Emergent”) as lender
(the “$100,000 Walleye Note”), which $100,000 Walleye Note was purchased by Assignee from Emergent pursuant to that
certain Note Purchase Agreement, dated August 3, 2023, by and between Emergent as seller and Assignee as purchaser (the “Emergent
NPA”), (iv) that certain $250,000 Unsecured Promissory Note of the Company, dated August 18, 2022, by and between the Company
as borrower and Emergent as lender (the “$250,000 Walleye Note”, and together with the $100,000 Walleye Note, collectively,
the “Emergent Notes”), which $250,000 Walleye Note was purchased by Assignee from Emergent pursuant to the Emergent
NPA, and (v) that certain Promissory Note, dated February 27, 2023, in the original principal amount of $1,823,529 (the “February
2023 Walleye Secured Note”, together with the $385,000 Walleye Note, the $437,500 Walleye Note, the $100,000 Walleye Note and
the $250,000 Walleye Note, collectively, the “Existing Notes”);
WHEREAS,
simultaneously with the execution of this Agreement, the Company and Assignee executed that certain Consolidated Amended and Restated
Note dated as of the date hereof in the original principal amount of $1,354,210 (the “Consolidated Amended and Restated Walleye
Note”), which Consolidated Amended and Restated Walleye Note consolidates, amends and restates (i) the $385,000 Walleye Note,
(ii) the $437,500 Walleye Note, (iii) the $100,000 Walleye Note and (iv) the $250,000 Walleye Note, subject to the terms and conditions
set forth therein.
WHEREAS,
simultaneously with the execution of this Agreement, Assignee has purchased the Initial Note from the Company pursuant to the Purchase
Agreement in the original principal amount of $156,250, and accordingly, the Parties are entering into this Agreement in accordance with
Section 2(b) of the Purchase Agreement in order to provide, among other things, that (i) Nascent shall, and the Company shall cause Nascent
to, pay Assignee fifteen percent (15%) of the distributions and proceeds that the Company would otherwise be entitled to receive from
Nascent pursuant to the Nascent Operating Agreement and/or the Proposed UCANN Distribution Agreement until Assignee receives an aggregate
amount of such distributions and proceeds (the “Additional Consideration Amount”) equal to the sum of (A) two hundred
percent (200%) of the aggregate purchase price of the Existing Notes other than the Emergent Notes (i.e., $4,500,000), plus (B)
two hundred percent (200%) of the aggregate original principal amount of the Emergent Notes (i.e., $700,000) (the sum of (A) and (B)
to be referred to herein as the “Prior Money Distribution Amount”), plus (C) one hundred percent (100%) of
the Purchase Price of the Initial Note (i.e. $125,000) (the “Initial New Money Distribution Amount”), plus
(D) one hundred percent (100%) of the aggregate Purchase Price of any subsequent Notes purchased by Assignee from the Company pursuant
to the Purchase Agreement (the “Subsequent New Money Distribution Amount”); provided, that if Assignee and/or
one or more New Buyers purchase Notes in the aggregate principal amount of the Maximum Offered Amount pursuant to the Purchase Agreement
on or prior to the New Money Multiple Deadline, then (1) the Initial New Money Distribution Amount shall be increased to two hundred
percent (200%) of the Purchase Price of the Initial Note (i.e., $250,000), and (2) the Subsequent New Money Distribution Amount shall
be increased to two hundred percent (200%) of the aggregate Purchase Price of such subsequent Notes purchased pursuant to the Purchase
Agreement (i.e., $2,750,000), such that the Additional Consideration Amount (if the Maximum Offered Amount of Notes is purchased on or
prior to the New Money Multiple Deadline) would be $8,200,000.
NOW,
THEREFORE, in accordance with the Purchase Agreement and in consideration of the premises and the mutual agreements hereinafter contained,
and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and Assignee,
intending to be legally bound, hereby agree as follows:
1.
Definitions. As used in this Agreement, each of the following terms has the meaning given to such term in this Section 1
or in the sections and subsections of this Agreement referred to below. Capitalized terms used and not defined herein have the meaning
given to such terms in the Purchase Agreement.
“Additional
Consideration Amount” has the meaning set forth in the recitals.
“Assignment”
has the meaning set forth in Section 4.
“Cash
Available for Distribution” has the meaning given to such term in the Nascent Operating Agreement (except for instances in
this Agreement specifically referring to “Cash Available for Distribution” as to be defined in the Proposed UCANN Distribution
Agreement).
“Distributions”
means (A) any and all distributions made by Nascent or proceeds received from Nascent, including without limitation (i) distributions
of Cash Available for Distribution under the Nascent Operating Agreement and (ii) distributions of “Cash Available for Distribution”
(under and as such term is to be defined in the Proposed UCANN Distribution Agreement), and (B) any and all distributions and proceeds
of any kind from any source related to, arising out of, or in connection with the Patents, including without limitation any royalties
from the Patents and any Patent Claims, including without limitation, any proceeds of any settlement with respect to any Patent Claim.
“Distributions
Rights” means, all right, title and interest of the Company to or in any and all Distributions, including without limitation
any right of the Company to be paid or receive such Distributions, whether now existing or hereafter arising.
“Equity
Interest” means all shares of capital stock (whether denominated as common stock or preferred stock), equity interests, beneficial
partnership or membership interests, joint venture interests, units, limited liability company interests, participations or other ownership
or profit interests in or equivalents (regardless of how designated) of or in a Person (other than an individual), whether voting or
non-voting.
“Initial
New Money Distribution Amount” has the meaning set forth in the recitals.
“Nascent
Operating Agreement” has the meaning set forth in Section 6(c)(ii).
“Patent”
means, (i) United States Patent No. US 9,730,911 B2 (Cannabis Extracts and Methods of Preparing and Using Same) and (ii) United States
Patent No. US 10,555,928 B2 (Cannabis Extracts and Methods and Preparing and Using Same), or any of them (collectively, the “Patents”).
“Patent
Claim” means, any claim, litigation, or other proceeding brought by or on behalf of the Company, Nascent or any other entity
in which the Company has an interest in order to enforce any alleged breach of any rights of the Company, Nascent or any other entity
in which the Company has an interest with respect to any of the Patents, whether now existing or hereafter arising (collectively, “Patent
Claims”).
“Person”
means an individual, partnership, corporation (including a business trust), joint stock company, trust, unincorporated association, joint
venture, limited liability company or other entity, or any governmental authority.
“Proposed
Blackmon Distribution Agreement” means a proposed agreement between the Company and Earnest Blackmon, an individual (“Blackmon”),
pursuant to which it is contemplated that the Company would agree to cause Nascent to pay Blackmon a portion of the Distributions that
the Company would otherwise be entitled to receive under the terms of the Nascent Operating Agreement equal to the sum of (A) fifty percent
(50%) of the Distributions that the Company would otherwise be entitled to receive from Nascent under the terms of the Nascent Operating
Agreement but for such Proposed Blackmon Distribution Agreement (the “Blackmon Gross Distributions”), minus
(B) the amounts payable to Creditors pursuant to the Proposed UCANN Distribution Agreement (up to a maximum of five percent of the total
amount of up to $10,000,000 of Distributions made pursuant to the Proposed UCANN Distribution Agreement), minus (C) eight percent
(8%) of the Blackmon Gross Distributions, which portion of the Blackmon Gross Distributions shall be paid to a third party marketing
and service company (such net Distributions proposed to be paid to Blackmon, the “Proposed Blackmon Distributions”).
“Proposed
Distribution and Contingent Payment Agreements” means, collectively, the Proposed Blackmon Distribution Agreement, the Proposed
McCarter Engagement Letter, the Proposed Patent Claim Financing Agreement, the Proposed UCANN Distribution Agreement (each, a “Proposed
Distribution and Contingent Payment Agreement”).
“Proposed
McCarter Engagement Letter” means a proposed engagement letter contemplated to be entered into by and among McCarter &
English LLP (“McCarter”), Nascent and/or the Company, pursuant to which it is contemplated that (i) McCarter would
agree to undertake the representation of the Company and/or Nascent as legal counsel in the Company’s and/or Nascent’s pursuit
of one or more Patent Claims and (ii) Nascent would agree to pay and/or the Company would agree to cause Nascent to pay, fees to McCarter
for such representation on a contingency basis in an amount equal to ten percent (10%) of the gross proceeds recovered with respect to
such Patent Claims (such proposed fees, the “Proposed McCarter Contingency Fees”).
“Proposed
Patent Claim Financing Agreement” means a proposed financing agreement contemplated to be entered into by Nascent and/or the
Company with a third-party lender (the “Patent Claim Lender”), pursuant to which it is contemplated that (i) the Patent
Claim Lender would advance one or more loans to Nascent (“Patent Claim Loans”) to be used by Nascent for the purpose
enabling Nascent and/or the Company to pursue one or more Patent Claims, and (ii) Nascent would agree to pay, and/or the Company would
agree to cause Nascent to pay, as first priority distributions, fees to the Patent Claim Lender in an amount equal to 200% of the aggregate
amount of Patent Claim Loans advanced by Patent Claim Lender under the Proposed Patent Claim Financing Agreement (such fees, the “Proposed
Patent Claim Lender Fees”).
“Proposed
UCANN Distribution Agreement” means a proposed Agreement for Distribution of Cash Distributions contemplated to be entered
into between and among Blackmon, John Walsh, an individual (“Walsh”), United Cannabis Corporation, a Colorado Corporation
(“United Cannabis”), UC Colorado Corporation, a Colorado corporation (“UC Colorado”), DCS Enterprises
of Green Bay, Inc., a Wisconsin corporation (“DCS”), the Company, Nascent and The Receivers, Inc., a Colorado Corporation,
in its capacity as the court-appointed receiver in Case No. 2020CV30483, in Jefferson County District Court, State of Colorado (the “UCC
Receiver”), pursuant to which, (1) the Company would among other things, cause Nascent to make distributions to the “Creditors”
(as to be defined in the Proposed UCANN Distribution Agreement) on the “Creditor List” (as to be defined in the UCANN Proposed
Distribution Agreement), of 5% of the Company’s share of the “Cash Available for Distribution” (as to be defined in
the Proposed UCANN Distribution Agreement) until such Creditors have been paid an aggregate of $10,000,000.00 for their claims as set
forth on the Creditor List (such distributions, “Proposed UCANN Pool Distributions”), and (2) Nascent would agree,
among other things, to make such Proposed UCANN Pool Distributions simultaneously with distributions of “Cash Available for Distributions”
(as to be defined in the Proposed UCANN Distribution Agreement) to DCS and the Company.
“Prior
Money Distribution Amount” has the meaning set forth in the recitals.
“Reversion”
has the meaning set forth in Section 4.
“Subsequent
New Money Distribution Amount” has the meaning set forth in the recitals.
2.
Additional Consideration Amount. The Parties agree and acknowledge that, as of the date of this Agreement, the Additional Consideration
Amount is equal to $5,325,000 (calculated as the sum of (A) the Prior Money Distribution Amount (i.e. $5,200,000) plus (B) the
Initial New Money Distribution Amount in effect prior to the Maximum Offered Amount of Notes being sold pursuant to the Purchase Agreement
on or prior to the New Money Multiple Deadline (i.e. $125,000)). The Additional Consideration Amount shall be increased at each subsequent
Closing under the Purchase Agreement by an amount equal to the Subsequent New Money Distribution Amount applicable to the subsequent
Note purchased by Assignee at such Closing (calculated as one hundred percent (100%) of the Purchase Price of such subsequent Note);
provided, that if Assignee and/or one or more New Buyers purchase Notes in the aggregate principal amount of the Maximum Offered
Amount pursuant to the Purchase Agreement on or prior to the New Money Multiple Deadline, then (1) the Initial New Money Distribution
Amount shall be increased to two hundred percent (200%) of the Purchase Price of the Initial Note (i.e. $250,000), and (2) the Subsequent
New Money Distribution Amount shall be increased to two hundred percent (200%) of the aggregate purchase price of subsequent Notes purchased
pursuant to the Purchase Agreement (i.e. $2,750,000) such that the Additional Consideration Amount (if the Maximum Offered Amount of
Notes is purchased on or prior to the New Money Multiple Deadline) would be $8,200,000. For the avoidance of doubt, in the event no subsequent
Notes are purchased pursuant to the Purchase Agreement after the date of this Agreement (i.e. the only Note purchased Assignee is the
Initial Note purchased by Assignee), the Additional Consideration Amount shall remain not less than $5,325,000, and the rights of Assignee
and the obligations of the Company and Nascent set forth in this Agreement as in effect on the date hereof with respect to the Additional
Consideration Amount in the amount of $5,325,000 shall not be contingent upon or require Assignee or any other Person to purchase any
Note other than the Initial Note.
3.
Payment of Distributions.
(a)
Upon receipt by Nascent at any time on or after the Effective Date of any proceeds as a result of or in connection with any Patent Claim,
simultaneously with and upon each and any occasion that Nascent pays any Distributions to the Company, Nascent shall pay Assignee fifteen
percent (15%) of the Distributions that the Company would otherwise be entitled to receive from Nascent pursuant to the Nascent Operating
Agreement and/or the Proposed UCANN Distribution Agreement but for the Assignment, as applicable, in cash in immediately available funds
in accordance with the wire instructions set forth on Schedule I hereto or as otherwise directed via instructions provided by
Assignee, until Assignee has received Distributions pursuant to this Section 3(a) in an amount equal to the Additional Consideration
Amount in effect at such time. The Company agrees to cause Nascent to comply with any and all of its obligations pursuant to this Agreement,
including without limitation, any obligation of Nascent to pay Assignee Distributions pursuant to this Section 3(a).
(b)
Any obligation of Nascent to pay (and any obligation of the Company to cause Nascent to pay) Distributions to Assignee under Section
3(a) above (any such obligation, an “Additional Consideration Obligation”) shall be in addition to and not in
substitution for the obligation of the Company to pay all principal, interest and other amounts owing to Assignee in respect of (i) the
Initial Note purchased by Assignee on the date hereof, (ii) any other Note purchased by Assignee pursuant to the Purchase Agreement,
(iii) the Consolidated Amended and Restated Walleye Note held by Assignee, and (iv) the February 2023 Walleye Note, and any Distributions
paid to Assignee pursuant to Section 3(a) above shall be applied towards the Additional Consideration Obligation and shall not
be deemed to satisfy the outstanding balance of any Note purchased by Assignee or any obligations of the Company owing to Assignee under
any other promissory note or other instrument held by Assignee. To the extent at any time Nascent owes any Additional Consideration Obligation
to Assignee pursuant to Section 3(a), the Company hereby guarantees the payment of such Additional Consideration Obligation to
Assignee in accordance with the terms of this Agreement.
4.
Assignment of Distributions Rights; Reversion of Distributions Rights. In furtherance of the foregoing, the Company does hereby
sell, transfer, assign, set over and otherwise convey to Assignee, all right, title and interest of the Company, whether now existing
or hereafter arising, in fifteen percent (15%) of all Distributions Rights (the “Purchased Distributions Rights”),
and all present and future rights, claims, demands, causes and choses in action in respect of any or all of the foregoing and all payments
on or under and all proceeds of any kind and nature in respect of any of the foregoing (the “Assignment”); provided,
that upon Assignee’s receipt of Distributions pursuant to Section 3(a) above in an amount equal to the Additional Consideration
Amount, the Purchased Distributions Rights assigned to Assignee pursuant to the Assignment shall automatically revert to the Company
(the “Reversion”).
5.
Assignment Intended as Sale; Grant of Security Interest. It is the intention of the Company and Assignee that the Assignment contemplated
by this Agreement shall constitute an absolute and irrevocable sale of the Purchased Distributions Rights from the Company to Assignee
free and clear of all liens and rights of others and it is intended that the beneficial interest in and title to the Purchased Distributions
Rights shall not be part of the Company’s estate in the event of the filing of a petition by or against the Company under any bankruptcy
or insolvency law; provided, for the avoidance of doubt and notwithstanding anything to the contrary set forth herein, the Purchased
Distribution Rights shall automatically revert to the Company upon Assignee’s receipt of Distributions pursuant to Section 3(a)
above in an amount equal to the Additional Consideration Amount. In the event that, notwithstanding the intent of the Company and
Assignee, the Assignment is held not to be a sale, this Agreement shall constitute a security agreement under applicable law and the
Company hereby grants to Assignee a continuing security interest in, lien on and right of set-off against all right, title and interest
of interest of the Company, whether now or hereafter arising, in and to the Purchased Distributions Rights as continuing collateral security
for the payment of any Additional Consideration Obligation due hereunder (the “Collateral”).
6.
Representations and Warranties of the Company and Nascent. The Company and Nascent each hereby makes the following representations
and warranties to Assignee on and as of the Effective Date:
(a)
Authorization; Enforcement. (i) Each of the Company and Nascent has all requisite corporate power and authority to enter into
and perform this Agreement and to consummate the transactions contemplated hereby including without limitation the Assignment and the
granting by the Company of security interests in the Collateral to Assignee hereunder; (ii) the execution and delivery of this Agreement
and the consummation by each of the Company and Nascent of the transactions contemplated hereby have been duly authorized by the Company’s
Board of Directors and the Company in its capacity as the manager of Nascent and no further consent or authorization of the Company,
Nascent, the Board of Directors of the Company or any shareholders or members of the Company or Nascent, as applicable, or any debt holders
of the Company or Nascent is required, (iii) this Agreement has been duly executed and delivered by each of the Company and Nascent by
its authorized representative, and such authorized representative is the true and official representative with authority to sign this
Agreement and bind the Company and Nascent accordingly, and (iv) this Agreement constitutes, a legal, valid and binding obligation of
the Company and Nascent, enforceable against the Company and Nascent in accordance with its terms.
(b)
No Conflicts. The execution, delivery and performance of this Agreement by the Company and Nascent and the consummation by the
Company and Nascent of the transactions contemplated hereby (including, without limitation, the Assignment and the granting by the Company
of security interests in the Collateral to Assignee hereunder) will not (i) conflict with or result in a violation of any provision of
the Certificate of Incorporation or By-laws of the Company or of the Nascent Charter or Nascent Operating Agreement, (ii) violate or
conflict with, or result in a breach of any provision of, or constitute a default (or an event which with notice or lapse of time or
both could become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement,
note, evidence of indebtedness, indenture, patent, patent license or instrument to which the Company, Nascent, or any Subsidiary of the
Company is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree applicable to the Company,
Nascent, or any Subsidiary of the Company or by which any property or asset of the Company, Nascent or any Subsidiary of the Company
is bound or affected.
(c)
Nascent and the Patents.
(i)
Attached hereto as Exhibit A-1 is a true and complete copy of the certificate of formation of Nascent as filed in the office of
the Secretary of the State of Nevada, together with all amendments thereto (the “Nascent Charter”). The Nascent Charter
is in full force and effect on and as of the date hereof, has not been amended, modified or repealed, and no proceedings for the amendment,
modification, superseding or rescission thereof are pending or contemplated, and no amendment or other document relating to or affecting
the Nascent Charter has been filed in the office of the Secretary of the State of Nevada since such date, and no action has been taken
by Nascent, the Company or any officers or any other members or its officers, manager, members or any other equity holders including
without limitation in contemplation of the filing of any such amendment or other document or in contemplation of the liquidation or dissolution
of Nascent. Attached hereto as Exhibit A-2 is a true, complete and correct copy of the limited liability company operating agreement
of Nascent, together with all amendments thereto (the “Nascent Operating Agreement”). The Nascent Operating Agreement
is in full force and effect on and as of the date hereof, has not been amended, modified, superseded or repealed, and no proceedings
for the amendment, modification, superseding or rescission thereof are pending or contemplated.
(d)
The Company’s Distributions Rights.
(i)
The Company is a member of Nascent holding sixty-seven percent (67%) of the outstanding Equity Interests in Nascent, and accordingly,
the Company is entitled to receive Distributions from Nascent of Cash Available for Distribution in its capacity as a member of Nascent,
subject to and in accordance with (1) the Nascent Operating Agreement, (2) any provisions of the Proposed UCANN Distribution Agreement
providing for distributions of “Cash Available for Distribution” (under and as to be defined in the Proposed UCANN Distribution
Agreement), (3) any provisions of any Proposed Distribution and Contingent Payment Agreement pursuant to which the Company and/or Nascent
has agreed or will agree to pay or distribute any Distributions of Cash Available for Distribution that the Company would otherwise be
entitled to receive pursuant to the Nascent Operating Agreement to any Person other than the Company, and (4) the terms and provisions
of this Agreement.
(ii)
The Company is the sole manager of Nascent, with the power to manage the business and affairs of Nascent, including the power to determine
the timing of distributions of Cash Available for Distribution to the members of Nascent, subject to and in accordance with (1) the Nascent
Operating Agreement, (2) any provisions of the Proposed UCANN Distribution Agreement (if and when the same is executed) providing for
the timing of distributions of “Cash Available for Distribution” (under and as to be defined in the Proposed UCANN Distribution
Agreement), (3) any provisions of the other Proposed Distribution and Payment Agreements (if and when the same are executed) affecting
the ability of the Company to determine the timing of Distributions of Cash Available for Distributions and (4) the terms and provisions
of this Agreement.
(iii)
Other than as provided pursuant to this Agreement and the Purchase Agreement, as of the date hereof neither the Company nor Nascent,
nor any Affiliate or the Company or Nascent has any obligations or commitments, or has entered into any agreement with any third party
Person, or executed any instrument or other document providing for the payment of fees, Distributions or other consideration to any third
party Person contingent or payable upon or in connection with a successful prosecution of one or more Patent Claims or providing for
the payment of Distributions of Cash Available for Distribution that the Company would otherwise be entitled to receive pursuant to the
Nascent Operating Agreement to any Person other than the Company.
(iv)
As of the date hereof, none of the Proposed Distribution and Contingent Payment Agreements has been fully executed and accordingly (A)
neither the Company nor Nascent has any commitment or obligation under any such Proposed Distribution and Contingent Payment Agreement
and (B) each such proposed Distribution and Contingent Payment Agreement may ultimately contain terms which differ from those described
in the definition thereof set forth in this Agreement. As of the date hereof, neither the Company nor Nascent, nor any Affiliate of the
Company or Nascent is contemplating entering into any agreement, document or instrument with any third Party Person providing for the
payment of fees, Distributions or other consideration to any third party Person contingent or payable upon or in connection with a successful
prosecution of one or more Patent Claims or providing for Distributions of Cash Available for Distribution that the Company would otherwise
be entitled to receive pursuant to the Nascent Operating Agreement to any Person other than the Company, other than (1) the Proposed
Distribution and Contingent Payment Agreements and (2) any ancillary documents to be delivered in connection therewith with terms that
do not provide for the payment of fees, Distributions or other consideration to any third party Person contingent or payable upon or
in connection with a successful prosecution of one or more Patent Claims and do not provide for the payment of Distributions that the
Company would otherwise be entitled to receive pursuant to the Nascent Operating Agreement to any Person other than the Company other
than the Proposed Blackmon Distributions, Proposed McCarter Contingency Fees, Proposed Patent Claim Lender Fees and Proposed UCANN Pool
Distributions.
7.
Title to Purchased Distributions Rights. It is the intention of the Company and Assignee that the Assignment contemplated by this
Agreement shall constitute an absolute and irrevocable sale of the Purchased Distributions Rights from the Company to Assignee free and
clear of all liens and rights of others and it is intended that the beneficial interest in and title to the Purchased Distributions Rights)
shall not be part of the Company’s estate in the event of the filing of a petition by or against the Company under any bankruptcy
or insolvency law; provided, for the avoidance of doubt and notwithstanding anything to the contrary set forth herein, the Purchased
Distribution Rights shall automatically revert to the Company upon Assignee’s receipt of Distributions pursuant to Section 3(a)
above in an amount equal to the Additional Consideration Amount. No portion of the Purchased Distributions Rights has been sold,
transferred, assigned, or pledged by the Company to any Person other than Assignee. The Company has good and marketable title to the
Purchased Distributions Rights and, prior to the Assignment contemplated by this Agreement, the Company is the sole owner thereof, free
and clear of all liens, claims, encumbrances, security interests, and rights of others, and upon the Assignment thereof to the Assignee,
Assignee shall have good and marketable title to the Purchased Distribution Rights and shall be the sole owner thereof, free and clear
of all liens, claims, encumbrances, security interests, and rights of others.
8.
Other Covenants and Agreements of Nascent and Company.
(a)
The Company shall, and shall cause Nascent to, use best efforts to, (i) cause the Patents to be contributed to Nascent pursuant to the
Nascent Operating Agreement, and (ii) cause all rights, title, and interest in the Patents to be assigned to Nascent, including without
limitation by causing any and all filings with the United States Patent Trademark Office necessary to effect such assignment under applicable
law, as soon as reasonably practicable following the date hereof. Upon the written request of Assignee delivered to the Company from
time to time, the Company shall promptly provide then current information to Assignee regarding the Company and Nascent’s efforts
to cause the Patents to be assigned to Nascent, including by providing Assignee with copies of any and all agreements or documents entered
into by the Company and/or Nascent and any filings made with the United States Patent and Trademark Office in pursuit of such assignment.
The Company and Nascent covenant and agree that, without the prior written consent of Assignee, neither the Company nor Nascent, nor
any Affiliate of the Company or Nascent shall enter into any agreement or execute any instrument providing for or permitting the assignment
of the Patents to any Person other than Nascent.
(b)
Until Assignee shall have received an amount of Distributions pursuant to Section 3(a) in an amount equal to the Additional Consideration
Amount and assuming Nascent acquires title to the Patents, the Company shall, and shall cause Nascent to, use commercially reasonable
efforts to pursue Patent Claims with a view to maximizing the amount of Cash Available for Distribution pursuant to the Nascent Operating
Agreement and the amount of “Cash Available for Distribution” (as to be defined in the Proposed UCANN Distribution Agreement)
and the amount of Distributions paid to Assignee pursuant to Section 3(a); and, in furtherance of the foregoing, the Company covenants
(i) to use commercially reasonable efforts to determine in coordination with Nascent’s auditor whether there is Cash Available
for Distribution and “Cash Available for Distribution” (as to be defined in the Proposed UCANN Distribution Agreement) at
least once every calendar quarter, and (ii) to the extent there is any Cash Available for Distribution in any calendar quarter and/or
“Cash Available for Distribution” (as to be defined in the Proposed UCANN Distribution Agreement) to use its power as manager
of Nascent to cause all of such Cash Available for Distribution and/or “Cash Available for Distribution” (as to be defined
in the Proposed UCANN Distribution Agreement) to be distributed in accordance with and subject to the Nascent Operating Agreement and/or
the Proposed UCANN Distribution Agreement, as applicable, subject in each case to the provisions of this Agreement, by the end of such
calendar quarter.
(c)
Until Assignee shall have received an amount of Distributions pursuant to Section 3(a) of this Agreement equal to the Additional
Consideration Amount, the Company shall not, without the prior written consent of Assignee, (i) sell, assign, exchange, pledge or otherwise
transfer, encumber, or otherwise diminish or impair any of its rights with respect to any portion of its Equity Interest in Nascent,
or any of its Distributions Rights (other than pursuant to the Assignment effected by this Agreement), or (ii) withdraw as manager of
Nascent.
(d)
Until Assignee shall have received an amount of Distributions pursuant to Section 3(a) of this Agreement equal to the Additional
Consideration Amount, neither Nascent nor the Company shall, nor shall the Company permit Nascent to, without the prior written consent
of Assignee, sell, assign, exchange, pledge or otherwise transfer, encumber, or otherwise diminish or impair any of Nascent’s rights,
whether now existing or hereafter arising, with respect to any of the Patents.
(e)
Until Assignee shall have received an amount of Distributions pursuant to Section 3(a) of this Agreement equal to the Additional
Consideration Amount, Nascent and the Company shall use commercially reasonable efforts to (i) enter into the Proposed Distribution and
Contingent Payment Distribution Agreements on final terms that do not provide for the payment of fees, Distributions or other consideration
to any third party Person contingent or payable upon or in connection with a successful prosecution of one or more Patent Claims and
do not provide for the payment of Distributions of Cash Available for Distribution that the Company would otherwise be entitled to receive
pursuant to the Nascent Operating Agreement to any Person, other than the Proposed Blackmon Distributions, Proposed McCarter Contingency
Fees, Proposed Patent Claim Lender Fees and Proposed UCANN Pool Distributions, and (ii) not enter into or permit any Affiliate of Nascent
or the Company to enter into, any agreement with any third party Person, or execute or permit any Affiliate of Nascent or the Company
to execute any instrument or document, providing for the payment of fees, Distributions or other consideration to any third party Person
contingent or payable upon or in connection with a successful prosecution of one or more Patent Claims or providing for the payment of
Distributions of Cash Available for Distribution that the Company would otherwise be entitled to receive pursuant to the Nascent Operating
Agreement to any Person other than the Company, other than the Proposed Blackmon Distributions, Proposed McCarter Contingency Fees, Proposed
Patent Claim Lender Fees and Proposed UCANN Pool Distributions.
(f)
Upon the entry by the Company, Nascent or any Affiliate of the Company or Nascent into any agreement with any third party Person, or
the execution by the Company, Nascent or any Affiliate of the Company or Nascent of any instrument or document providing for the payment
of fees, Distributions or other consideration to any third party Person contingent or payable upon or in connection with a successful
prosecution of one or more Patent Claims or providing for the payment of Distributions that the Company would otherwise be entitled to
receive pursuant to the Nascent Operating Agreement to any Person other than the Company, including without limitation any of the Proposed
Distribution and Contingent Payment Agreements and any ancillary documents executed in connection therewith, the Company shall promptly,
and in any event within three (3) Business Days following the date any such agreement, instrument or document, is executed by the Company,
Nascent or any Affiliate of the Company, send written notice thereof to Assignee and provide a duly executed copy of each such agreement,
instrument or document, to Assignee. For the avoidance of doubt, the agreements, instruments and documents required to be provided by
the Company to Assignee pursuant to this Section 8(e) include any amendments or other instruments modifying, waiving or terminating
any provisions of any agreement, instrument and/or other document otherwise required to be delivered by the Company to Assignee pursuant
to the foregoing sentence of this Section 8(e).
(g)
Until Assignee shall have received an amount of Distributions pursuant to Section 3(a) of this Agreement equal to the Additional
Consideration Amount, the Company shall not, and the Company shall not permit Nascent to, amend, modify, waive, terminate any term or
provision in the Nascent Operating Agreement or consent to any such amendment, modification, waiver or termination, to the extent doing
so would reasonably be expected to impair, decrease or delay the payment of (i) the amount of Cash Available for Distribution that would
otherwise be available at any time to be paid as Distributions to the members of Nascent (including the Company), (ii) the potential
amount of any Distributions that the Company, Nascent or any entity in which the Company has an interest, would otherwise recover and/or
be entitled to in the event that the Company, Nascent or any entity in which the Company has an interest is successful in prosecuting
any Patent Claim or (iii) the potential amount of Distributions that would otherwise be distributed to Assignee pursuant to the terms
of this Agreement.
9.
Miscellaneous.
(a)
Governing Law; Venue. This Agreement shall be governed by and construed in accordance with the laws of the State of New York without
regard to principles of conflicts of laws. Any action brought by any Party against any other Party or Parties concerning the transactions
contemplated by this Agreement, or any other agreement, certificate, instrument or document contemplated hereby shall be brought only
in the Court of Chancery of the State of Delaware or, to the extent such court does not have subject matter jurisdiction, the United
States District Court for the District of Delaware or, to the extent that neither of the foregoing courts has jurisdiction, the Superior
Court of the State of Delaware. The Parties to this Agreement hereby irrevocably waive any objection to jurisdiction and venue of any
action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens.
EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE
HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTIONS CONTEMPLATED HEREBY. The prevailing Party shall
be entitled to recover from the other Party and/or Parties, as applicable, its reasonable attorney’s fees and costs. Each Party
hereby irrevocably waives personal service of process and consents to process being served in any suit, action or proceeding in connection
with this Agreement or any other agreement, certificate, instrument or document contemplated hereby or thereby by mailing a copy thereof
via registered or certified mail or overnight delivery (with evidence of delivery) to such Party at the address in effect for notices
to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing
contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.
(b)
Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of
which shall constitute one and the same agreement and shall become effective when counterparts have been signed by each Party and delivered
to the other Party. A facsimile or .pdf signature shall be considered due execution and shall be binding upon the signatory thereto with
the same force and effect as if the signature were an original, not a facsimile or .pdf signature. Delivery of a counterpart signature
hereto by facsimile or email/.pdf transmission shall be deemed validly delivery thereof.
(c)
Construction; Headings. This Agreement shall be deemed to be jointly drafted by Nascent, the Company and Assignee and shall not
be construed against any person as the drafter hereof. The headings of this Agreement are for convenience of reference only and shall
not form part of, or affect the interpretation of, this Agreement.
(d)
Severability. In the event that any provision of this Agreement is invalid or unenforceable under any applicable statute or rule
of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to
conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect
the validity or enforceability of any other provision of this Agreement, or any other agreement, certificate, instrument or document
contemplated hereby or thereby.
(e)
Entire Agreement. This Agreement and the other Transaction Documents contain the entire understanding of the parties with respect
to the matters covered herein and therein and supersede any prior understandings or written or oral agreements between the Parties respecting
the subject matter of this Agreement and the other Transaction Documents. To the extent of any conflict between any term or provision
of this Agreement and/or any other Transaction Document, on the one hand, and any term or provision in any prior agreement between any
of the Parties (including without limitation that certain letter agreement re: Waiver of Security Interest dated as of March 22, 2023
by and between the Company and Assignee), on the other hand, with respect to the matters covered in this Agreement and the other Transaction
Documents, the terms of this Agreement and the other Transaction Documents shall control.
(f)
Amendments. No provision of this Agreement or any agreement or instrument contemplated hereby may be waived or amended other than
by an instrument in writing signed by each of the Parties.
(g)
Notices. All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be
in writing and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified,
return receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted
by hand delivery, telegram, e-mail or facsimile, addressed as set forth below or to such other address as such Party shall have specified
most recently by written notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective
(1) upon hand delivery or delivery by e-mail or facsimile, with accurate confirmation generated by the transmitting facsimile machine,
at the address or number designated below (if delivered on a Business Day during normal business hours where such notice is to be received),
or the first Business Day following such delivery (if delivered other than on a Business Day during normal business hours where such
notice is to be received) or (2) on the second Business Day following the date of mailing by express courier service, fully prepaid,
addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses for such communications
shall be:
If
to Nascent and/or the Company, to:
CAN
B̅ CORP.
960
South Broadway, Suite 120
Hicksville,
NY 11801
Attention:
Marco Alfonsi
e-mail:
info@canbiola.com
If
to Assignee, to:
Walleye
Opportunities Master Fund Ltd
2800
Niagara Lane North
Plymouth,
MN 55447
e-mail:
legal@walleyecapital.com
(h)
Binding Effect; Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the Parties and their
successors and assigns. the Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of Assignee. Assignee may assign its rights hereunder to any Person without the consent of the Company.
(i)
Third Party Beneficiaries. This Agreement is intended for the benefit of the Parties hereto and their respective permitted successors
and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.
(j)
Survival. The representations and warranties of the Company and Nascent and the agreements and covenants set forth in this Agreement
shall survive the sale, transfer and assignment of the Purchased Distributions Rights to the Company.
(k)
Further Assurances. Each Party shall do and perform, or cause to be done and performed, all such further acts and things, and
shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request
in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated
hereby.
(l)
No Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against any party.
(m)
Indemnification. the Company shall defend, indemnify and hold harmless Assignee, and its stockholders, partners, members, officers,
directors, employees and direct or indirect investors and any of the foregoing persons’ agents or other representatives (including,
without limitation, those retained in connection with the transactions contemplated by this Agreement) (collectively, the “Indemnitees”)
from and against any and all actions, causes of action, suits, claims, losses, costs, penalties, fees, liabilities and damages, and expenses
in connection therewith (irrespective of whether any such Indemnitee is a party to the action for which indemnification hereunder is
sought), and including reasonable attorneys’ fees and disbursements (the “Indemnified Liabilities”), incurred
by any Indemnitee as a result of, or arising out of, or relating to (i) any misrepresentation or breach of any representation or warranty
made by the Company, (ii) any breach of any covenant, agreement or obligation of the Company contained in this Agreement or (iii) any
cause of action, suit or claim brought or made against such Indemnitee by a third party (including for these purposes a derivative action
brought on behalf of the Company) and arising out of or resulting from the execution, delivery, performance or enforcement of this Agreement.
To the extent that the foregoing undertaking by the Company may be unenforceable for any reason, the Company shall make the maximum contribution
to the payment and satisfaction of each of the Indemnified Liabilities that is permissible under applicable law. The indemnification
obligations of the Company under this Section 9(m) shall survive the termination of this Agreement and the other Transaction Documents.
(n)
Remedies. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Company
by vitiating the intent and purpose of the transactions contemplated hereby and under the Purchase Agreement. Accordingly, the Company
acknowledges that the remedy at law for a breach of its obligations under this Agreement or any other agreement, certificate, instrument
or document contemplated hereby will be inadequate and agrees, in the event of a breach or threatened breach by the Company of the provisions
of this Agreement, or any other agreement, certificate, instrument or document contemplated hereby, that Assignee shall be entitled,
in addition to all other available remedies at law or in equity, and in addition to the penalties assessable herein, to an injunction
or injunctions restraining, preventing or curing any breach of this Agreement, or any other agreement, certificate, instrument or document
contemplated hereby, and to enforce specifically the terms and provisions hereof and thereof, without the necessity of showing economic
loss and without any bond or other security being required.
(o)
Payment Set Aside. To the extent that the (i) the Company makes a payment or payments to the Assignee hereunder, or pursuant to
any other agreement, certificate, instrument or document contemplated hereby, or (ii) Assignee enforces or exercises its rights hereunder,
pursuant to this Agreement or pursuant to any other Transaction Document, or any agreement, certificate, instrument or document contemplated
hereby or thereby, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are for any reason
(A) subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, or disgorged by the Assignee, or
(B) are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other person or entity under
any law (including, without limitation, any bankruptcy law, foreign, state or federal law, common law or equitable cause of action),
then (1) to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and
continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred and (2) the Company
shall immediately pay to Assignee a dollar amount equal to the amount that was for any reason (x) subsequently invalidated, declared
to be fraudulent or preferential, set aside, recovered from, or disgorged by Assignee, or (y) required to be refunded, repaid or otherwise
restored to Assignee, a trustee, receiver or any other Person or entity under any law (including, without limitation, any bankruptcy
law, foreign, state or federal law, common law or equitable cause of action).
(p)
Failure or Indulgence Not Waiver. No failure or delay on the part of Assignee in the exercise of any power, right or privilege
hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude
other or further exercise thereof or of any other right, power or privileges. All rights and remedies of Assignee existing hereunder
are cumulative to, and not exclusive of, any rights or remedies otherwise available.
[Signature
Pages Follow]
IN
WITNESS WHEREOF, the Parties have caused this Agreement to be executed by their duly authorized representatives as of the date first
written above.
|
NASCENT: |
|
|
|
NASCENT
PHARMA, LLC |
|
|
|
By: |
Can
B̅ Corp., its sole Manager |
|
By: |
/s/
Marco Alfonsi |
|
Name: |
Marco
Alfonsi |
|
Title: |
Chief
Executive Officer |
|
|
COMPANY: |
|
|
|
|
|
CAN
B̅ CORP. |
|
|
|
|
By: |
/s/Marco
Alfonsi |
|
Name: |
Marco
Alfonsi |
|
Title: |
Chief
Executive Officer |
|
|
ASSIGNEE: |
|
|
|
|
|
WALLEYE
OPPORTUNITIES MASTER FUND LTD |
|
|
|
|
By: |
/s/William
England |
|
Name: |
William
England |
|
Title: |
Chief
Executive Officer of the Manager |
[Signature
Page to Distribution and Assignment Agreement]
Schedule
I
Wire
Instructions
(for
payments to Assignee)
(omitted)
EXHIBIT
A-1
Nascent
Pharma, LLC Certificate of Formation
(omitted)
EXHIBIT
A-2
Nascent
Pharma, LLC Operating Agreement
(omitted)
Exhibit
9.5
REGISTRATION
RIGHTS AGREEMENT
REGISTRATION
RIGHTS AGREEMENT (this “Agreement”), dated as of October 27, 2023, by and between CAN B̅ CORP., a
Florida corporation (the “Company”), and the investor identified on the signature page hereto (together with it permitted
assigns, the “Investor”). Capitalized terms used herein and not otherwise defined herein shall have the respective
meanings set forth in the securities purchase agreement by and between the parties hereto, dated as of October 26, 2023 (as amended,
restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
WHEREAS:
The
Company has agreed, upon the terms and subject to the conditions of the Purchase Agreement, to sell to the Investor the Securities and
to induce the Investor to enter into the Purchase Agreement, the Company has agreed to provide certain registration rights under the
Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor statute (collectively, the “Securities
Act”), and applicable state securities laws.
NOW,
THEREFORE, in consideration of the promises and the mutual covenants contained herein and other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Company and the Investor hereby agree as follows:
1.
DEFINITIONS.
As
used in this Agreement, the following terms shall have the following meanings:
a.
“Effective Date” means the date that the applicable Registration Statement has been declared effective by the SEC.
b.
“Investor” shall have the meaning set forth above.
c.
“Person” means any individual or entity including but not limited to any corporation, a limited liability company,
an association, a partnership, an organization, a business, an individual, a governmental or political subdivision thereof or a governmental
agency.
d.
“Register,” “registered,” and “registration” refer to a registration effected
by preparing and filing one or more registration statements of the Company in compliance with the Securities Act and/or pursuant to Rule
415 under the Securities Act or any successor rule providing for offering securities on a continuous basis (“Rule 415”),
and the declaration or ordering of effectiveness of such registration statement(s) by the United States Securities and Exchange Commission
(the “SEC”).
e.
“Registrable Securities” means all of the (i) Conversion Shares issuable under the Note purchased by the Investor
on the initial Closing Date, (ii) Conversion Shares issuable under the Consolidated Amended and Restated Walleye Note, and (iii) shares
of Common Stock issued to the Investor as a result of any stock split, stock dividend, recapitalization, exchange or similar event or
otherwise, without regard to any limitation on purchases under the Purchase Agreement or the related agreements entered into therewith.1
f.
“Registration Statement” means one or more registration statements of the Company covering only the sale of the Registrable
Securities.
2.
REGISTRATION.
a.
Mandatory Registration. The Company shall, within forty five (45) calendar days from the date of this Agreement (the “Filing
Deadline”), file with the SEC an initial Registration Statement covering the maximum number of Registrable Securities as shall
be permitted to be included thereon in accordance with applicable SEC rules, regulations and interpretations, including but not limited
to Rule 415 under the Securities Act, so as to permit the resale of such Registrable Securities by the Investor at then-prevailing market
prices (and not fixed prices), subject to the aggregate number of authorized shares of the Company’s Common Stock then available
for issuance in its Certificate of Incorporation. The initial Registration Statement shall register only Registrable Securities unless
otherwise approved by the Investor. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such
Registration Statement and any amendment or supplement to such Registration Statement and any related prospectus prior to its filing
with the SEC, and the Company shall give due consideration to all reasonable comments. The Investor shall furnish all information reasonably
requested by the Company for inclusion therein. The Company shall have the Registration Statement and any amendment declared effective
by the SEC no later than the Effectiveness Deadline. The Company shall keep the Registration Statement effective pursuant to Rule 415
promulgated under the Securities Act and available for the resale by the Investor of all of the Registrable Securities covered thereby
at all times until the date on which the Investor shall have resold all the Registrable Securities covered thereby and no Available Amount
remains under the Purchase Agreements (the “Registration Period”). The Registration Statement (including any amendments
or supplements thereto and prospectuses contained therein) shall not contain any untrue statement of a material fact or omit to state
a material fact required to be stated therein, or necessary to make the statements therein, in light of the circumstances in which they
were made, not misleading. In the event that the Registration Statement becomes stale, the Company shall immediately file one or more
post-effective amendments to obtain an effective Registration Statement.
b.
Rule 424 Prospectus. The Company shall, as required by applicable securities regulations, from time to time file (in each case,
at the earliest possible date) with the SEC, pursuant to Rule 424 promulgated under the Securities Act, the prospectus and prospectus
supplements, if any, to be used in connection with sales of the Registrable Securities under the Registration Statement. The Company
shall file such initial prospectus covering the Investor’s sale of the Registrable Securities on the same date that the Registration
Statement is declared effective by the SEC. The Investor and its counsel shall have a reasonable opportunity to review and comment upon
such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments. The Investor shall
use its reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor receives the final
pre-filing version of such prospectus.
c.
Sufficient Number of Shares Registered. In the event the number of shares available under the Registration Statement is insufficient
to cover all of the Registrable Securities, the Company shall amend the Registration Statement or file a new Registration Statement (a
“New Registration Statement”), so as to cover all of such Registrable Securities (subject to the limitations set forth
in Section 2(a)) as soon as practicable, but in any event not later than ten (10) Business Days after the necessity thereof arises, subject
to any limits that may be imposed by the SEC pursuant to Rule 415 under the Securities Act. The Company shall use it reasonable best
efforts to cause such amendment and/or New Registration Statement to become effective as soon as practicable following the filing thereof.
In the event that any of the Registrable Securities are not included in the Registration Statement, or have not been included in any
New Registration Statement and the Company files any other registration statement under the Securities Act (other than on Form S-4, Form
S-8, or with respect to other employee related plans or rights offerings) (“Other Registration Statement”) then the
Company shall include such remaining Registrable Securities in such Other Registration Statement. The Company agrees that it shall not
file any such Other Registration Statement unless all of the Registrable Securities have been included in such Other Registration Statement
or otherwise have been registered for resale as described above.
d.
Offering. If the staff of the SEC (the “Staff”) or the SEC seeks to characterize any offering pursuant to a
Registration Statement filed pursuant to this Agreement as constituting an offering of securities that does not permit such Registration
Statement to become effective and be used for resales by the Investor under Rule 415 at then prevailing market prices (and not fixed
prices), or if after the filing of the initial Registration Statement with the SEC pursuant to Section 2(a), the Company is otherwise
required by the Staff or the SEC to reduce the number of Registrable Securities included in such initial Registration Statement, then
the Company shall reduce the number of Registrable Securities to be included in such initial Registration Statement (with the prior consent,
which shall not be unreasonably withheld, of the Investor and its legal counsel as to the specific Registrable Securities to be removed
therefrom) until such time as the Staff and the SEC shall so permit such Registration Statement to become effective and be used as aforesaid.
In the event of any reduction in Registrable Securities pursuant to this paragraph, the Company shall file one or more New Registration
Statements in accordance with Section 2(c) until such time as all Registrable Securities have been included in Registration Statements
that have been declared effective and the prospectus contained therein is available for use by the Investor. Notwithstanding any provision
herein or in the Purchase Agreement to the contrary, the Company’s obligations to register Registrable Securities (and any related
conditions to the Investor’s obligations) shall be qualified as necessary to comport with any requirement of the SEC or the Staff
as addressed in this Section 2(d).
e.
Effect of Failure to File and Obtain and Maintain Effectiveness of any Registration Statement.
(i)
If a Registration Statement covering the resale of all of the Registrable Securities required to be covered thereby (disregarding any
reduction pursuant to Section 2(d)) and required to be filed by the Company pursuant to this Agreement is not filed with the SEC on or
before the Filing Deadline for such Registration Statement then, as partial relief for the damages to Investor by reason of any such
delay in its ability to sell the underlying Common Stock (which remedy shall not be exclusive of any other remedies available at law
or in equity, including, without limitation, specific performance), to the extent no Conversion Shares have been registered, the Company
shall be obligated to make payments to Investor, as liquidated damages and not as a penalty, in an amount equal to 2% of the amount then
currently outstanding under the Initial Note and the Consolidated Amended and Restated Walleye Note (including, without limitation, all
principal, interest and other payments due thereon) for each 30-day period following the Filing Deadline, and such payments shall be
made to Investor in cash not later than two (2) Trading Days after the end of each 30-day period.
(ii)
If a Registration Statement covering the resale of all of the Registrable Securities required to be covered thereby (disregarding any
reduction pursuant to Section 2(d)) and required to be filed by the Company pursuant to this Agreement (x) is not declared effective
by the SEC on or before the Effectiveness Deadline (as defined below) for such Registration Statement (an “Effectiveness Failure”),
and (y) if on the Business Day immediately following the Effective Date for such Registration Statement the Company shall not have filed
a “final” prospectus for such Registration Statement with the SEC under Rule 424 in accordance with Section 2(b) (whether
or not such a prospectus is technically required by such rule), then, as partial relief for the damages to Investor by reason of any
such delay in its ability to sell the underlying Common Shares (which remedy shall not be exclusive of any other remedies available at
law or in equity, including, without limitation, the remedies set forth in Section 2(e)(i) above) the Company shall be deemed to not
have satisfied this clause (ii) and such event shall be deemed to be an Effectiveness Failure), then to the extent no Conversion Shares
have been registered, the Company shall be obligated to make payments to Investor, as liquidated damages and not as a penalty, in an
amount equal to 2% of the amount then currently outstanding under the Initial Note and the Consolidated Amended and Restated Walleye
Note (including, without limitation, all principal, interest and other payments due thereon) for each 30-day period or pro rata for any
portion thereof following the Effectiveness Deadline, and such payments shall be made to Investor in cash not later than two (2) Trading
Days after the end of each 30-day period. “Effectiveness Deadline” means (i) with respect to the initial Registration Statement
required to be filed pursuant to Section 2(a), the earlier of the (A) 90th calendar day following the date of this Agreement (or, if
such Registration Statement is subject to a full review by the SEC, the 120th calendar day after the date of this Agreement) and (B)
2nd Business Day after the date the Company is notified (orally or in writing, whichever is earlier) by the SEC that such Registration
Statement will not be reviewed or will not be subject to further review and (ii) with respect to any additional Registration Statements
that may be required to be filed by the Company pursuant to this Agreement, the earlier of the (A) 30th calendar day following the date
on which the Company was required to file such additional Registration Statement (or, if such Registration Statement is subject to a
full review by the SEC, the 90th calendar day after such required filing date) and (B) 2nd Business Day after the date the Company is
notified (orally or in writing, whichever is earlier) by the SEC that such Registration Statement will not be reviewed or will not be
subject to further review.
3.
RELATED OBLIGATIONS.
With
respect to the Registration Statement and whenever any Registrable Securities are to be registered pursuant to Section 2 including on
any New Registration Statement, the Company shall use its reasonable best efforts to effect the registration of the Registrable Securities
in accordance with the intended method of disposition thereof and, pursuant thereto, the Company shall have the following obligations:
a.
The Company shall prepare and file with the SEC such amendments (including post-effective amendments) and supplements to any registration
statement and the prospectus used in connection with such registration statement, which prospectus is to be filed pursuant to Rule 424
promulgated under the Securities Act, as may be necessary to keep the Registration Statement or any New Registration Statement effective
at all times during the Registration Period, and, during such period, comply with the provisions of the Securities Act with respect to
the disposition of all Registrable Securities of the Company covered by the Registration Statement or any New Registration Statement
until such time as all of such Registrable Securities shall have been disposed of in accordance with the intended methods of disposition
by the seller or sellers thereof as set forth in such registration statement.
b.
The Company shall permit the Investor to review and comment upon the Registration Statement or any New Registration Statement and all
amendments and supplements thereto at least two (2) Business Days prior to their filing with the SEC, and not file any document in a
form to which Investor reasonably objects. The Investor shall use its reasonable best efforts to comment upon the Registration Statement
or any New Registration Statement and any amendments or supplements thereto within two (2) Business Days from the date the Investor receives
the final version thereof. The Company shall furnish to the Investor, without charge, any correspondence from the SEC or the Staff to
the Company or its representatives relating to the Registration Statement or any New Registration Statement.
c.
Upon request of the Investor, the Company shall furnish to the Investor, (i) promptly after the same is prepared and filed with the SEC,
at least one copy of such registration statement and any amendment(s) thereto, including financial statements and schedules, all documents
incorporated therein by reference and all exhibits, (ii) upon the effectiveness of any registration statement, a copy of the prospectus
included in such registration statement and all amendments and supplements thereto (or such other number of copies as the Investor may
reasonably request) and (iii) such other documents, including copies of any preliminary or final prospectus, as the Investor may reasonably
request from time to time in order to facilitate the disposition of the Registrable Securities owned by the Investor. For the avoidance
of doubt, any filing available to the Investor via the SEC’s live EDGAR system shall be deemed “furnished to the Investor”
hereunder.
d.
The Company shall use reasonable best efforts to (i) register and qualify the Registrable Securities covered by a registration statement
under such other securities or “blue sky” laws of such jurisdictions in the United States as the Investor reasonably requests,
(ii) prepare and file in those jurisdictions, such amendments (including post-effective amendments) and supplements to such registrations
and qualifications as may be necessary to maintain the effectiveness thereof during the Registration Period, (iii) take such other actions
as may be necessary to maintain such registrations and qualifications in effect at all times during the Registration Period, and (iv)
take all other actions reasonably necessary or advisable to qualify the Registrable Securities for sale in such jurisdictions; provided,
however, that the Company shall not be required in connection therewith or as a condition thereto to (x) qualify to do business in any
jurisdiction where it would not otherwise be required to qualify but for this Section 3(d), (y) subject itself to general taxation in
any such jurisdiction, or (z) file a general consent to service of process in any such jurisdiction. The Company shall promptly notify
the Investor who holds Registrable Securities of the receipt by the Company of any notification with respect to the suspension of the
registration or qualification of any of the Registrable Securities for sale under the securities or “blue sky” laws of any
jurisdiction in the United States or its receipt of actual notice of the initiation or threatening of any proceeding for such purpose.
e.
As promptly as practicable after becoming aware of such event or facts, the Company shall notify the Investor in writing of the happening
of any event or existence of such facts as a result of which the prospectus included in any registration statement, as then in effect,
includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make
the statements therein, in light of the circumstances under which they were made, not misleading, and promptly prepare a supplement or
amendment to such registration statement to correct such untrue statement or omission, and deliver a copy of such supplement or amendment
to the Investor (or such other number of copies as the Investor may reasonably request). The Company shall also promptly notify the Investor
in writing (i) when a prospectus or any prospectus supplement or post-effective amendment has been filed, and when a registration statement
or any post-effective amendment has become effective (notification of such effectiveness shall be delivered to the Investor by email
on the same day of such effectiveness and by overnight mail), (ii) of any request by the SEC for amendments or supplements to any registration
statement or related prospectus or related information, and (iii) of the Company’s reasonable determination that a post-effective
amendment to a registration statement would be appropriate.
f.
The Company shall use its reasonable best efforts to prevent the issuance of any stop order or other suspension of effectiveness of any
registration statement, or the suspension of the qualification of any Registrable Securities for sale in any jurisdiction and, if such
an order or suspension is issued, to obtain the withdrawal of such order or suspension at the earliest possible moment and to notify
the Investor of the issuance of such order and the resolution thereof or its receipt of actual notice of the initiation or threat of
any proceeding for such purpose.
g.
The Company shall (i) cause all the Registrable Securities to be listed on each securities exchange on which securities of the same class
or series issued by the Company are then listed, if any, if the listing of such Registrable Securities is then permitted under the rules
of such exchange, or (ii) secure designation and quotation of all the Registrable Securities on the Principal Market. The Company shall
pay all fees and expenses in connection with satisfying its obligation under this Section.
h.
The Company shall cooperate with the Investor to facilitate the timely preparation and delivery of the Registrable Securities (not bearing
any restrictive legend) either by DWAC, DRS, or in certificated form if DWAC or DRS is unavailable, to be offered pursuant to any registration
statement and enable such Registrable Securities to be in such denominations or amounts as the Investor may reasonably request and registered
in such names as the Investor may request.
i.
The Company shall at all times provide a transfer agent and registrar with respect to its Common Stock.
j.
If reasonably requested by the Investor, the Company shall (i) immediately incorporate in a prospectus supplement or post-effective amendment
such information as the Investor believes should be included therein relating to the sale and distribution of Registrable Securities,
including, without limitation, information with respect to the number of Registrable Securities being sold, the purchase price being
paid therefor and any other terms of the offering of the Registrable Securities; (ii) make all required filings of such prospectus supplement
or post-effective amendment as soon as practicable upon notification of the matters to be incorporated in such prospectus supplement
or post-effective amendment; and (iii) supplement or make amendments to any registration statement.
k.
The Company shall use its reasonable best efforts to cause the Registrable Securities covered by any registration statement to be registered
with or approved by such other governmental agencies or authorities as may be necessary to consummate the disposition of such Registrable
Securities.
l.
Within one (1) Business Day after any registration statement which includes the Registrable Securities is ordered effective by the SEC,
the Company shall deliver, and shall cause legal counsel for the Company to deliver, to the transfer agent for such Registrable Securities
(with copies to the Investor) confirmation that such registration statement has been declared effective by the SEC in the form attached
hereto as Exhibit A. Thereafter, if requested by the Investor at any time, the Company shall require its counsel to deliver to
the Investor a written confirmation whether or not the effectiveness of such registration statement has lapsed at any time for any reason
(including, without limitation, the issuance of a stop order) and whether or not the registration statement is current and available
to the Investor for sale of all of the Registrable Securities.
m.
The Company shall take all other reasonable actions necessary to expedite and facilitate disposition by the Investor of Registrable Securities
pursuant to any registration statement.
4.
OBLIGATIONS OF THE INVESTOR.
a.
The Company shall notify the Investor in writing of the information the Company reasonably requires from the Investor in connection with
any registration statement hereunder. The Investor shall furnish to the Company such information regarding itself, the Registrable Securities
held by it and the intended method of disposition of the Registrable Securities held by it as shall be reasonably required to effect
the registration of such Registrable Securities and shall execute such documents in connection with such registration as the Company
may reasonably request.
b.
The Investor agrees to cooperate with the Company as reasonably requested by the Company in connection with the preparation and filing
of any registration statement hereunder.
c.
The Investor agrees that, upon receipt of any notice from the Company of the happening of any event or existence of facts of the kind
described in Section 3(f) or the first sentence of 3(e), the Investor will immediately discontinue disposition of Registrable Securities
pursuant to any registration statement(s) covering such Registrable Securities until the Investor’s receipt of the copies of the
supplemented or amended prospectus contemplated by Section 3(f) or the first sentence of 3(e). Notwithstanding anything to the contrary,
the Company shall cause its transfer agent to promptly deliver shares of Common Stock without any restrictive legend in accordance with
the terms of the Purchase Agreement or the related agreements entered into therewith, as applicable, in connection with any sale of Registrable
Securities with respect to which an Investor has entered into a contract for sale prior to the Investor’s receipt of a notice from
the Company of the happening of any event of the kind described in Section 3(f) or the first sentence of Section 3(e) and for which the
Investor has not yet settled.
5.
EXPENSES OF REGISTRATION.
All
reasonable expenses, other than sales or brokerage commissions, incurred in connection with registrations, filings or qualifications
pursuant to Sections 2 and 3, including, without limitation, all registration, listing and qualifications fees, printers and accounting
fees, and fees and disbursements of counsel for the Company, shall be paid by the Company.
6.
INDEMNIFICATION.
a.
To the fullest extent permitted by law, the Company will, and hereby does, indemnify, hold harmless and defend the Investor, each Person,
if any, who controls the Investor, the members, the directors, officers, partners, employees, agents, representatives of the Investor
and each Person, if any, who controls the Investor within the meaning of the Securities Act or the Securities Exchange Act of 1934, as
amended (the “Exchange Act”) (each, an “Indemnified Person”), against any losses, claims, damages,
liabilities, judgments, fines, penalties, charges, costs, attorneys’ fees, amounts paid in settlement or expenses, joint or several,
(collectively, “Claims”) incurred in investigating, preparing or defending any action, claim, suit, inquiry, proceeding,
investigation or appeal taken from the foregoing by or before any court or governmental, administrative or other regulatory agency, body
or the SEC, whether pending or threatened, whether or not an indemnified party is or may be a party thereto (“Indemnified Damages”),
to which any of them may become subject insofar as such Claims (or actions or proceedings, whether commenced or threatened, in respect
thereof) arise out of or are based upon: (i) any untrue statement or alleged untrue statement of a material fact in the Registration
Statement, any New Registration Statement or any post-effective amendment thereto or in any filing made in connection with the qualification
of the offering under the securities or other “blue sky” laws of any jurisdiction in which Registrable Securities are offered
(“Blue Sky Filing”), or the omission or alleged omission to state a material fact required to be stated therein or
necessary to make the statements therein not misleading, (ii) any untrue statement or alleged untrue statement of a material fact contained
in the final prospectus (as amended or supplemented, if the Company files any amendment thereof or supplement thereto with the SEC) or
the omission or alleged omission to state therein any material fact necessary to make the statements made therein, in light of the circumstances
under which the statements therein were made, not misleading, (iii) any violation or alleged violation by the Company of the Securities
Act, the Exchange Act, any other law, including, without limitation, any state securities law, or any rule or regulation thereunder relating
to the offer or sale of the Registrable Securities pursuant to the Registration Statement or any New Registration Statement or (iv) any
material violation by the Company of this Agreement (the matters in the foregoing clauses (i) through (iv) being, collectively, “Violations”).
The Company shall reimburse each Indemnified Person promptly as such expenses are incurred and are due and payable, for any reasonable
legal fees or other reasonable expenses incurred by them in connection with investigating or defending any such Claim. Notwithstanding
anything to the contrary contained herein, the indemnification agreement contained in this Section 6(a): (i) shall not apply to a Claim
by an Indemnified Person arising out of or based upon a Violation which occurs in reliance upon and in conformity with information about
the Investor furnished in writing to the Company by such Indemnified Person expressly for use in connection with the preparation of the
Registration Statement, any New Registration Statement or any such amendment thereof or supplement thereto, if such prospectus was timely
made available by the Company pursuant to Section 3(c) or Section 3(e); (ii) with respect to any superseded prospectus, shall not inure
to the benefit of any such person from whom the person asserting any such Claim purchased the Registrable Securities that are the subject
thereof (or to the benefit of any person controlling such person) if the untrue statement or omission of material fact contained in the
superseded prospectus was corrected in the revised prospectus, as then amended or supplemented, if such revised prospectus was timely
made available by the Company pursuant to Section 3(c) or Section 3(e), and the Indemnified Person was promptly advised in writing not
to use the incorrect prospectus prior to the use giving rise to a violation and such Indemnified Person, notwithstanding such advice,
used it; (iii) shall not be available to the extent such Claim is based on a failure of the Investor to deliver or to cause to be delivered
the prospectus made available by the Company, if such prospectus was timely made available by the Company pursuant to Section 3(c) or
Section 3(e); and (iv) shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written
consent of the Company, which consent shall not be unreasonably withheld. Such indemnity shall remain in full force and effect regardless
of any investigation made by or on behalf of the Indemnified Person and shall survive the transfer of the Registrable Securities by the
Investor pursuant to Section 9.
b.
Promptly after receipt by an Indemnified Person or Indemnified Party under this Section 6 of notice of the commencement of any action
or proceeding (including any governmental action or proceeding) involving a Claim, such Indemnified Person or Indemnified Party shall,
if a Claim in respect thereof is to be made against any indemnifying party under this Section 6, deliver to the indemnifying party a
written notice of the commencement thereof, and the indemnifying party shall have the right to participate in, and, to the extent the
indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume control of the defense thereof
with counsel mutually satisfactory to the indemnifying party and the Indemnified Person or the Indemnified Party, as the case may be;
provided, however, that an Indemnified Person or Indemnified Party shall have the right to retain its own counsel with the fees and expenses
to be paid by the indemnifying party, if, in the reasonable opinion of counsel retained by the indemnifying party, the representation
by such counsel of the Indemnified Person or Indemnified Party and the indemnifying party would be inappropriate due to actual or potential
differing interests between such Indemnified Person or Indemnified Party and any other party represented by such counsel in such proceeding.
The Indemnified Party or Indemnified Person shall cooperate fully with the indemnifying party in connection with any negotiation or defense
of any such action or claim by the indemnifying party and shall furnish to the indemnifying party all information reasonably available
to the Indemnified Party or Indemnified Person which relates to such action or claim. The indemnifying party shall keep the Indemnified
Party or Indemnified Person fully apprised at all times as to the status of the defense or any settlement negotiations with respect thereto.
No indemnifying party shall be liable for any settlement of any action, claim or proceeding effected without its written consent, provided,
however, that the indemnifying party shall not unreasonably withhold, delay or condition its consent. No indemnifying party shall, without
the consent of the Indemnified Party or Indemnified Person, consent to entry of any judgment or enter into any settlement or other compromise
which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party or Indemnified
Person of a release from all liability in respect to such claim or litigation. Following indemnification as provided for hereunder, the
indemnifying party shall be subrogated to all rights of the Indemnified Party or Indemnified Person with respect to all third parties,
firms or corporations relating to the matter for which indemnification has been made. The failure to deliver written notice to the indemnifying
party within a reasonable time of the commencement of any such action shall not relieve such indemnifying party of any liability to the
Indemnified Person or Indemnified Party under this Section 6, except to the extent that the indemnifying party is prejudiced in its ability
to defend such action.
c.
The indemnification required by this Section 6 shall be made by periodic payments of the amount thereof during the course of the investigation
or defense, as and when bills are received or Indemnified Damages are incurred.
d.
The indemnity agreements contained herein shall be in addition to (i) any cause of action or similar right of the Indemnified Party or
Indemnified Person against the indemnifying party or others, and (ii) any liabilities the indemnifying party may be subject to pursuant
to the law.
7.
CONTRIBUTION.
To
the extent any indemnification by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum
contribution with respect to any amounts for which it would otherwise be liable under Section 6 to the fullest extent permitted by law;
provided, however, that: (i) no seller of Registrable Securities guilty of fraudulent misrepresentation (within the meaning of Section
11(f) of the Securities Act) shall be entitled to contribution from any seller of Registrable Securities who was not guilty of fraudulent
misrepresentation; and (ii) contribution by any seller of Registrable Securities shall be limited in amount to the net amount of proceeds
received by such seller from the sale of such Registrable Securities.
8.
REPORTS AND DISCLOSURE UNDER THE SECURITIES ACTS.
With
a view to making available to the Investor the benefits of Rule 144 promulgated under the Securities Act or any other similar rule or
regulation of the SEC that may at any time permit the Investor to sell securities of the Company to the public without registration (“Rule
144”), the Company agrees, at the Company’s sole expense, to:
a.
make and keep public information available, as those terms are understood and defined in Rule 144;
b.
file with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange
Act so long as the Company remains subject to such requirements and the filing of such reports and other documents is required for the
applicable provisions of Rule 144;
c.
furnish to the Investor so long as the Investor owns Registrable Securities, promptly upon request, (i) a written statement by the Company
that it has complied with the reporting and or disclosure provisions of Rule 144, the Securities Act and the Exchange Act, (ii) a copy
of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company, and (iii)
such other information as may be reasonably requested to permit the Investor to sell such securities pursuant to Rule 144 without registration;
and
d.
take such additional action as is requested by the Investor to enable the Investor to sell the Registrable Securities pursuant to Rule
144, including, without limitation, delivering all such legal opinions, consents, certificates, resolutions and instructions to the Company’s
Transfer Agent as may be requested from time to time by the Investor and otherwise fully cooperate with Investor and Investor’s
broker to effect such sale of securities pursuant to Rule 144.
The
Company agrees that damages may be an inadequate remedy for any breach of the terms and provisions of this Section 8 and that Investor
shall, whether or not it is pursuing any remedies at law, be entitled to equitable relief in the form of a preliminary or permanent injunctions,
without having to post any bond or other security, upon any breach or threatened breach of any such terms or provisions.
9.
ASSIGNMENT OF REGISTRATION RIGHTS.
The
Company shall not assign this Agreement or any rights or obligations hereunder without the prior written consent of the Investor.
10.
AMENDMENT OF REGISTRATION RIGHTS.
No
provision of this Agreement may be amended or waived by the parties from and after the date that is one Business Day immediately preceding
the initial filing of the Registration Statement with the SEC. Subject to the immediately preceding sentence, no provision of this Agreement
may be (i) amended other than by a written instrument signed by both parties hereto or (ii) waived other than in a written instrument
signed by the party against whom enforcement of such waiver is sought. Failure of any party to exercise any right or remedy under this
Agreement or otherwise, or delay by a party in exercising such right or remedy, shall not operate as a waiver thereof.
11.
MISCELLANEOUS.
a.
A Person is deemed to be a holder of Registrable Securities whenever such Person owns or is deemed to own of record such Registrable
Securities. If the Company receives conflicting instructions, notices or elections from two or more Persons with respect to the same
Registrable Securities, the Company shall act upon the basis of instructions, notice or election received from the registered owner of
such Registrable Securities.
b.
Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must be in
writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by email
(provided confirmation of transmission is mechanically or electronically generated and kept on file by the sending party); or (iii) one
(1) Business Day after deposit with a nationally recognized overnight delivery service, in each case properly addressed to the party
to receive the same. The addresses for such communications shall be:
If
to the Company, to:
CAN
B̅ CORP.
960
South Broadway, Suite 120
Hicksville,
NY 11801
Email:
info@canbiola.com
Attention:
Marco Alfonsi
If
to the Investor:
As
provided on the signature page hereto
or
at such other address and/or to the attention of such other person as the recipient party has specified by written notice given to each
other party three (3) Business Days prior to the effectiveness of such change. Written confirmation of receipt (A) given by the recipient
of such notice, consent, waiver or other communication, (B) mechanically or electronically generated by the sender’s email account
containing the time, date, recipient email address, as applicable, and an image of the first page of such transmission or (C) provided
by a nationally recognized overnight delivery service, shall be rebuttable evidence of personal service, receipt by, or receipt from
a nationally recognized overnight delivery service in accordance with clause (i), (ii) or (iii) above, respectively.
c.
The corporate laws of the State of Delaware shall govern all issues concerning this Agreement. All other questions concerning the construction,
validity, enforcement and interpretation of this Agreement shall be governed by the internal laws of the State of Delaware, without giving
effect to any choice of law or conflict of law provision or rule (whether of the State of Delaware or any other jurisdictions) that would
cause the application of the laws of any jurisdictions other than the State of Delaware. Each party hereby irrevocably submits to the
exclusive jurisdiction of the Court of Chancery of the State of Delaware or, to the extent such court does not have subject matter jurisdiction,
the United States District Court for the District of Delaware or, to the extent that neither of the foregoing courts has jurisdiction,
the Superior Court of the State of Delaware, for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any
claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an
inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service
of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the
address for such notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process
and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by
law. If any provision of this Agreement shall be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability shall
not affect the validity or enforceability of the remainder of this Agreement in that jurisdiction or the validity or enforceability of
any provision of this Agreement in any other jurisdiction.
d.
The Agreement, Purchase Agreement, Initial Note, Consolidated Amended and Restated Walleye Note and ancillary documentation entered into
between the Company and Investor therewith constitute the entire agreement among the parties hereto with respect to the subject matter
hereof and thereof. There are no restrictions, promises, warranties or undertakings, other than those set forth or referred to herein
and therein. The Agreement, Purchase Agreement, Initial Note, Consolidated Amended and Restated Walleye Note and ancillary documentation
entered into between the Company and Investor therewith supersede all prior agreements and understandings among the parties hereto with
respect to the subject matter hereof and thereof.
e.
Subject to the requirements of Section 9, this Agreement shall inure to the benefit of and be binding upon the successors and permitted
assigns of each of the parties hereto.
f.
The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof.
g.
This Agreement may be executed in identical counterparts, each of which shall be deemed an original but all of which shall constitute
one and the same agreement. This Agreement, once executed by a party, may be delivered to the other party hereto by e-mail in a “.pdf”
format data file of a copy of this Agreement bearing the signature of the party so delivering this Agreement.
h.
Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all
such other agreements, certificates, instruments and documents, as the other party may reasonably request in order to carry out the intent
and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.
i.
The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules
of strict construction will be applied against any party.
j.
This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns, and is not for
the benefit of, nor may any provision hereof be enforced by, any other Person.
*
* * * * *
IN
WITNESS WHEREOF, the parties have caused this Agreement to be duly executed as of day and year first above written.
THE COMPANY: |
|
|
|
|
CAN B̅ CORP. |
|
|
|
|
By: |
/s/
Marco Alfonsi |
|
Name: |
MARCO ALFONSI |
|
Title:
|
CHIEF EXECUTIVE OFFICER |
|
INVESTOR: |
|
|
|
|
WALLEYE
OPPORTUNITIES MASTER FUND LTD |
|
|
|
|
By: |
/s/
William England |
|
Name:
|
William England |
|
Title: |
Chief Executive Officer of the Manager |
|
Address
for Notice: 2800 Niagara Lane North, Plymouth, MN 55447
E-mail
for Notice: legal@walleyecapital.com
[Signature
Page to Registration Rights Agreement]
EXHIBIT
A
TO
REGISTRATION RIGHTS AGREEMENT
FORM
OF NOTICE OF EFFECTIVENESS
OF
REGISTRATION STATEMENT
______________,
2023
________________
________________
________________
Re:
Effectiveness of Registration Statement
Ladies
and Gentlemen:
We
are counsel to CAN B̅ CORP., a Florida corporation (the “Company”), and have represented the Company in connection
with that certain Securities Purchase Agreement, dated as of October 26, 2023 (the “Purchase Agreement”), entered
into by and between the Company and Walleye Opportunities Master Fund Ltd, a Cayman Islands company (the “Investor”)
pursuant to which the Company has agreed to issue to the Investor certain shares of common stock of the Company, nil par value per share,
in accordance with the terms of the Purchase Agreement and the related documents referenced below. In connection with the transactions
contemplated by the Purchase Agreement, the Company has registered with the U.S. Securities & Exchange Commission the following shares
of Common Stock:
| (1) | ___________
Conversion Shares (as defined in the Purchase Agreement) issued and/or to be issued to the
Investor upon the conversion of the Initial Note (as defined in the Purchase Agreement) in
accordance with the Initial Note. |
| | |
| (2) | ___________
Conversion Shares issued and/or to be issued to the Investor upon the conversion of the Consolidated
Amended and Restated Walleye Note (as defined in the Purchase Agreement) in accordance with
the Consolidated Amended and Restated Walleye Note. |
Pursuant
to the Purchase Agreement, the Company also has entered into a Registration Rights Agreement, dated as of the initial Closing Date (under
and as defined in the Purchase Agreement) with the Investor (the “Registration Rights Agreement”) pursuant to which
the Company agreed, among other things, to register the Registrable Securities (as defined in the Registration Rights Agreement) under
the Securities Act of 1933, as amended (the “Securities Act”). In connection with the Company’s obligations
under the Purchase Agreement and the Registration Rights Agreement, on [_____], 2023, the Company filed a Registration Statement (File
No. 333-[_________]) (the “Registration Statement”) with the Securities and Exchange Commission (the “SEC”)
relating to the resale of the Registrable Securities.
In
connection with the foregoing, we advise you that a member of the SEC’s staff has advised us by telephone that the SEC has entered
an order declaring the Registration Statement effective under the Securities Act at [_____] [A.M./P.M.] on [__________], 2023 and we
have no knowledge, after telephonic inquiry of a member of the SEC’s staff, that any stop order suspending its effectiveness has
been issued or that any proceedings for that purpose are pending before, or threatened by, the SEC and the Registrable Securities are
available for resale under the Securities Act pursuant to the Registration Statement and may be issued without any restrictive legend.
|
Very truly yours, |
|
[Company Counsel] |
|
|
|
|
|
|
|
By: |
|
|
|
|
cc: |
Walleye Opportunities Master Fund Ltd |
|
|
v3.23.3
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 2 such as Street or Suite number
+ References
+ Details
Name: |
dei_EntityAddressAddressLine2 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
CAN B (QB) (USOTC:CANB)
Historical Stock Chart
From Apr 2024 to May 2024
CAN B (QB) (USOTC:CANB)
Historical Stock Chart
From May 2023 to May 2024